,Metabolite,Sensor,Metabolite.Pathway,Sensor.Pathway,Metabolite.Names,Long.Range.Channel
0,HMDB0000012,SLC29A2,Pyrimidine metabolism,,Deoxyuridine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1,HMDB0000014,SLC29A2,Pyrimidine metabolism,,Deoxycytidine,"Blood,Feces,Urine"
2,HMDB0000016,NR0B2,Steroidogenesis,WP138: Androgen receptor signaling pathway; WP2879: Farnesoid X receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway,Deoxycorticosterone,"Amniotic Fluid,Blood"
3,HMDB0000016,NR3C2,Steroidogenesis,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Deoxycorticosterone,"Amniotic Fluid,Blood"
4,HMDB0000022,TAAR1,Tyrosine metabolism,WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,3-Methoxytyramine,"Blood,Cerebrospinal Fluid (CSF),Urine"
5,HMDB0000030,SLC5A6,"Alanine, aspartate and glutamate metabolism; Biotin metabolism; Citric acid cycle; Glutamate metabolism; Glycolysis_gluconeogenesis; Nitrogen metabolism; Propanoate metabolism; Pyruvate metabolism; Valine, leucine and isoleucine degradation",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,Biotin,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
6,HMDB0000030,EPHA2,"Alanine, aspartate and glutamate metabolism; Biotin metabolism; Citric acid cycle; Glutamate metabolism; Glycolysis_gluconeogenesis; Nitrogen metabolism; Propanoate metabolism; Pyruvate metabolism; Valine, leucine and isoleucine degradation",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Biotin,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
7,HMDB0000031,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Androsterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
8,HMDB0000034,SLC29A2,Purine metabolism,,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
9,HMDB0000034,SLC35F5,Purine metabolism,,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
10,HMDB0000034,SLC28A3,Purine metabolism,,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
11,HMDB0000034,SLC29A3,Purine metabolism,,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
12,HMDB0000034,RET,Purine metabolism,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
13,HMDB0000034,ACVR2B,Purine metabolism,WP2857: Mesodermal commitment pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP5316: Primary ovarian insufficiency,Adenine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
14,HMDB0000037,NR3C2,Steroidogenesis,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Aldosterone,"Blood,Saliva,Urine"
15,HMDB0000042,MECR,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,WP357: Fatty acid biosynthesis; WP4317: Mitochondrial fatty acid synthesis pathway,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
16,HMDB0000042,NCR3LG1,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,WP5092: Interactions of natural killer cells in pancreatic cancer,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
17,HMDB0000042,RTN4R,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,WP2431: Spinal cord injury; WP4657: 22q11.2 copy number variation syndrome; WP5366: NF1 copy number variation syndrome ; WP5406: 13q12.12 copy number variation,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
18,HMDB0000042,TRBC2,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
19,HMDB0000042,FLT1,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
20,HMDB0000042,NCOA2,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
21,HMDB0000042,PTH1R,Amino sugar metabolism; Aspartate metabolism; Pyruvate metabolism,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Acetic acid,"Blood,Breast Milk,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
22,HMDB0000043,SLC6A12,"Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Methionine metabolism",,Betaine,"Blood,Breast Milk,Feces,Saliva,Urine"
23,HMDB0000045,ADORA1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Aspartate metabolism; Butyrate metabolism; Cysteine metabolism; Fatty acid metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Propanoate metabolism; Purine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Thiamine metabolism; Urea cycle","WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine monophosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
24,HMDB0000045,EGFR,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Aspartate metabolism; Butyrate metabolism; Cysteine metabolism; Fatty acid metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Propanoate metabolism; Purine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Thiamine metabolism; Urea cycle","WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Adenosine monophosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
25,HMDB0000045,RET,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Aspartate metabolism; Butyrate metabolism; Cysteine metabolism; Fatty acid metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Propanoate metabolism; Purine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Thiamine metabolism; Urea cycle",WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Adenosine monophosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
26,HMDB0000050,ADORA3,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
27,HMDB0000050,SLC29A2,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism",,Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
28,HMDB0000050,ADORA2A,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism","WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
29,HMDB0000050,SLC29A1,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism",WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
30,HMDB0000050,ADORA2B,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP4963: p53 transcriptional gene network; WP80: Nucleotide GPCRs",Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
31,HMDB0000050,RET,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism",WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
32,HMDB0000050,ADORA1,"Glycine, serine and threonine metabolism; Methionine metabolism; Purine metabolism; Selenocompound metabolism","WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
33,HMDB0000051,CALCRL,"Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; D-arginine and d-ornithine metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Purine metabolism; Pyrimidine metabolism; Selenocompound metabolism; Tyrosine metabolism; Urea cycle; Vitamin b6 metabolism","WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Ammonia,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Urine"
34,HMDB0000053,AR,Androgen and estrogen metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Androstenedione,"Blood,Cerebrospinal Fluid (CSF),Urine"
35,HMDB0000056,MRGPRD,Aspartate metabolism; Beta-alanine metabolism; Histidine metabolism; Propanoate metabolism; Pyrimidine metabolism,,beta-Alanine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
36,HMDB0000062,SLC22A5,Biosynthesis of unsaturated fatty acids; Fatty acid metabolism,WP5123: Mitochondrial fatty acid oxidation disorders,L-Carnitine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
37,HMDB0000063,NR3C1,Steroidogenesis,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Cortisol,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
38,HMDB0000064,SLC16A12,"Arginine and proline metabolism; Glycine, serine and threonine metabolism",,Creatine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
39,HMDB0000067,GRPR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
40,HMDB0000067,CHRNA7,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
41,HMDB0000067,ADRA2C,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
42,HMDB0000067,GABBR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP4159: GABA receptor signaling; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
43,HMDB0000067,EDNRB,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2197: Endothelin pathways; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
44,HMDB0000067,SLC1A2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP2447: Amyotrophic lateral sclerosis (ALS); WP5083: Neuroinflammation and glutamatergic signaling; WP5094: Orexin receptor pathway; WP5314: Lactate shuttle in glial cells; WP5417: Cell lineage map for neuronal differentiation,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
45,HMDB0000067,PTH1R,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
46,HMDB0000067,SLC6A4,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
47,HMDB0000067,GHRHR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
48,HMDB0000067,ADGRG3,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
49,HMDB0000067,OPRK1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
50,HMDB0000067,P2RY12,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
51,HMDB0000067,CXCR3,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5284: Cell interactions of the pancreatic cancer microenvironment",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
52,HMDB0000067,CASR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP501: GPCRs, class C metabotropic glutamate, pheromone",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
53,HMDB0000067,ABCG2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
54,HMDB0000067,MRGPRX2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP3591: Sleep regulation,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
55,HMDB0000067,LDLR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2846: PCSK9-mediated LDL receptor degradation; WP3408: Evolocumab mechanism to reduce LDL cholesterol; WP3601: Lipid particles composition; WP399: Wnt signaling pathway and pluripotency; WP430: Statin inhibition of cholesterol production; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4904: LDLRAD4 and what we know about it; WP5108: Familial  hyperlipidemia type 1; WP5109: Familial hyperlipidemia type 2; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5220: Metabolic reprogramming in pancreatic cancer; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5409: PAFAH1B1 copy number variation; WP710: DNA damage response (only ATM dependent)",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
56,HMDB0000067,DRD1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP5231: Hippocampal synaptogenesis and neurogenesis; WP58: Monoamine GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
57,HMDB0000067,TRPV2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
58,HMDB0000067,GABBR2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
59,HMDB0000067,GLP1R,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP334: GPCRs, class B secretin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
60,HMDB0000067,GRM2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
61,HMDB0000067,OPRM1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
62,HMDB0000067,GALR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
63,HMDB0000067,BDKRB2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4969: RAS and bradykinin pathways in COVID-19; WP5089: Kinin-Kallikrein pathway; WP51: Regulation of actin cytoskeleton; WP5360: KCNQ2-related epilepsies; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
64,HMDB0000067,C3AR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP455: GPCRs, class A rhodopsin-like; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
65,HMDB0000067,GRM1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP2636: Common pathways underlying drug addiction; WP3853: ERK pathway in Huntington's disease; WP3947: Serotonin and anxiety; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4875: Disruption of postsynaptic signaling by CNV; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
66,HMDB0000067,P2RY1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5360: KCNQ2-related epilepsies; WP80: Nucleotide GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
67,HMDB0000067,RORC,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
68,HMDB0000067,HTR2B,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
69,HMDB0000067,ACKR3,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP289: Myometrial relaxation and contraction pathways; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP5224: 2q37 copy number variation syndrome",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
70,HMDB0000067,VIPR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP334: GPCRs, class B secretin-like; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
71,HMDB0000067,GRM3,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
72,HMDB0000067,OXTR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP2889: Oxytocin signaling; WP289: Myometrial relaxation and contraction pathways; WP3591: Sleep regulation; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
73,HMDB0000067,CD247,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP5362: TAR syndrome; WP69: T-cell receptor signaling pathway,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
74,HMDB0000067,MTNR1A,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
75,HMDB0000067,ADRB2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
76,HMDB0000067,AGTR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2328: Allograft rejection; WP24: Peptide GPCRs; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4883: SARS-CoV-2 and ACE2 receptor: molecular mechanisms; WP4969: RAS and bradykinin pathways in COVID-19; WP5036: Angiotensin II receptor type 1 pathway; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5076: Soluble ACE2-mediated cell entry of SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5158: Urotensin-II-mediated signaling pathway; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5360: KCNQ2-related epilepsies; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
77,HMDB0000067,TBXA2R,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
78,HMDB0000067,CNR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
79,HMDB0000067,SCARB1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4846: SARS-CoV-2 and COVID-19 pathway; WP5110: Familial hyperlipidemia type 3; WP5238: Cholestasis; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP716: Vitamin A and carotenoid metabolism",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
80,HMDB0000067,CRHR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
81,HMDB0000067,NPC1L1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
82,HMDB0000067,OPRD1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
83,HMDB0000067,GPR35,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP455: GPCRs, class A rhodopsin-like; WP5224: 2q37 copy number variation syndrome",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
84,HMDB0000067,CMKLR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP455: GPCRs, class A rhodopsin-like; WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
85,HMDB0000067,ADORA2A,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
86,HMDB0000067,GIPR,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP334: GPCRs, class B secretin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
87,HMDB0000067,SLC7A5,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
88,HMDB0000067,CCR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
89,HMDB0000067,GALR2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
90,HMDB0000067,ABCB1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
91,HMDB0000067,GPR161,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP4249: Hedgehog signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4803: Ciliopathies; WP5202: Alstrom syndrome; WP5234: Bardet-Biedl syndrome",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
92,HMDB0000067,HTR2A,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
93,HMDB0000067,CD3D,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5130: Th17 cell differentiation pathway; WP5362: TAR syndrome; WP69: T-cell receptor signaling pathway,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
94,HMDB0000067,HTR2C,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
95,HMDB0000067,FPR2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
96,HMDB0000067,CYSLTR2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP3624: Lung fibrosis; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX)",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
97,HMDB0000067,RORA,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP170: Nuclear receptors; WP236: Adipogenesis; WP3594: Circadian rhythm genes; WP3893: Development and heterogeneity of the ILC family; WP4149: White fat cell differentiation; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
98,HMDB0000067,CD36,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP2586: Aryl hydrocarbon receptor pathway; WP3942: PPAR signaling pathway; WP4823: Genes controlling nephrogenesis; WP5061: Fatty acid transporters; WP5181: Roles of ceramides in development of insulin resistance; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
99,HMDB0000067,PKD2,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP2571: Polycystic kidney disease pathway; WP4803: Ciliopathies; WP5234: Bardet-Biedl syndrome,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
100,HMDB0000067,SLC44A1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP5219: Diet-dependent trimethylamine/trimethylamine N-oxide metabolism ,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
101,HMDB0000067,ABCG1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP299: Nuclear receptors in lipid metabolism and toxicity; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
102,HMDB0000067,GPR158,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
103,HMDB0000067,RORB,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,WP3594: Circadian rhythm genes; WP5205: Clock-controlled autophagy in bone metabolism,Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
104,HMDB0000067,CCR9,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
105,HMDB0000067,FPR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP2806: Complement system; WP455: GPCRs, class A rhodopsin-like",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
106,HMDB0000067,ABCA1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
107,HMDB0000067,HCRTR1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
108,HMDB0000067,ADRB1,Primary bile acid biosynthesis; Steroid biosynthesis; Steroidogenesis,"WP2197: Endothelin pathways; WP3298: Melatonin metabolism and effects; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Cholesterol,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
109,HMDB0000068,ADRB3,Tyrosine metabolism; Tyrosine metabolism,"WP4321: Thermogenesis; WP455: GPCRs, class A rhodopsin-like; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
110,HMDB0000068,ADRA2B,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5221: 2q11.2 copy number variation syndrome; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
111,HMDB0000068,ADRB2,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
112,HMDB0000068,ADRA2C,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
113,HMDB0000068,ADRA2A,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
114,HMDB0000068,ADRA1A,Tyrosine metabolism; Tyrosine metabolism,"WP1403: AMP-activated protein kinase signaling; WP2197: Endothelin pathways; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
115,HMDB0000068,ADRA1B,Tyrosine metabolism; Tyrosine metabolism,"WP1403: AMP-activated protein kinase signaling; WP2877: Vitamin D receptor pathway; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
116,HMDB0000068,ADRB1,Tyrosine metabolism; Tyrosine metabolism,"WP2197: Endothelin pathways; WP3298: Melatonin metabolism and effects; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
117,HMDB0000068,ADRA1D,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Epinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
118,HMDB0000071,SLC29A2,Purine metabolism,,Deoxyinosine,"Blood,Feces,Saliva,Urine"
119,HMDB0000073,SLC6A3,Tyrosine metabolism; Tyrosine metabolism,WP2371: Parkinson's disease pathway; WP2855: Dopaminergic neurogenesis; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4220: Neurotransmitter disorders; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
120,HMDB0000073,SLC22A3,Tyrosine metabolism; Tyrosine metabolism,WP2267: Synaptic vesicle pathway,Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
121,HMDB0000073,DRD5,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
122,HMDB0000073,DRD4,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
123,HMDB0000073,DRD3,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
124,HMDB0000073,SLC22A2,Tyrosine metabolism; Tyrosine metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
125,HMDB0000073,DRD2,Tyrosine metabolism; Tyrosine metabolism,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
126,HMDB0000073,DRD1,Tyrosine metabolism; Tyrosine metabolism,"WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP5231: Hippocampal synaptogenesis and neurogenesis; WP58: Monoamine GPCRs",Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
127,HMDB0000073,TRPV1,Tyrosine metabolism; Tyrosine metabolism,WP3947: Serotonin and anxiety; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
128,HMDB0000073,SLC22A5,Tyrosine metabolism; Tyrosine metabolism,WP5123: Mitochondrial fatty acid oxidation disorders,Dopamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
129,HMDB0000077,AR,Androgen and estrogen metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Dehydroepiandrosterone,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
130,HMDB0000085,SLC29A2,Purine metabolism,,Deoxyguanosine,"Blood,Feces,Saliva,Urine"
131,HMDB0000089,SLC29A1,Pyrimidine metabolism,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Cytidine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
132,HMDB0000089,SLC29A2,Pyrimidine metabolism,,Cytidine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
133,HMDB0000094,CYTH3,Citric acid cycle,WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
134,HMDB0000094,PILRA,Citric acid cycle,,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
135,HMDB0000094,TACR1,Citric acid cycle,WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
136,HMDB0000094,EDNRB,Citric acid cycle,"WP2197: Endothelin pathways; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
137,HMDB0000094,FCER1A,Citric acid cycle,WP2865: IL1 and megakaryocytes in obesity,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
138,HMDB0000094,ADRB1,Citric acid cycle,"WP2197: Endothelin pathways; WP3298: Melatonin metabolism and effects; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
139,HMDB0000094,ANTXR2,Citric acid cycle,,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
140,HMDB0000094,NECTIN1,Citric acid cycle,,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
141,HMDB0000094,SLC13A5,Citric acid cycle,,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
142,HMDB0000094,MFSD10,Citric acid cycle,,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
143,HMDB0000094,OPRK1,Citric acid cycle,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
144,HMDB0000094,EGFR,Citric acid cycle,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
145,HMDB0000094,ALK,Citric acid cycle,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
146,HMDB0000094,C5AR1,Citric acid cycle,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
147,HMDB0000094,HCRTR1,Citric acid cycle,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
148,HMDB0000094,PPARG,Citric acid cycle,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
149,HMDB0000094,ADORA2A,Citric acid cycle,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Citric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
150,HMDB0000097,SLC1A1,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
151,HMDB0000097,SLC44A2,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
152,HMDB0000097,SLC22A2,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
153,HMDB0000097,SLC44A1,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP5219: Diet-dependent trimethylamine/trimethylamine N-oxide metabolism ,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
154,HMDB0000097,SLC22A5,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP5123: Mitochondrial fatty acid oxidation disorders,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
155,HMDB0000097,SLC44A3,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
156,HMDB0000097,SLC22A1,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
157,HMDB0000097,SLC5A7,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP727: Monoamine transport,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
158,HMDB0000097,SLC44A4,"Glycine, serine and threonine metabolism; Methionine metabolism; Phospholipid biosynthesis",,Choline,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
159,HMDB0000101,SLC29A2,Purine metabolism,,Deoxyadenosine,"Blood,Feces,Urine"
160,HMDB0000108,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Ethanol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
161,HMDB0000108,CHRNA5,,WP1602: Nicotine effect on dopaminergic neurons,Ethanol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
162,HMDB0000112,SLC6A11,Glutamate metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
163,HMDB0000112,GABRD,Glutamate metabolism,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5345: 1p36 copy number variation syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
164,HMDB0000112,GABRR1,Glutamate metabolism,WP3998: Prader-Willi and Angelman syndrome,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
165,HMDB0000112,GABRA4,Glutamate metabolism,WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
166,HMDB0000112,GABRB3,Glutamate metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
167,HMDB0000112,SLC6A8,Glutamate metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5190: Creatine pathway,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
168,HMDB0000112,SLC6A13,Glutamate metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
169,HMDB0000112,GABBR2,Glutamate metabolism,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
170,HMDB0000112,SLC6A12,Glutamate metabolism,,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
171,HMDB0000112,GABBR1,Glutamate metabolism,"WP4159: GABA receptor signaling; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
172,HMDB0000112,GRID1,Glutamate metabolism,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
173,HMDB0000112,GABRG2,Glutamate metabolism,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
174,HMDB0000112,SLC6A6,Glutamate metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5313: Carnosine metabolism of glial cells,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
175,HMDB0000112,GABRB2,Glutamate metabolism,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
176,HMDB0000112,GABRA1,Glutamate metabolism,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
177,HMDB0000112,SLC6A1,Glutamate metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,gamma-Aminobutyric acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
178,HMDB0000115,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Glycolic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
179,HMDB0000121,FOLR2,One carbon pool by folate; Pterine biosynthesis,WP176: Folate metabolism; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Folic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Urine"
180,HMDB0000121,FOLR1,One carbon pool by folate; Pterine biosynthesis,WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Folic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Urine"
181,HMDB0000121,SLC19A1,One carbon pool by folate; Pterine biosynthesis,WP176: Folate metabolism; WP3996: Ethanol effects on histone modifications; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Folic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Urine"
182,HMDB0000122,SLC2A2,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5446: GLP-1 secretion from intestine to portal vein,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
183,HMDB0000122,SLC2A1,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
184,HMDB0000122,TRPV4,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
185,HMDB0000122,SLC2A8,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
186,HMDB0000122,SLC2A6,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
187,HMDB0000122,SLC2A10,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
188,HMDB0000122,SLC2A12,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
189,HMDB0000122,CHRM2,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,"WP117: GPCRs, other; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
190,HMDB0000122,SLC2A7,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
191,HMDB0000122,SLC2A9,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
192,HMDB0000122,SLC2A4,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP1403: AMP-activated protein kinase signaling; WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP236: Adipogenesis; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4030: SCFA and skeletal muscle substrate metabolism; WP4657: 22q11.2 copy number variation syndrome; WP481: Insulin signaling; WP4844: Influence of laminopathies on Wnt signaling; WP4970: Galanin receptor pathway; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5094: Orexin receptor pathway; WP5181: Roles of ceramides in development of insulin resistance; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP534: Glycolysis and gluconeogenesis; WP5346: 8p23.1 copy number variation syndrome; WP5355: Metabolic Epileptic Disorders,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
193,HMDB0000122,SLC2A3,Galactose metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP5083: Neuroinflammation and glutamatergic signaling; WP5283: Chronic hyperglycemia impairment of neuron function; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,D-Glucose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
194,HMDB0000123,GLRB,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP5417: Cell lineage map for neuronal differentiation,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
195,HMDB0000123,SLC16A10,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
196,HMDB0000123,GLRA2,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP5417: Cell lineage map for neuronal differentiation,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
197,HMDB0000123,GRIN2D,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP2059: Alzheimer's disease and miRNA effects; WP3944: Serotonin and anxiety-related events; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
198,HMDB0000123,SLC36A1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
199,HMDB0000123,GRIN1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2431: Spinal cord injury; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3676: BDNF-TrkB signaling; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
200,HMDB0000123,GLRA1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP5417: Cell lineage map for neuronal differentiation,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
201,HMDB0000123,GRIN2A,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP2059: Alzheimer's disease and miRNA effects; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4685: Melanoma; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
202,HMDB0000123,GLRA3,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",WP5417: Cell lineage map for neuronal differentiation,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
203,HMDB0000123,LAIR1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism",,Glycine,"Bile,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
204,HMDB0000125,KLRK1,Arachidonic acid metabolism; Glutamate metabolism; Glutathione metabolism; Pyruvate metabolism,WP5092: Interactions of natural killer cells in pancreatic cancer,Glutathione,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
205,HMDB0000125,CD79B,Arachidonic acid metabolism; Glutamate metabolism; Glutathione metabolism; Pyruvate metabolism,WP23: B cell receptor signaling pathway,Glutathione,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
206,HMDB0000125,PPARG,Arachidonic acid metabolism; Glutamate metabolism; Glutathione metabolism; Pyruvate metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Glutathione,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
207,HMDB0000125,TREM1,Arachidonic acid metabolism; Glutamate metabolism; Glutathione metabolism; Pyruvate metabolism,WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP4478: LTF danger signal response pathway,Glutathione,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
208,HMDB0000125,ABCB6,Arachidonic acid metabolism; Glutamate metabolism; Glutathione metabolism; Pyruvate metabolism,,Glutathione,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
209,HMDB0000131,GRK2,Galactose metabolism; Glycerolipid metabolism,WP3929: Chemokine signaling pathway; WP4249: Hedgehog signaling pathway; WP47: Hedgehog signaling pathway; WP5426: HDAC6 interactions in the central nervous system,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
210,HMDB0000131,PTK2B,Galactose metabolism; Glycerolipid metabolism,WP205: IL-7 signaling pathway; WP2263: Androgen receptor network in prostate cancer; WP2374: Oncostatin M signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP313: Hepatocyte growth factor receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3929: Chemokine signaling pathway; WP437: EGF/EGFR signaling pathway; WP4666: Hepatitis B infection; WP4747: Netrin-UNC5B signaling pathway; WP49: IL-2 signaling pathway; WP5097: CCL18 signaling pathway; WP5399: NPHP1 deletion syndrome; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP69: T-cell receptor signaling pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
211,HMDB0000131,NCOA2,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
212,HMDB0000131,MCOLN2,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
213,HMDB0000131,PTPRN,Galactose metabolism; Glycerolipid metabolism,WP5380: 5q35 copy number variation,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
214,HMDB0000131,TGFBR1,Galactose metabolism; Glycerolipid metabolism,WP2795: Cardiac hypertrophic response; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP3646: Hepatitis C and hepatocellular carcinoma; WP366: TGF-beta signaling pathway; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP382: MAPK signaling pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3945: TYROBP causal network in microglia; WP400: p38 MAPK signaling pathway; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4263: Pancreatic adenocarcinoma pathway; WP4331: Neovascularization processes; WP4666: Hepatitis B infection; WP4816: TGF-beta receptor signaling in skeletal dysplasias; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4904: LDLRAD4 and what we know about it; WP5036: Angiotensin II receptor type 1 pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5382: TGFβ/Smad signaling pathway; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer; WP560: TGF-beta receptor signaling,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
215,HMDB0000131,TNFRSF11A,Galactose metabolism; Glycerolipid metabolism,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3594: Circadian rhythm genes; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP5187: mRNA vaccine activation of dendritic cell and induction of IFN-1; WP5205: Clock-controlled autophagy in bone metabolism,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
216,HMDB0000131,ANTXR2,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
217,HMDB0000131,CHRNA7,Galactose metabolism; Glycerolipid metabolism,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
218,HMDB0000131,RORC,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
219,HMDB0000131,FGFR2,Galactose metabolism; Glycerolipid metabolism,WP1539: Angiogenesis; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2795: Cardiac hypertrophic response; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2858: Ectoderm differentiation; WP382: MAPK signaling pathway; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4842: Mammalian disorder of sexual development; WP4872: MAP3K1 role in promoting and blocking gonadal determination; WP5053: Development of ureteric collection system; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
220,HMDB0000131,ADGRG1,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
221,HMDB0000131,TRAC,Galactose metabolism; Glycerolipid metabolism,WP5078: T cell modulation in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
222,HMDB0000131,NTRK2,Galactose metabolism; Glycerolipid metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP4565: Neural crest cell migration in cancer; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5087: Pleural mesothelioma; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5400: 6q16 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
223,HMDB0000131,MERTK,Galactose metabolism; Glycerolipid metabolism,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
224,HMDB0000131,RTN4R,Galactose metabolism; Glycerolipid metabolism,WP2431: Spinal cord injury; WP4657: 22q11.2 copy number variation syndrome; WP5366: NF1 copy number variation syndrome ; WP5406: 13q12.12 copy number variation,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
225,HMDB0000131,INSR,Galactose metabolism; Glycerolipid metabolism,WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
226,HMDB0000131,TRBC2,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
227,HMDB0000131,NTRK1,Galactose metabolism; Glycerolipid metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
228,HMDB0000131,TBL1XR1,Galactose metabolism; Glycerolipid metabolism,WP4312: Rett syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
229,HMDB0000131,PPARA,Galactose metabolism; Glycerolipid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
230,HMDB0000131,F2R,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP127: IL-5 signaling pathway; WP2038: Microtubule cytoskeleton regulation; WP286: IL-3 signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2865: IL1 and megakaryocytes in obesity; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP51: Regulation of actin cytoskeleton; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5300: TROP2 regulatory signaling; WP5434: Pathways in cancer; WP558: Complement and coagulation cascades",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
231,HMDB0000131,CD44,Galactose metabolism; Glycerolipid metabolism,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
232,HMDB0000131,KLRK1,Galactose metabolism; Glycerolipid metabolism,WP5092: Interactions of natural killer cells in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
233,HMDB0000131,TNFRSF14,Galactose metabolism; Glycerolipid metabolism,WP5345: 1p36 copy number variation syndrome; WP5362: TAR syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
234,HMDB0000131,CYTH3,Galactose metabolism; Glycerolipid metabolism,WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
235,HMDB0000131,TIRAP,Galactose metabolism; Glycerolipid metabolism,WP2324: AGE/RAGE pathway; WP3851: TLR4 signaling and tolerance; WP3858: Toll-like receptor signaling related to MyD88; WP4136: Fibrin complement receptor 3 signaling pathway; WP4666: Hepatitis B infection; WP75: Toll-like receptor signaling pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
236,HMDB0000131,ADGRB3,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
237,HMDB0000131,NPHS1,Galactose metabolism; Glycerolipid metabolism,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP4758: Nephrotic syndrome; WP4823: Genes controlling nephrogenesis; WP5236: Markers of kidney cell lineage,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
238,HMDB0000131,CD22,Galactose metabolism; Glycerolipid metabolism,WP23: B cell receptor signaling pathway; WP5078: T cell modulation in pancreatic cancer; WP5092: Interactions of natural killer cells in pancreatic cancer; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
239,HMDB0000131,AGER,Galactose metabolism; Glycerolipid metabolism,WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
240,HMDB0000131,GRIK1,Galactose metabolism; Glycerolipid metabolism,WP5083: Neuroinflammation and glutamatergic signaling,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
241,HMDB0000131,NR3C1,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
242,HMDB0000131,LAIR1,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
243,HMDB0000131,ESR1,Galactose metabolism; Glycerolipid metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
244,HMDB0000131,NCOA1,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
245,HMDB0000131,IZUMO1R,Galactose metabolism; Glycerolipid metabolism,WP176: Folate metabolism,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
246,HMDB0000131,EPHA8,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
247,HMDB0000131,LGR4,Galactose metabolism; Glycerolipid metabolism,WP3594: Circadian rhythm genes,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
248,HMDB0000131,GRM7,Galactose metabolism; Glycerolipid metabolism,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
249,HMDB0000131,CNR1,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
250,HMDB0000131,IL7R,Galactose metabolism; Glycerolipid metabolism,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
251,HMDB0000131,GRIN2A,Galactose metabolism; Glycerolipid metabolism,WP2059: Alzheimer's disease and miRNA effects; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4685: Melanoma; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
252,HMDB0000131,CRHR2,Galactose metabolism; Glycerolipid metabolism,"WP2355: Corticotropin-releasing hormone signaling pathway; WP334: GPCRs, class B secretin-like",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
253,HMDB0000131,NR4A1,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP382: MAPK signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP5142: Calcium mediated T-cell apoptosis involved in inclusion body myositis,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
254,HMDB0000131,NISCH,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
255,HMDB0000131,EPOR,Galactose metabolism; Glycerolipid metabolism,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
256,HMDB0000131,SELL,Galactose metabolism; Glycerolipid metabolism,WP2806: Complement system; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
257,HMDB0000131,CHRM1,Galactose metabolism; Glycerolipid metabolism,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
258,HMDB0000131,MTNR1A,Galactose metabolism; Glycerolipid metabolism,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
259,HMDB0000131,IL2RG,Galactose metabolism; Glycerolipid metabolism,WP205: IL-7 signaling pathway; WP22: IL-9 signaling pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP395: IL-4 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
260,HMDB0000131,PTPN4,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
261,HMDB0000131,RARA,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
262,HMDB0000131,TRBC1,Galactose metabolism; Glycerolipid metabolism,WP5078: T cell modulation in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
263,HMDB0000131,FCGR1A,Galactose metabolism; Glycerolipid metabolism,WP3937: Microglia pathogen phagocytosis pathway; WP5293: Acute myeloid leukemia,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
264,HMDB0000131,GRIA2,Galactose metabolism; Glycerolipid metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
265,HMDB0000131,TNFRSF9,Galactose metabolism; Glycerolipid metabolism,WP5078: T cell modulation in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
266,HMDB0000131,FCGR2C,Galactose metabolism; Glycerolipid metabolism,WP5346: 8p23.1 copy number variation syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
267,HMDB0000131,TFRC,Galactose metabolism; Glycerolipid metabolism,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
268,HMDB0000131,EPHA4,Galactose metabolism; Glycerolipid metabolism,WP2431: Spinal cord injury; WP2854: Gene regulatory network modeling somitogenesis ; WP4549: Fragile X syndrome; WP4785: Somitogenesis in the context of spondylocostal dysostosis,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
269,HMDB0000131,CXCR4,Galactose metabolism; Glycerolipid metabolism,"WP24: Peptide GPCRs; WP2406: Cardiac progenitor differentiation; WP2849: Hematopoietic stem cell differentiation; WP3678: Amplification and expansion of oncogenic pathways as metastatic traits; WP3929: Chemokine signaling pathway; WP4298: Acute viral myocarditis; WP4331: Neovascularization processes; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP4823: Genes controlling nephrogenesis; WP5055: Burn wound healing; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5224: 2q37 copy number variation syndrome; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5362: TAR syndrome; WP5380: 5q35 copy number variation; WP5422: IL-19 signaling pathway; WP5434: Pathways in cancer",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
270,HMDB0000131,RACK1,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP4630: Measles virus infection; WP5036: Angiotensin II receptor type 1 pathway; WP5300: TROP2 regulatory signaling; WP585: Interferon type I signaling pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
271,HMDB0000131,RORA,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP3594: Circadian rhythm genes; WP3893: Development and heterogeneity of the ILC family; WP4149: White fat cell differentiation; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
272,HMDB0000131,LRP6,Galactose metabolism; Glycerolipid metabolism,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
273,HMDB0000131,PGR,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
274,HMDB0000131,FGFR1,Galactose metabolism; Glycerolipid metabolism,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
275,HMDB0000131,CSF1R,Galactose metabolism; Glycerolipid metabolism,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
276,HMDB0000131,EGFR,Galactose metabolism; Glycerolipid metabolism,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
277,HMDB0000131,LDLR,Galactose metabolism; Glycerolipid metabolism,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2846: PCSK9-mediated LDL receptor degradation; WP3408: Evolocumab mechanism to reduce LDL cholesterol; WP3601: Lipid particles composition; WP399: Wnt signaling pathway and pluripotency; WP430: Statin inhibition of cholesterol production; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4904: LDLRAD4 and what we know about it; WP5108: Familial  hyperlipidemia type 1; WP5109: Familial hyperlipidemia type 2; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5220: Metabolic reprogramming in pancreatic cancer; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5409: PAFAH1B1 copy number variation; WP710: DNA damage response (only ATM dependent)",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
278,HMDB0000131,FCGR2A,Galactose metabolism; Glycerolipid metabolism,WP2431: Spinal cord injury; WP4961: STING pathway in Kawasaki-like disease and COVID-19; WP5346: 8p23.1 copy number variation syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
279,HMDB0000131,IGF1R,Galactose metabolism; Glycerolipid metabolism,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
280,HMDB0000131,ITGB7,Galactose metabolism; Glycerolipid metabolism,WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP306: Focal adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
281,HMDB0000131,TRAV12-3,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
282,HMDB0000131,SORT1,Galactose metabolism; Glycerolipid metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
283,HMDB0000131,NR0B2,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP2879: Farnesoid X receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
284,HMDB0000131,ALK,Galactose metabolism; Glycerolipid metabolism,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
285,HMDB0000131,ERBB2,Galactose metabolism; Glycerolipid metabolism,WP2034: Leptin signaling pathway; WP2037: Prolactin signaling pathway; WP2261: Glioblastoma signaling pathways; WP2571: Polycystic kidney disease pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3651: Pathways affected in adenoid cystic carcinoma; WP3680: Physico-chemical features and toxicity-associated pathways; WP4155: Endometrial cancer; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP437: EGF/EGFR signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5221: 2q11.2 copy number variation syndrome; WP5287: 17q12 copy number variation syndrome; WP5434: Pathways in cancer; WP673: ErbB signaling pathway; WP710: DNA damage response (only ATM dependent),Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
286,HMDB0000131,ITGAM,Galactose metabolism; Glycerolipid metabolism,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
287,HMDB0000131,NCOR1,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
288,HMDB0000131,NRP1,Galactose metabolism; Glycerolipid metabolism,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
289,HMDB0000131,TBXA2R,Galactose metabolism; Glycerolipid metabolism,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
290,HMDB0000131,DRD4,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
291,HMDB0000131,TRAV22,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
292,HMDB0000131,GRIN2B,Galactose metabolism; Glycerolipid metabolism,WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4754: IL-18 signaling pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
293,HMDB0000131,AQP3,Galactose metabolism; Glycerolipid metabolism,WP3527: Pre-implantation embryo; WP5085: Vasopressin-regulated water reabsorption,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
294,HMDB0000131,ADIPOR2,Galactose metabolism; Glycerolipid metabolism,WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
295,HMDB0000131,NR1I2,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
296,HMDB0000131,EPHA3,Galactose metabolism; Glycerolipid metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
297,HMDB0000131,PPARG,Galactose metabolism; Glycerolipid metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
298,HMDB0000131,AR,Galactose metabolism; Glycerolipid metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
299,HMDB0000131,HAVCR2,Galactose metabolism; Glycerolipid metabolism,WP4217: Ebola virus infection in host; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5078: T cell modulation in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
300,HMDB0000131,TGFBR2,Galactose metabolism; Glycerolipid metabolism,WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP366: TGF-beta signaling pathway; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP382: MAPK signaling pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4263: Pancreatic adenocarcinoma pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4666: Hepatitis B infection; WP4674: Head and neck squamous cell carcinoma; WP4816: TGF-beta receptor signaling in skeletal dysplasias; WP4904: LDLRAD4 and what we know about it; WP5036: Angiotensin II receptor type 1 pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5316: Primary ovarian insufficiency; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5382: TGFβ/Smad signaling pathway; WP5434: Pathways in cancer; WP560: TGF-beta receptor signaling,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
301,HMDB0000131,SIGMAR1,Galactose metabolism; Glycerolipid metabolism,WP5356: Affected pathways in Duchenne muscular dystrophy,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
302,HMDB0000131,ERBB3,Galactose metabolism; Glycerolipid metabolism,WP1591: Heart development; WP2261: Glioblastoma signaling pathways; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP4806: EGFR tyrosine kinase inhibitor resistance; WP673: ErbB signaling pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
303,HMDB0000131,FCGR2B,Galactose metabolism; Glycerolipid metabolism,WP4630: Measles virus infection; WP5346: 8p23.1 copy number variation syndrome,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
304,HMDB0000131,FCER2,Galactose metabolism; Glycerolipid metabolism,WP2806: Complement system,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
305,HMDB0000131,MECR,Galactose metabolism; Glycerolipid metabolism,WP357: Fatty acid biosynthesis; WP4317: Mitochondrial fatty acid synthesis pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
306,HMDB0000131,OLR1,Galactose metabolism; Glycerolipid metabolism,WP176: Folate metabolism; WP3942: PPAR signaling pathway; WP4022: Pyrimidine metabolism; WP405: Eukaryotic transcription initiation; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP4655: Cytosolic DNA-sensing pathway; WP5222: 2q13 copy number variation syndrome; WP5367: Rubinstein-Taybi syndrome 1; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
307,HMDB0000131,NR5A2,Galactose metabolism; Glycerolipid metabolism,WP170: Nuclear receptors,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
308,HMDB0000131,KDR,Galactose metabolism; Glycerolipid metabolism,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
309,HMDB0000131,CD320,Galactose metabolism; Glycerolipid metabolism,WP4271: Vitamin B12 disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
310,HMDB0000131,FCGRT,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
311,HMDB0000131,NCOR2,Galactose metabolism; Glycerolipid metabolism,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP268: Notch signaling; WP4312: Rett syndrome; WP61: Notch signaling pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
312,HMDB0000131,TRPA1,Galactose metabolism; Glycerolipid metabolism,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
313,HMDB0000131,ADGRL3,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
314,HMDB0000131,CCR5,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP4298: Acute viral myocarditis; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5431: FLT3 p.Gln640SerfsTer8 signaling pathway",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
315,HMDB0000131,MAGI2,Galactose metabolism; Glycerolipid metabolism,WP3651: Pathways affected in adenoid cystic carcinoma,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
316,HMDB0000131,FCGR3A,Galactose metabolism; Glycerolipid metabolism,WP2806: Complement system; WP5092: Interactions of natural killer cells in pancreatic cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
317,HMDB0000131,ESRRG,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
318,HMDB0000131,IL6ST,Galactose metabolism; Glycerolipid metabolism,WP1528: Physiological and pathological hypertrophy of the heart; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2332: Interleukin-11 signaling pathway; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP2815: Mammary gland development pathway - Involution (Stage 4 of 4); WP364: IL6 signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5036: Angiotensin II receptor type 1 pathway; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
319,HMDB0000131,ADORA2A,Galactose metabolism; Glycerolipid metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
320,HMDB0000131,TRPV4,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
321,HMDB0000131,NSD1,Galactose metabolism; Glycerolipid metabolism,WP2369: Histone modifications; WP3651: Pathways affected in adenoid cystic carcinoma; WP5380: 5q35 copy number variation,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
322,HMDB0000131,EPHA2,Galactose metabolism; Glycerolipid metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
323,HMDB0000131,FASLG,Galactose metabolism; Glycerolipid metabolism,WP1772: Apoptosis modulation and signaling; WP2328: Allograft rejection; WP2507: Nanomaterial induced apoptosis; WP254: Apoptosis; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3646: Hepatitis C and hepatocellular carcinoma; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4396: Nonalcoholic fatty liver disease; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4754: IL-18 signaling pathway; WP4864: Host-pathogen interaction of human coronaviruses - apoptosis; WP4963: p53 transcriptional gene network; WP5078: T cell modulation in pancreatic cancer; WP5090: Complement system in neuronal development and plasticity; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer; WP710: DNA damage response (only ATM dependent),Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
324,HMDB0000131,RXRA,Galactose metabolism; Glycerolipid metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
325,HMDB0000131,FGFR4,Galactose metabolism; Glycerolipid metabolism,WP3651: Pathways affected in adenoid cystic carcinoma; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4787: Osteoblast differentiation and related diseases; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5428: FGFR4 p.G388R signaling pathway; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
326,HMDB0000131,NR3C2,Galactose metabolism; Glycerolipid metabolism,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
327,HMDB0000131,PTPN3,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
328,HMDB0000131,IFNGR2,Galactose metabolism; Glycerolipid metabolism,"WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP619: Type II interferon signaling",Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
329,HMDB0000131,PPARD,Galactose metabolism; Glycerolipid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
330,HMDB0000131,ITGB1,Galactose metabolism; Glycerolipid metabolism,WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
331,HMDB0000131,PIGR,Galactose metabolism; Glycerolipid metabolism,,Glycerol,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
332,HMDB0000132,SLC29A2,Purine metabolism,,Guanine,"Blood,Cellular Cytoplasm,Feces,Saliva,Urine"
333,HMDB0000133,SLC29A2,Purine metabolism,,Guanosine,"Blood,Breast Milk,Cellular Cytoplasm,Feces,Saliva,Urine"
334,HMDB0000133,SLC29A1,Purine metabolism,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Guanosine,"Blood,Breast Milk,Cellular Cytoplasm,Feces,Saliva,Urine"
335,HMDB0000134,SLC13A5,Arginine and proline metabolism; Aspartate metabolism; Citric acid cycle; Oxidative phosphorylation; Phenylalanine and tyrosine metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,,Fumaric acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
336,HMDB0000142,NCOA2,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
337,HMDB0000142,RET,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
338,HMDB0000142,CALCRL,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
339,HMDB0000142,GNRHR,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP5362: TAR syndrome",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
340,HMDB0000142,NCOR1,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
341,HMDB0000142,NR0B2,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,WP138: Androgen receptor signaling pathway; WP2879: Farnesoid X receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
342,HMDB0000142,GFRA2,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
343,HMDB0000142,ESR1,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
344,HMDB0000142,GRB7,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,WP304: Kit receptor signaling pathway; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP5287: 17q12 copy number variation syndrome,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
345,HMDB0000142,PPARG,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
346,HMDB0000142,EGFR,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
347,HMDB0000142,AGTR2,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,"WP24: Peptide GPCRs; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4830: GDNF/RET signaling axis; WP4969: RAS and bradykinin pathways in COVID-19; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5316: Primary ovarian insufficiency; WP554: ACE inhibitor pathway",Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
348,HMDB0000142,NECTIN1,Androgen and estrogen metabolism; One carbon pool by folate; Pterine biosynthesis; Steroid biosynthesis; Tryptophan metabolism,,Formic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
349,HMDB0000143,SLC2A8,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Galactose,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
350,HMDB0000143,SLC2A1,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,D-Galactose,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
351,HMDB0000143,SLC2A2,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism,WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5446: GLP-1 secretion from intestine to portal vein,D-Galactose,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
352,HMDB0000143,SLC2A3,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP5083: Neuroinflammation and glutamatergic signaling; WP5283: Chronic hyperglycemia impairment of neuron function; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,D-Galactose,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
353,HMDB0000143,SLC2A10,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Galactose,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
354,HMDB0000145,ESR1,Androgen and estrogen metabolism; Sulfur metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Estrone,"Blood,Urine"
355,HMDB0000148,GRM1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP2636: Common pathways underlying drug addiction; WP3853: ERK pathway in Huntington's disease; WP3947: Serotonin and anxiety; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4875: Disruption of postsynaptic signaling by CNV; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
356,HMDB0000148,GRIN1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2431: Spinal cord injury; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3676: BDNF-TrkB signaling; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
357,HMDB0000148,GRM8,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
358,HMDB0000148,GRIK4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
359,HMDB0000148,GRID2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
360,HMDB0000148,GRIA1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2447: Amyotrophic lateral sclerosis (ALS); WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3680: Physico-chemical features and toxicity-associated pathways; WP4222: Phosphodiesterases in neuronal function; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4906: 3q29 copy number variation syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5094: Orexin receptor pathway; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
361,HMDB0000148,GRIA3,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
362,HMDB0000148,SLC1A2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2447: Amyotrophic lateral sclerosis (ALS); WP5083: Neuroinflammation and glutamatergic signaling; WP5094: Orexin receptor pathway; WP5314: Lactate shuttle in glial cells; WP5417: Cell lineage map for neuronal differentiation,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
363,HMDB0000148,GRM3,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
364,HMDB0000148,GRM7,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
365,HMDB0000148,GRIN2A,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2059: Alzheimer's disease and miRNA effects; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4685: Melanoma; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
366,HMDB0000148,GRIA2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
367,HMDB0000148,SLC1A5,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
368,HMDB0000148,GRM2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
369,HMDB0000148,SLC3A2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
370,HMDB0000148,GRIN2D,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2059: Alzheimer's disease and miRNA effects; WP3944: Serotonin and anxiety-related events; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
371,HMDB0000148,SLC1A1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
372,HMDB0000148,GRIA4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
373,HMDB0000148,GRM5,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
374,HMDB0000148,GRM4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
375,HMDB0000148,GIPR,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP334: GPCRs, class B secretin-like",L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
376,HMDB0000148,TRPV1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP3947: Serotonin and anxiety; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
377,HMDB0000148,GRIK1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
378,HMDB0000148,GRIN3A,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
379,HMDB0000148,GRIK2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4148: Splicing factor NOVA regulated synaptic proteins; WP5083: Neuroinflammation and glutamatergic signaling; WP5345: 1p36 copy number variation syndrome,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
380,HMDB0000148,GRID1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Purine metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,L-Glutamic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
381,HMDB0000151,ESR2,Androgen and estrogen metabolism,WP170: Nuclear receptors; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP5316: Primary ovarian insufficiency; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Estradiol,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
382,HMDB0000151,NR1I2,Androgen and estrogen metabolism,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Estradiol,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
383,HMDB0000151,ESR1,Androgen and estrogen metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Estradiol,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
384,HMDB0000153,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Estriol,"Amniotic Fluid,Blood,Urine"
385,HMDB0000156,CSF1R,Citric acid cycle; Glycolysis_gluconeogenesis; Pyruvate metabolism,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Malic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
386,HMDB0000156,SLC13A5,Citric acid cycle; Glycolysis_gluconeogenesis; Pyruvate metabolism,,Malic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
387,HMDB0000156,SLC1A3,Citric acid cycle; Glycolysis_gluconeogenesis; Pyruvate metabolism,WP2267: Synaptic vesicle pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5417: Cell lineage map for neuronal differentiation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Malic acid,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
388,HMDB0000157,SLC29A2,Purine metabolism,,Hypoxanthine,"Amniotic Fluid,Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
389,HMDB0000158,GPR35,Phenylalanine and tyrosine metabolism; Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5224: 2q37 copy number variation syndrome",L-Tyrosine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
390,HMDB0000158,ESR1,Phenylalanine and tyrosine metabolism; Tyrosine metabolism; Tyrosine metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",L-Tyrosine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
391,HMDB0000158,SLC16A10,Phenylalanine and tyrosine metabolism; Tyrosine metabolism; Tyrosine metabolism,WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,L-Tyrosine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
392,HMDB0000158,SLC7A5,Phenylalanine and tyrosine metabolism; Tyrosine metabolism; Tyrosine metabolism,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Tyrosine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
393,HMDB0000159,SLC16A10,Phenylalanine and tyrosine metabolism,WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,L-Phenylalanine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
394,HMDB0000159,SLC7A5,Phenylalanine and tyrosine metabolism,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Phenylalanine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
395,HMDB0000159,GPR142,Phenylalanine and tyrosine metabolism,,L-Phenylalanine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
396,HMDB0000159,SLC43A2,Phenylalanine and tyrosine metabolism,,L-Phenylalanine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
397,HMDB0000159,SLC43A1,Phenylalanine and tyrosine metabolism,WP5220: Metabolic reprogramming in pancreatic cancer,L-Phenylalanine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
398,HMDB0000163,SLC2A3,Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP5083: Neuroinflammation and glutamatergic signaling; WP5283: Chronic hyperglycemia impairment of neuron function; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,D-Maltose,"Blood,Feces,Sweat,Urine"
399,HMDB0000167,SLC43A1,"Glycine, serine and threonine metabolism",WP5220: Metabolic reprogramming in pancreatic cancer,L-Threonine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
400,HMDB0000168,SLC1A5,Aspartate metabolism; Nitrogen metabolism,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Asparagine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
401,HMDB0000168,SLC43A1,Aspartate metabolism; Nitrogen metabolism,WP5220: Metabolic reprogramming in pancreatic cancer,L-Asparagine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
402,HMDB0000169,GABRA1,Fructose and mannose metabolism; Galactose metabolism,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
403,HMDB0000169,TFRC,Fructose and mannose metabolism; Galactose metabolism,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
404,HMDB0000169,ITGB2,Fructose and mannose metabolism; Galactose metabolism,WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
405,HMDB0000169,CHRNA7,Fructose and mannose metabolism; Galactose metabolism,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
406,HMDB0000169,MPL,Fructose and mannose metabolism; Galactose metabolism,WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4950: 16p11.2 distal deletion syndrome,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
407,HMDB0000169,GABRB2,Fructose and mannose metabolism; Galactose metabolism,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
408,HMDB0000169,UNC5B,Fructose and mannose metabolism; Galactose metabolism,WP4747: Netrin-UNC5B signaling pathway,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
409,HMDB0000169,SLC2A3,Fructose and mannose metabolism; Galactose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP5083: Neuroinflammation and glutamatergic signaling; WP5283: Chronic hyperglycemia impairment of neuron function; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
410,HMDB0000169,ADGRB1,Fructose and mannose metabolism; Galactose metabolism,WP4963: p53 transcriptional gene network,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
411,HMDB0000169,PTH1R,Fructose and mannose metabolism; Galactose metabolism,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
412,HMDB0000169,IL2RB,Fructose and mannose metabolism; Galactose metabolism,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
413,HMDB0000169,EGFR,Fructose and mannose metabolism; Galactose metabolism,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
414,HMDB0000169,SLC2A2,Fructose and mannose metabolism; Galactose metabolism,WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5446: GLP-1 secretion from intestine to portal vein,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
415,HMDB0000169,MRC1,Fructose and mannose metabolism; Galactose metabolism,,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
416,HMDB0000169,SLC2A1,Fructose and mannose metabolism; Galactose metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,D-Mannose,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
417,HMDB0000172,SLC43A2,"Valine, leucine and isoleucine degradation",,L-Isoleucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
418,HMDB0000172,SLC43A1,"Valine, leucine and isoleucine degradation",WP5220: Metabolic reprogramming in pancreatic cancer,L-Isoleucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
419,HMDB0000174,TRAC,Fructose and mannose metabolism,WP5078: T cell modulation in pancreatic cancer,L-Fucose,"Blood,Breast Milk,Feces,Saliva,Urine"
420,HMDB0000174,IL7R,Fructose and mannose metabolism,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,L-Fucose,"Blood,Breast Milk,Feces,Saliva,Urine"
421,HMDB0000174,LRP6,Fructose and mannose metabolism,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,L-Fucose,"Blood,Breast Milk,Feces,Saliva,Urine"
422,HMDB0000177,SLC7A5,Beta-alanine metabolism; Histidine metabolism; Nitrogen metabolism,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Histidine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
423,HMDB0000177,SLC38A4,Beta-alanine metabolism; Histidine metabolism; Nitrogen metabolism,,L-Histidine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
424,HMDB0000181,SLC16A10,Tyrosine metabolism; Tyrosine metabolism,WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,L-Dopa,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
425,HMDB0000182,SLC38A4,Biotin metabolism; Lysine degradation,,L-Lysine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
426,HMDB0000182,SLC7A2,Biotin metabolism; Lysine degradation,WP5355: Metabolic Epileptic Disorders,L-Lysine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
427,HMDB0000182,SLC7A1,Biotin metabolism; Lysine degradation,"WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP2895: Differentiation of white and brown adipocyte; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4357: NRF2-ARE regulation; WP4963: p53 transcriptional gene network; WP5083: Neuroinflammation and glutamatergic signaling; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5213: Amino acid metabolism in triple-negative breast cancer cells",L-Lysine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
428,HMDB0000182,SLC7A3,Biotin metabolism; Lysine degradation,,L-Lysine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
429,HMDB0000187,SLC43A1,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism",WP5220: Metabolic reprogramming in pancreatic cancer,L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
430,HMDB0000187,SLC3A2,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism","WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
431,HMDB0000187,SLC7A10,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism",WP2895: Differentiation of white and brown adipocyte; WP5083: Neuroinflammation and glutamatergic signaling,L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
432,HMDB0000187,SLC1A4,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism",WP5083: Neuroinflammation and glutamatergic signaling,L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
433,HMDB0000187,SLC1A5,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism","WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
434,HMDB0000187,ESR1,"Glycine, serine and threonine metabolism; Methionine metabolism; Nitrogen metabolism; Selenocompound metabolism; Starch and sucrose metabolism","WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",L-Serine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
435,HMDB0000190,SLC16A1,Glycolysis_gluconeogenesis; Pyruvate metabolism,WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP4549: Fragile X syndrome; WP4742: Ketogenesis and ketolysis; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells,L-Lactic acid,"Bile,Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
436,HMDB0000190,HCAR1,Glycolysis_gluconeogenesis; Pyruvate metabolism,"WP455: GPCRs, class A rhodopsin-like",L-Lactic acid,"Bile,Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
437,HMDB0000191,SLC1A1,Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Glutamate metabolism; Nitrogen metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,L-Aspartic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
438,HMDB0000191,SLC1A2,Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Glutamate metabolism; Nitrogen metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,WP2447: Amyotrophic lateral sclerosis (ALS); WP5083: Neuroinflammation and glutamatergic signaling; WP5094: Orexin receptor pathway; WP5314: Lactate shuttle in glial cells; WP5417: Cell lineage map for neuronal differentiation,L-Aspartic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
439,HMDB0000191,RPSA,Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Glutamate metabolism; Nitrogen metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,WP477: Cytoplasmic ribosomal proteins; WP4906: 3q29 copy number variation syndrome,L-Aspartic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
440,HMDB0000191,SLC1A3,Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Glutamate metabolism; Nitrogen metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,WP2267: Synaptic vesicle pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5417: Cell lineage map for neuronal differentiation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,L-Aspartic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
441,HMDB0000191,SLC1A5,Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Glutamate metabolism; Nitrogen metabolism; Purine metabolism; Tyrosine metabolism; Urea cycle,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Aspartic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
442,HMDB0000195,SLC29A1,Purine metabolism,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Inosine,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Pericardial Effusion,Saliva,Urine"
443,HMDB0000195,SLC29A2,Purine metabolism,,Inosine,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Pericardial Effusion,Saliva,Urine"
444,HMDB0000207,EDNRB,,"WP2197: Endothelin pathways; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
445,HMDB0000207,GCGR,,"WP334: GPCRs, class B secretin-like",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
446,HMDB0000207,HCRTR2,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
447,HMDB0000207,ADRA2C,,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
448,HMDB0000207,GRM5,,"WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
449,HMDB0000207,CHRM5,,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
450,HMDB0000207,ADRA2A,,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
451,HMDB0000207,ADIPOR1,,WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
452,HMDB0000207,LTB4R,,"WP117: GPCRs, other; WP2431: Spinal cord injury; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; WP80: Nucleotide GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
453,HMDB0000207,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
454,HMDB0000207,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
455,HMDB0000207,HCRTR1,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
456,HMDB0000207,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
457,HMDB0000207,MTNR1A,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
458,HMDB0000207,CYSLTR1,,"WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5424: Omega-6-fatty acids in senescence",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
459,HMDB0000207,AGTR2,,"WP24: Peptide GPCRs; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4830: GDNF/RET signaling axis; WP4969: RAS and bradykinin pathways in COVID-19; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5316: Primary ovarian insufficiency; WP554: ACE inhibitor pathway",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
460,HMDB0000207,HTR2C,,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
461,HMDB0000207,OPRL1,,"WP24: Peptide GPCRs; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
462,HMDB0000207,GRM1,,"WP117: GPCRs, other; WP2636: Common pathways underlying drug addiction; WP3853: ERK pathway in Huntington's disease; WP3947: Serotonin and anxiety; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4875: Disruption of postsynaptic signaling by CNV; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
463,HMDB0000207,CCR5,,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP4298: Acute viral myocarditis; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5431: FLT3 p.Gln640SerfsTer8 signaling pathway",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
464,HMDB0000207,C5AR1,,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
465,HMDB0000207,HTR2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
466,HMDB0000207,ADORA1,,"WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
467,HMDB0000207,CNR2,,"WP247: Small ligand GPCRs; WP3869: Cannabinoid receptor signaling; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
468,HMDB0000207,OPRD1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
469,HMDB0000207,CRHR1,,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
470,HMDB0000207,DRD4,,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
471,HMDB0000207,S1PR5,,WP26: S1P receptor signal transduction; WP5121: Sphingolipid metabolism in senescence,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
472,HMDB0000207,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
473,HMDB0000207,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
474,HMDB0000207,OPRK1,,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
475,HMDB0000207,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
476,HMDB0000207,CCR2,,"WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP3624: Lung fibrosis; WP3929: Chemokine signaling pathway; WP4397: Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5088: Prostaglandin signaling; WP5284: Cell interactions of the pancreatic cancer microenvironment",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
477,HMDB0000207,SLC27A5,,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
478,HMDB0000207,CHRM1,,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
479,HMDB0000207,CYSLTR2,,"WP3624: Lung fibrosis; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX)",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
480,HMDB0000207,CXCR4,,"WP24: Peptide GPCRs; WP2406: Cardiac progenitor differentiation; WP2849: Hematopoietic stem cell differentiation; WP3678: Amplification and expansion of oncogenic pathways as metastatic traits; WP3929: Chemokine signaling pathway; WP4298: Acute viral myocarditis; WP4331: Neovascularization processes; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP4823: Genes controlling nephrogenesis; WP5055: Burn wound healing; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5224: 2q37 copy number variation syndrome; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5362: TAR syndrome; WP5380: 5q35 copy number variation; WP5422: IL-19 signaling pathway; WP5434: Pathways in cancer",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
481,HMDB0000207,FFAR4,,,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
482,HMDB0000207,HCAR2,,,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
483,HMDB0000207,MC4R,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5445: Hunger and satiety",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
484,HMDB0000207,GLP1R,,"WP334: GPCRs, class B secretin-like",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
485,HMDB0000207,TACR1,,WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
486,HMDB0000207,PTH1R,,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
487,HMDB0000207,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
488,HMDB0000207,CCR9,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP455: GPCRs, class A rhodopsin-like",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
489,HMDB0000207,CHRM4,,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
490,HMDB0000207,PTGER3,,"WP247: Small ligand GPCRs; WP4483: Relationship between inflammation, COX-2 and EGFR; WP455: GPCRs, class A rhodopsin-like; WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
491,HMDB0000207,CNR1,,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
492,HMDB0000207,DRD2,,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
493,HMDB0000207,ADIPOR2,,WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,Oleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
494,HMDB0000208,OXGR1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Citric acid cycle; Cysteine metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Lysine degradation; Nitrogen metabolism; Phenylalanine and tyrosine metabolism; Propanoate metabolism; Tryptophan metabolism; Tyrosine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,Oxoglutaric acid,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
495,HMDB0000214,SLC7A2,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Urea cycle",WP5355: Metabolic Epileptic Disorders,Ornithine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
496,HMDB0000214,SLC7A3,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Urea cycle",,Ornithine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
497,HMDB0000214,SLC7A1,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Urea cycle","WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP2895: Differentiation of white and brown adipocyte; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4357: NRF2-ARE regulation; WP4963: p53 transcriptional gene network; WP5083: Neuroinflammation and glutamatergic signaling; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5213: Amino acid metabolism in triple-negative breast cancer cells",Ornithine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
498,HMDB0000216,ADRB1,Tyrosine metabolism; Tyrosine metabolism,"WP2197: Endothelin pathways; WP3298: Melatonin metabolism and effects; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
499,HMDB0000216,ADRA2B,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5221: 2q11.2 copy number variation syndrome; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
500,HMDB0000216,SLC22A2,Tyrosine metabolism; Tyrosine metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
501,HMDB0000216,SLC22A3,Tyrosine metabolism; Tyrosine metabolism,WP2267: Synaptic vesicle pathway,Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
502,HMDB0000216,ADRA2A,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
503,HMDB0000216,SLC22A1,Tyrosine metabolism; Tyrosine metabolism,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
504,HMDB0000216,ADRA1B,Tyrosine metabolism; Tyrosine metabolism,"WP1403: AMP-activated protein kinase signaling; WP2877: Vitamin D receptor pathway; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
505,HMDB0000216,ADRA2C,Tyrosine metabolism; Tyrosine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
506,HMDB0000216,ADRA1D,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
507,HMDB0000216,ADRA1A,Tyrosine metabolism; Tyrosine metabolism,"WP1403: AMP-activated protein kinase signaling; WP2197: Endothelin pathways; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
508,HMDB0000216,ADRB2,Tyrosine metabolism; Tyrosine metabolism,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
509,HMDB0000216,ADRB3,Tyrosine metabolism; Tyrosine metabolism,"WP4321: Thermogenesis; WP455: GPCRs, class A rhodopsin-like; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Norepinephrine,"Blood,Cerebrospinal Fluid (CSF),Urine"
510,HMDB0000220,HTR2A,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
511,HMDB0000220,MRGPRD,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
512,HMDB0000220,HTR2B,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
513,HMDB0000220,CRHR1,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
514,HMDB0000220,HNF4A,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP1403: AMP-activated protein kinase signaling; WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP5236: Markers of kidney cell lineage; WP5417: Cell lineage map for neuronal differentiation,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
515,HMDB0000220,SLC27A5,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
516,HMDB0000220,FPR2,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
517,HMDB0000220,OPRK1,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
518,HMDB0000220,PKD2,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP2571: Polycystic kidney disease pathway; WP4803: Ciliopathies; WP5234: Bardet-Biedl syndrome,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
519,HMDB0000220,HTR4,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP734: Serotonin receptor 4/6/7 and NR3C signaling",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
520,HMDB0000220,RXRG,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP170: Nuclear receptors; WP236: Adipogenesis; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
521,HMDB0000220,CRHR2,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP2355: Corticotropin-releasing hormone signaling pathway; WP334: GPCRs, class B secretin-like",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
522,HMDB0000220,PTH1R,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
523,HMDB0000220,PPARA,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
524,HMDB0000220,CALCR,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
525,HMDB0000220,PTH2R,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP334: GPCRs, class B secretin-like; WP5316: Primary ovarian insufficiency",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
526,HMDB0000220,HNF4G,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
527,HMDB0000220,RXRB,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
528,HMDB0000220,NCOA2,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
529,HMDB0000220,C5AR1,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
530,HMDB0000220,ADRB2,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
531,HMDB0000220,GHRHR,Fatty acid elongation in mitochondria; Fatty acid metabolism; Glycerolipid metabolism; Primary bile acid biosynthesis; Steroid biosynthesis,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Palmitic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
532,HMDB0000234,GPRC6A,Androgen and estrogen metabolism,,Testosterone,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
533,HMDB0000234,NCOA2,Androgen and estrogen metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Testosterone,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
534,HMDB0000234,AR,Androgen and estrogen metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Testosterone,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
535,HMDB0000235,SLC19A1,Thiamine metabolism,WP176: Folate metabolism; WP3996: Ethanol effects on histone modifications; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Thiamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
536,HMDB0000235,SLC22A1,Thiamine metabolism,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Thiamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
537,HMDB0000235,SLC19A2,Thiamine metabolism,WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4297: Thiamine metabolic pathways,Thiamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
538,HMDB0000235,SLC19A3,Thiamine metabolism,WP4297: Thiamine metabolic pathways,Thiamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
539,HMDB0000237,FGFR1,Propanoate metabolism,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Propionic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
540,HMDB0000243,SLC16A11,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Citric acid cycle; Cysteine metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Nitrogen metabolism; Pyruvate metabolism; Urea cycle",,Pyruvic acid,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
541,HMDB0000243,SLC16A1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Citric acid cycle; Cysteine metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Nitrogen metabolism; Pyruvate metabolism; Urea cycle",WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP4549: Fragile X syndrome; WP4742: Ketogenesis and ketolysis; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells,Pyruvic acid,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
542,HMDB0000244,SLC52A2,Riboflavin metabolism,WP5037: Riboflavin and CoQ disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Riboflavin,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
543,HMDB0000244,SLC52A1,Riboflavin metabolism,WP5037: Riboflavin and CoQ disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Riboflavin,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
544,HMDB0000248,THRA,Tyrosine metabolism,WP170: Nuclear receptors; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias,Thyroxine,"Blood,Saliva,Urine"
545,HMDB0000248,SLC16A2,Tyrosine metabolism,WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects,Thyroxine,"Blood,Saliva,Urine"
546,HMDB0000248,THRB,Tyrosine metabolism,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Thyroxine,"Blood,Saliva,Urine"
547,HMDB0000254,SLC13A5,"Arginine and proline metabolism; Butyrate metabolism; Citric acid cycle; Glutamate metabolism; Ketone body metabolism; Oxidative phosphorylation; Valine, leucine and isoleucine degradation",,Succinic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
548,HMDB0000254,PTGDR2,"Arginine and proline metabolism; Butyrate metabolism; Citric acid cycle; Glutamate metabolism; Ketone body metabolism; Oxidative phosphorylation; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",Succinic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
549,HMDB0000254,SUCNR1,"Arginine and proline metabolism; Butyrate metabolism; Citric acid cycle; Glutamate metabolism; Ketone body metabolism; Oxidative phosphorylation; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like",Succinic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
550,HMDB0000254,LRP6,"Arginine and proline metabolism; Butyrate metabolism; Citric acid cycle; Glutamate metabolism; Ketone body metabolism; Oxidative phosphorylation; Valine, leucine and isoleucine degradation",WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Succinic acid,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
551,HMDB0000259,HTR2C,Tryptophan metabolism,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
552,HMDB0000259,HTR3B,Tryptophan metabolism,WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
553,HMDB0000259,TRPC6,Tryptophan metabolism,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3676: BDNF-TrkB signaling; WP4758: Nephrotic syndrome; WP5356: Affected pathways in Duchenne muscular dystrophy,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
554,HMDB0000259,SLC22A1,Tryptophan metabolism,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
555,HMDB0000259,HTR1A,Tryptophan metabolism,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5417: Cell lineage map for neuronal differentiation; WP5444: Acetaminophen in analgesia and antipyresis; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
556,HMDB0000259,HTR1B,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP722: Serotonin HTR1 group and FOS pathway",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
557,HMDB0000259,PPARG,Tryptophan metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
558,HMDB0000259,SLC6A4,Tryptophan metabolism,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
559,HMDB0000259,HTR2A,Tryptophan metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
560,HMDB0000259,HTR6,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP734: Serotonin receptor 4/6/7 and NR3C signaling",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
561,HMDB0000259,HTR3A,Tryptophan metabolism,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
562,HMDB0000259,HTR2B,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
563,HMDB0000259,HTR1D,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP722: Serotonin HTR1 group and FOS pathway",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
564,HMDB0000259,HTR4,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP734: Serotonin receptor 4/6/7 and NR3C signaling",Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
565,HMDB0000259,SLC22A2,Tryptophan metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Serotonin,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
566,HMDB0000262,SLC29A2,Pyrimidine metabolism,,Thymine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
567,HMDB0000265,SLC16A2,Tyrosine metabolism,WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects,Liothyronine,"Blood,Saliva,Urine"
568,HMDB0000265,AR,Tyrosine metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Liothyronine,"Blood,Saliva,Urine"
569,HMDB0000265,THRA,Tyrosine metabolism,WP170: Nuclear receptors; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias,Liothyronine,"Blood,Saliva,Urine"
570,HMDB0000265,THRB,Tyrosine metabolism,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Liothyronine,"Blood,Saliva,Urine"
571,HMDB0000272,GRM4,"Glycine, serine and threonine metabolism","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Phosphoserine,"Blood,Cerebrospinal Fluid (CSF),Urine"
572,HMDB0000272,TIMD4,"Glycine, serine and threonine metabolism",WP4217: Ebola virus infection in host,Phosphoserine,"Blood,Cerebrospinal Fluid (CSF),Urine"
573,HMDB0000273,SLC29A2,Pyrimidine metabolism,,Thymidine,"Amniotic Fluid,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
574,HMDB0000273,SLC29A1,Pyrimidine metabolism,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Thymidine,"Amniotic Fluid,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
575,HMDB0000277,S1PR2,Starch and sucrose metabolism,WP247: Small ligand GPCRs; WP26: S1P receptor signal transduction; WP5121: Sphingolipid metabolism in senescence,Sphingosine 1-phosphate,Blood
576,HMDB0000277,S1PR1,Starch and sucrose metabolism,"WP117: GPCRs, other; WP247: Small ligand GPCRs; WP26: S1P receptor signal transduction; WP3888: VEGFA-VEGFR2 signaling; WP5121: Sphingolipid metabolism in senescence; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5316: Primary ovarian insufficiency",Sphingosine 1-phosphate,Blood
577,HMDB0000277,S1PR5,Starch and sucrose metabolism,WP26: S1P receptor signal transduction; WP5121: Sphingolipid metabolism in senescence,Sphingosine 1-phosphate,Blood
578,HMDB0000277,SPNS2,Starch and sucrose metabolism,,Sphingosine 1-phosphate,Blood
579,HMDB0000277,S1PR3,Starch and sucrose metabolism,WP247: Small ligand GPCRs; WP26: S1P receptor signal transduction; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids,Sphingosine 1-phosphate,Blood
580,HMDB0000285,P2RY6,Amino sugar metabolism; Galactose metabolism; Nucleotide sugars metabolism; Pyrimidine metabolism; Starch and sucrose metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Uridine triphosphate,Saliva
581,HMDB0000285,P2RY11,Amino sugar metabolism; Galactose metabolism; Nucleotide sugars metabolism; Pyrimidine metabolism; Starch and sucrose metabolism,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Uridine triphosphate,Saliva
582,HMDB0000285,P2RY4,Amino sugar metabolism; Galactose metabolism; Nucleotide sugars metabolism; Pyrimidine metabolism; Starch and sucrose metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Uridine triphosphate,Saliva
583,HMDB0000285,P2RY2,Amino sugar metabolism; Galactose metabolism; Nucleotide sugars metabolism; Pyrimidine metabolism; Starch and sucrose metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Uridine triphosphate,Saliva
584,HMDB0000286,P2RY14,Galactose metabolism; Nucleotide sugars metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Uridine diphosphate glucose,"Blood,Feces,Urine"
585,HMDB0000292,ADORA1,Purine metabolism,"WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Xanthine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
586,HMDB0000294,SLC5A1,Arginine and proline metabolism; D-arginine and d-ornithine metabolism; Urea cycle,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP5446: GLP-1 secretion from intestine to portal vein,Urea,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
587,HMDB0000294,SLC5A5,Arginine and proline metabolism; D-arginine and d-ornithine metabolism; Urea cycle,WP1981: Thyroxine (thyroid hormone) production; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,Urea,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
588,HMDB0000294,SLC14A2,Arginine and proline metabolism; D-arginine and d-ornithine metabolism; Urea cycle,,Urea,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
589,HMDB0000294,SLC14A1,Arginine and proline metabolism; D-arginine and d-ornithine metabolism; Urea cycle,,Urea,"Blood,Breast Milk,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
590,HMDB0000295,P2RY6,Amino sugar metabolism; Androgen and estrogen metabolism; Galactose metabolism; Porphyrin metabolism; Pyrimidine metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Uridine 5'-diphosphate,Blood
591,HMDB0000296,SLC29A1,Pyrimidine metabolism,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Uridine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Urine"
592,HMDB0000296,SLC29A2,Pyrimidine metabolism,,Uridine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Urine"
593,HMDB0000300,SLC29A2,Beta-alanine metabolism; Pyrimidine metabolism,,Uracil,"Amniotic Fluid,Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
594,HMDB0000305,RARG,Retinol metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
595,HMDB0000305,RARA,Retinol metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
596,HMDB0000305,RBP1,Retinol metabolism,WP2446: Retinoblastoma gene in cancer; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
597,HMDB0000305,RBP4,Retinol metabolism,WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
598,HMDB0000305,STRA6,Retinol metabolism,,Vitamin A,"Blood,Feces,Saliva"
599,HMDB0000305,RARB,Retinol metabolism,WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
600,HMDB0000305,RBP2,Retinol metabolism,WP2338: miRNA biogenesis; WP4549: Fragile X syndrome; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP716: Vitamin A and carotenoid metabolism,Vitamin A,"Blood,Feces,Saliva"
601,HMDB0000335,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",16a-Hydroxyestrone,Blood
602,HMDB0000338,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",2-Hydroxyestradiol,Urine
603,HMDB0000464,LDLRAD3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
604,HMDB0000464,TRPM8,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP5224: 2q37 copy number variation syndrome,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
605,HMDB0000464,AXL,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4217: Ebola virus infection in host; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5090: Complement system in neuronal development and plasticity,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
606,HMDB0000464,PPARG,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
607,HMDB0000464,LDLR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2846: PCSK9-mediated LDL receptor degradation; WP3408: Evolocumab mechanism to reduce LDL cholesterol; WP3601: Lipid particles composition; WP399: Wnt signaling pathway and pluripotency; WP430: Statin inhibition of cholesterol production; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4904: LDLRAD4 and what we know about it; WP5108: Familial  hyperlipidemia type 1; WP5109: Familial hyperlipidemia type 2; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5220: Metabolic reprogramming in pancreatic cancer; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5409: PAFAH1B1 copy number variation; WP710: DNA damage response (only ATM dependent)",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
608,HMDB0000464,CASR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP501: GPCRs, class C metabotropic glutamate, pheromone",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
609,HMDB0000464,ESR1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
610,HMDB0000464,RET,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
611,HMDB0000464,CDH17,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5390: Pancreatic cancer subtypes,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
612,HMDB0000464,GABBR2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
613,HMDB0000464,TFRC,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
614,HMDB0000464,SORT1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
615,HMDB0000464,MC5R,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
616,HMDB0000464,TYROBP,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
617,HMDB0000464,IGF1R,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
618,HMDB0000464,LRP1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2059: Alzheimer's disease and miRNA effects; WP3664: Regulation of Wnt / B-catenin signaling by small molecule compounds; WP430: Statin inhibition of cholesterol production; WP5108: Familial  hyperlipidemia type 1; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5145: COVID-19 structural coverage map; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
619,HMDB0000464,CXADR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4298: Acute viral myocarditis; WP5407: 15q11q13 copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
620,HMDB0000464,ZP3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP34: Ovarian infertility; WP5316: Primary ovarian insufficiency; WP5401: 7q11.23 distal copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
621,HMDB0000464,NRP1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
622,HMDB0000464,TIMD4,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4217: Ebola virus infection in host,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
623,HMDB0000464,CUBN,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1533: Vitamin B12 metabolism; WP4271: Vitamin B12 disorders; WP4758: Nephrotic syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
624,HMDB0000464,FCER2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2806: Complement system,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
625,HMDB0000464,VLDLR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP5110: Familial hyperlipidemia type 3; WP5409: PAFAH1B1 copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
626,HMDB0000464,KDR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
627,HMDB0000464,GRM3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
628,HMDB0000464,KREMEN1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP5087: Pleural mesothelioma,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
629,HMDB0000464,PTPRN,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP5380: 5q35 copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
630,HMDB0000464,CD320,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4271: Vitamin B12 disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
631,HMDB0000464,GRID1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
632,HMDB0000464,ADGRL3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
633,HMDB0000464,NCOR2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP268: Notch signaling; WP4312: Rett syndrome; WP61: Notch signaling pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
634,HMDB0000464,ITGAM,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
635,HMDB0000464,NSD1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2369: Histone modifications; WP3651: Pathways affected in adenoid cystic carcinoma; WP5380: 5q35 copy number variation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
636,HMDB0000464,EPS15,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP3888: VEGFA-VEGFR2 signaling; WP4217: Ebola virus infection in host; WP437: EGF/EGFR signaling pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
637,HMDB0000464,RIPK2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP69: T-cell receptor signaling pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
638,HMDB0000464,GRID2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
639,HMDB0000464,DDR1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP3670: Interactions between LOXL4 and oxidative stress pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
640,HMDB0000464,GFRAL,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
641,HMDB0000464,LRP6,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
642,HMDB0000464,CELSR1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP117: GPCRs, other; WP4657: 22q11.2 copy number variation syndrome; WP5053: Development of ureteric collection system",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
643,HMDB0000464,ITGB2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
644,HMDB0000464,ITGA5,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP306: Focal adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4541: Hippo-Merlin signaling dysregulation; WP5300: TROP2 regulatory signaling,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
645,HMDB0000464,MC4R,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5445: Hunger and satiety",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
646,HMDB0000464,GRIN1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2431: Spinal cord injury; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3676: BDNF-TrkB signaling; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
647,HMDB0000464,GRIN2A,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2059: Alzheimer's disease and miRNA effects; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4685: Melanoma; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
648,HMDB0000464,CHRNA7,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
649,HMDB0000464,SLC3A1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs),Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
650,HMDB0000464,NCOA1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
651,HMDB0000464,EFNA5,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2877: Vitamin D receptor pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4172: PI3K-Akt signaling pathway; WP5087: Pleural mesothelioma,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
652,HMDB0000464,SELL,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2806: Complement system; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
653,HMDB0000464,RXFP1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP117: GPCRs, other; WP289: Myometrial relaxation and contraction pathways",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
654,HMDB0000464,NCR3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP5092: Interactions of natural killer cells in pancreatic cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
655,HMDB0000464,INSR,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
656,HMDB0000464,CRHR1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
657,HMDB0000464,ADGRL1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP334: GPCRs, class B secretin-like",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
658,HMDB0000464,CLEC7A,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
659,HMDB0000464,S100A6,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2363: Gastric cancer network 2; WP2877: Vitamin D receptor pathway; WP5055: Burn wound healing; WP98: Prostaglandin synthesis and regulation,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
660,HMDB0000464,AGER,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
661,HMDB0000464,ADGRE2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
662,HMDB0000464,TRPV4,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
663,HMDB0000464,CD300LF,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
664,HMDB0000464,ITLN1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
665,HMDB0000464,RXFP2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP289: Myometrial relaxation and contraction pathways,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
666,HMDB0000464,SCARA5,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
667,HMDB0000464,SLC40A1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
668,HMDB0000464,ITGAV,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1434: Osteopontin signaling; WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP306: Focal adhesion; WP322: Osteoblast signaling; WP3301: MFAP5-mediated ovarian cancer cell motility and invasiveness; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4541: Hippo-Merlin signaling dysregulation; WP4560: MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; WP4658: Small cell lung cancer; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5033: Genes associated with the development of rheumatoid arthritis; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5434: Pathways in cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
669,HMDB0000464,MRC1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
670,HMDB0000464,TRPC3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP3676: BDNF-TrkB signaling; WP3888: VEGFA-VEGFR2 signaling; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5356: Affected pathways in Duchenne muscular dystrophy,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
671,HMDB0000464,HAVCR2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4217: Ebola virus infection in host; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5078: T cell modulation in pancreatic cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
672,HMDB0000464,PKD2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2571: Polycystic kidney disease pathway; WP4803: Ciliopathies; WP5234: Bardet-Biedl syndrome,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
673,HMDB0000464,TRPC5,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
674,HMDB0000464,TRPA1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
675,HMDB0000464,FOLR1,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
676,HMDB0000464,TRPM4,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP5083: Neuroinflammation and glutamatergic signaling,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
677,HMDB0000464,SLC7A9,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs),Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
678,HMDB0000464,GRM7,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
679,HMDB0000464,LRP8,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
680,HMDB0000464,MERTK,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
681,HMDB0000464,ESRRG,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
682,HMDB0000464,CLEC4D,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
683,HMDB0000464,TRPC6,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3676: BDNF-TrkB signaling; WP4758: Nephrotic syndrome; WP5356: Affected pathways in Duchenne muscular dystrophy,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
684,HMDB0000464,TRPV6,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2877: Vitamin D receptor pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
685,HMDB0000464,PPARD,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
686,HMDB0000464,P2RX3,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP4900: Purinergic signaling,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
687,HMDB0000464,TRPM2,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,WP2858: Ectoderm differentiation; WP5115: Network map of SARS-CoV-2 signaling pathway,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
688,HMDB0000464,SLAMF6,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,,Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
689,HMDB0000464,ADGRE5,Alpha-linolenic acid metabolism; Androgen and estrogen metabolism; Arachidonic acid metabolism; Beta-alanine metabolism; Histidine metabolism; Inositol phosphate metabolism; One carbon pool by folate; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Urea cycle,"WP2877: Vitamin D receptor pathway; WP334: GPCRs, class B secretin-like",Calcium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
690,HMDB0000492,VIPR1,Starch and sucrose metabolism,"WP334: GPCRs, class B secretin-like; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
691,HMDB0000492,RET,Starch and sucrose metabolism,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
692,HMDB0000492,CCR5,Starch and sucrose metabolism,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP4298: Acute viral myocarditis; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5431: FLT3 p.Gln640SerfsTer8 signaling pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
693,HMDB0000492,ANTXR2,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
694,HMDB0000492,PTPRS,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
695,HMDB0000492,TNFRSF9,Starch and sucrose metabolism,WP5078: T cell modulation in pancreatic cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
696,HMDB0000492,ITLN1,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
697,HMDB0000492,PTPRJ,Starch and sucrose metabolism,WP3888: VEGFA-VEGFR2 signaling,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
698,HMDB0000492,GLRA3,Starch and sucrose metabolism,WP5417: Cell lineage map for neuronal differentiation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
699,HMDB0000492,AGTR1,Starch and sucrose metabolism,"WP2328: Allograft rejection; WP24: Peptide GPCRs; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4883: SARS-CoV-2 and ACE2 receptor: molecular mechanisms; WP4969: RAS and bradykinin pathways in COVID-19; WP5036: Angiotensin II receptor type 1 pathway; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5076: Soluble ACE2-mediated cell entry of SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5158: Urotensin-II-mediated signaling pathway; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5360: KCNQ2-related epilepsies; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
700,HMDB0000492,EPHA1,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
701,HMDB0000492,SORT1,Starch and sucrose metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
702,HMDB0000492,LRP6,Starch and sucrose metabolism,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
703,HMDB0000492,NCOA2,Starch and sucrose metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
704,HMDB0000492,GABRB3,Starch and sucrose metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
705,HMDB0000492,NR3C2,Starch and sucrose metabolism,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
706,HMDB0000492,FGFR1,Starch and sucrose metabolism,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
707,HMDB0000492,TRAF4,Starch and sucrose metabolism,WP4658: Small cell lung cancer; WP4963: p53 transcriptional gene network; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
708,HMDB0000492,IZUMO1R,Starch and sucrose metabolism,WP176: Folate metabolism,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
709,HMDB0000492,CHRM2,Starch and sucrose metabolism,"WP117: GPCRs, other; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
710,HMDB0000492,TRAV26-1,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
711,HMDB0000492,CLEC7A,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
712,HMDB0000492,CD300LF,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
713,HMDB0000492,TNFRSF11A,Starch and sucrose metabolism,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3594: Circadian rhythm genes; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP5187: mRNA vaccine activation of dendritic cell and induction of IFN-1; WP5205: Clock-controlled autophagy in bone metabolism,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
714,HMDB0000492,PTPRE,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
715,HMDB0000492,RTN4R,Starch and sucrose metabolism,WP2431: Spinal cord injury; WP4657: 22q11.2 copy number variation syndrome; WP5366: NF1 copy number variation syndrome ; WP5406: 13q12.12 copy number variation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
716,HMDB0000492,TRAC,Starch and sucrose metabolism,WP5078: T cell modulation in pancreatic cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
717,HMDB0000492,ADORA2A,Starch and sucrose metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
718,HMDB0000492,CSF1R,Starch and sucrose metabolism,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
719,HMDB0000492,F2R,Starch and sucrose metabolism,"WP117: GPCRs, other; WP127: IL-5 signaling pathway; WP2038: Microtubule cytoskeleton regulation; WP286: IL-3 signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2865: IL1 and megakaryocytes in obesity; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP51: Regulation of actin cytoskeleton; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5300: TROP2 regulatory signaling; WP5434: Pathways in cancer; WP558: Complement and coagulation cascades",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
720,HMDB0000492,FAS,Starch and sucrose metabolism,WP1403: AMP-activated protein kinase signaling; WP1530: miRNA regulation of DNA damage response; WP1772: Apoptosis modulation and signaling; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2059: Alzheimer's disease and miRNA effects; WP2328: Allograft rejection; WP236: Adipogenesis; WP2507: Nanomaterial induced apoptosis; WP254: Apoptosis; WP2874: Liver X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP357: Fatty acid biosynthesis; WP3594: Circadian rhythm genes; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3646: Hepatitis C and hepatocellular carcinoma; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3965: Lipid metabolism pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4290: Metabolic reprogramming in colon cancer; WP4396: Nonalcoholic fatty liver disease; WP4484: Control of immune tolerance by vasoactive intestinal peptide; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP4724: Omega-9 fatty acid synthesis; WP4754: IL-18 signaling pathway; WP4864: Host-pathogen interaction of human coronaviruses - apoptosis; WP4932: 7q11.23 copy number variation syndrome; WP4963: p53 transcriptional gene network; WP5066: FOXA2 pathway; WP5078: T cell modulation in pancreatic cancer; WP5090: Complement system in neuronal development and plasticity; WP5111: Familial hyperlipidemia type 4; WP5124: Alzheimer's disease; WP5220: Metabolic reprogramming in pancreatic cancer; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer; WP707: DNA damage response; WP710: DNA damage response (only ATM dependent),Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
721,HMDB0000492,MCOLN2,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
722,HMDB0000492,NPHS1,Starch and sucrose metabolism,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP4758: Nephrotic syndrome; WP4823: Genes controlling nephrogenesis; WP5236: Markers of kidney cell lineage,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
723,HMDB0000492,MERTK,Starch and sucrose metabolism,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
724,HMDB0000492,PTPN4,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
725,HMDB0000492,EPHA5,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
726,HMDB0000492,EPHA2,Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
727,HMDB0000492,NPR3,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
728,HMDB0000492,FCGRT,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
729,HMDB0000492,SLC2A1,Starch and sucrose metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
730,HMDB0000492,UNC5B,Starch and sucrose metabolism,WP4747: Netrin-UNC5B signaling pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
731,HMDB0000492,GABRD,Starch and sucrose metabolism,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5345: 1p36 copy number variation syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
732,HMDB0000492,ITGB2,Starch and sucrose metabolism,WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
733,HMDB0000492,EPHA7,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
734,HMDB0000492,NTRK1,Starch and sucrose metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
735,HMDB0000492,NR1H4,Starch and sucrose metabolism,WP2289: Drug induction of bile acid pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4396: Nonalcoholic fatty liver disease; WP5238: Cholestasis,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
736,HMDB0000492,TNFSF11,Starch and sucrose metabolism,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2848: Pluripotent stem cell differentiation pathway; WP2877: Vitamin D receptor pathway; WP322: Osteoblast signaling; WP4262: Breast cancer pathway; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP5205: Clock-controlled autophagy in bone metabolism; WP5347: IL-26 signaling pathways; WP5402: 10q22q23 copy number variation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
737,HMDB0000492,GRID1,Starch and sucrose metabolism,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
738,HMDB0000492,ITGAV,Starch and sucrose metabolism,WP1434: Osteopontin signaling; WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP306: Focal adhesion; WP322: Osteoblast signaling; WP3301: MFAP5-mediated ovarian cancer cell motility and invasiveness; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4541: Hippo-Merlin signaling dysregulation; WP4560: MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; WP4658: Small cell lung cancer; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5033: Genes associated with the development of rheumatoid arthritis; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
739,HMDB0000492,GRM2,Starch and sucrose metabolism,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
740,HMDB0000492,AR,Starch and sucrose metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
741,HMDB0000492,EPHB3,Starch and sucrose metabolism,WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
742,HMDB0000492,PPARG,Starch and sucrose metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
743,HMDB0000492,GLRB,Starch and sucrose metabolism,WP5417: Cell lineage map for neuronal differentiation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
744,HMDB0000492,RORC,Starch and sucrose metabolism,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
745,HMDB0000492,GABRA2,Starch and sucrose metabolism,WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
746,HMDB0000492,GRB7,Starch and sucrose metabolism,WP304: Kit receptor signaling pathway; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP5287: 17q12 copy number variation syndrome,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
747,HMDB0000492,SLC6A4,Starch and sucrose metabolism,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
748,HMDB0000492,GABRG2,Starch and sucrose metabolism,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
749,HMDB0000492,PDGFRA,Starch and sucrose metabolism,WP1539: Angiogenesis; WP2261: Glioblastoma signaling pathways; WP2328: Allograft rejection; WP2406: Cardiac progenitor differentiation; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
750,HMDB0000492,EGFR,Starch and sucrose metabolism,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
751,HMDB0000492,CELSR1,Starch and sucrose metabolism,"WP117: GPCRs, other; WP4657: 22q11.2 copy number variation syndrome; WP5053: Development of ureteric collection system",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
752,HMDB0000492,MECR,Starch and sucrose metabolism,WP357: Fatty acid biosynthesis; WP4317: Mitochondrial fatty acid synthesis pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
753,HMDB0000492,CASR,Starch and sucrose metabolism,"WP501: GPCRs, class C metabotropic glutamate, pheromone",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
754,HMDB0000492,FLT1,Starch and sucrose metabolism,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
755,HMDB0000492,AGER,Starch and sucrose metabolism,WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
756,HMDB0000492,AXL,Starch and sucrose metabolism,WP4217: Ebola virus infection in host; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5090: Complement system in neuronal development and plasticity,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
757,HMDB0000492,EFNB2,Starch and sucrose metabolism,WP2431: Spinal cord injury; WP5205: Clock-controlled autophagy in bone metabolism,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
758,HMDB0000492,SLC17A1,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
759,HMDB0000492,RIPK2,Starch and sucrose metabolism,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP69: T-cell receptor signaling pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
760,HMDB0000492,GRIA2,Starch and sucrose metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
761,HMDB0000492,NCOA1,Starch and sucrose metabolism,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
762,HMDB0000492,KREMEN1,Starch and sucrose metabolism,WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP5087: Pleural mesothelioma,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
763,HMDB0000492,SLC26A6,Starch and sucrose metabolism,WP1981: Thyroxine (thyroid hormone) production; WP4917: Proximal tubule transport,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
764,HMDB0000492,IFNAR2,Starch and sucrose metabolism,"WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP4630: Measles virus infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4912: SARS coronavirus and innate immunity; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5098: T-cell activation SARS-CoV-2; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5434: Pathways in cancer; WP585: Interferon type I signaling pathways; WP75: Toll-like receptor signaling pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
765,HMDB0000492,HCRTR1,Starch and sucrose metabolism,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
766,HMDB0000492,EPHA3,Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
767,HMDB0000492,OSCAR,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
768,HMDB0000492,NECTIN2,Starch and sucrose metabolism,WP727: Monoamine transport,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
769,HMDB0000492,PPARD,Starch and sucrose metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
770,HMDB0000492,TNK2,Starch and sucrose metabolism,"WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3933: Kennedy pathway from sphingolipids; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP437: EGF/EGFR signaling pathway; WP524: G13 signaling pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
771,HMDB0000492,FGFR2,Starch and sucrose metabolism,WP1539: Angiogenesis; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2795: Cardiac hypertrophic response; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2858: Ectoderm differentiation; WP382: MAPK signaling pathway; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4842: Mammalian disorder of sexual development; WP4872: MAP3K1 role in promoting and blocking gonadal determination; WP5053: Development of ureteric collection system; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
772,HMDB0000492,ESRRG,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
773,HMDB0000492,PTPRU,Starch and sucrose metabolism,WP581: EPO receptor signaling,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
774,HMDB0000492,ROR2,Starch and sucrose metabolism,WP2406: Cardiac progenitor differentiation; WP2858: Ectoderm differentiation; WP363: Wnt signaling pathway; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP5087: Pleural mesothelioma,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
775,HMDB0000492,RXRA,Starch and sucrose metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
776,HMDB0000492,NCOR1,Starch and sucrose metabolism,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
777,HMDB0000492,TRGC1,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
778,HMDB0000492,RXRB,Starch and sucrose metabolism,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
779,HMDB0000492,ITGAM,Starch and sucrose metabolism,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
780,HMDB0000492,GRM3,Starch and sucrose metabolism,"WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
781,HMDB0000492,NR4A2,Starch and sucrose metabolism,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
782,HMDB0000492,SLC26A9,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
783,HMDB0000492,IL22RA1,Starch and sucrose metabolism,WP4538: Regulatory circuits of the STAT3 signaling pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
784,HMDB0000492,ERBB2,Starch and sucrose metabolism,WP2034: Leptin signaling pathway; WP2037: Prolactin signaling pathway; WP2261: Glioblastoma signaling pathways; WP2571: Polycystic kidney disease pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3651: Pathways affected in adenoid cystic carcinoma; WP3680: Physico-chemical features and toxicity-associated pathways; WP4155: Endometrial cancer; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP437: EGF/EGFR signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5221: 2q11.2 copy number variation syndrome; WP5287: 17q12 copy number variation syndrome; WP5434: Pathways in cancer; WP673: ErbB signaling pathway; WP710: DNA damage response (only ATM dependent),Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
785,HMDB0000492,PTPRR,Starch and sucrose metabolism,WP382: MAPK signaling pathway; WP437: EGF/EGFR signaling pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
786,HMDB0000492,ADGRB1,Starch and sucrose metabolism,WP4963: p53 transcriptional gene network,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
787,HMDB0000492,FOLR1,Starch and sucrose metabolism,WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
788,HMDB0000492,GRM8,Starch and sucrose metabolism,"WP117: GPCRs, other; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
789,HMDB0000492,GLRA1,Starch and sucrose metabolism,WP5417: Cell lineage map for neuronal differentiation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
790,HMDB0000492,IL6ST,Starch and sucrose metabolism,WP1528: Physiological and pathological hypertrophy of the heart; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2332: Interleukin-11 signaling pathway; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP2815: Mammary gland development pathway - Involution (Stage 4 of 4); WP364: IL6 signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5036: Angiotensin II receptor type 1 pathway; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
791,HMDB0000492,TRPV6,Starch and sucrose metabolism,WP2877: Vitamin D receptor pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
792,HMDB0000492,LILRB2,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
793,HMDB0000492,TAMALIN,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
794,HMDB0000492,DDR1,Starch and sucrose metabolism,WP3670: Interactions between LOXL4 and oxidative stress pathway,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
795,HMDB0000492,GABRA1,Starch and sucrose metabolism,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
796,HMDB0000492,HTR3A,Starch and sucrose metabolism,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
797,HMDB0000492,SLC6A1,Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
798,HMDB0000492,S100A6,Starch and sucrose metabolism,WP2363: Gastric cancer network 2; WP2877: Vitamin D receptor pathway; WP5055: Burn wound healing; WP98: Prostaglandin synthesis and regulation,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
799,HMDB0000492,CLCN5,Starch and sucrose metabolism,WP1981: Thyroxine (thyroid hormone) production,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
800,HMDB0000492,ESR1,Starch and sucrose metabolism,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
801,HMDB0000492,RARG,Starch and sucrose metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
802,HMDB0000492,EPHB4,Starch and sucrose metabolism,WP2877: Vitamin D receptor pathway; WP4331: Neovascularization processes; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
803,HMDB0000492,LGR4,Starch and sucrose metabolism,WP3594: Circadian rhythm genes,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
804,HMDB0000492,GABRR1,Starch and sucrose metabolism,WP3998: Prader-Willi and Angelman syndrome,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
805,HMDB0000492,KIT,Starch and sucrose metabolism,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
806,HMDB0000492,FCGR3A,Starch and sucrose metabolism,WP2806: Complement system; WP5092: Interactions of natural killer cells in pancreatic cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
807,HMDB0000492,OPRM1,Starch and sucrose metabolism,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
808,HMDB0000492,IGF1R,Starch and sucrose metabolism,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
809,HMDB0000492,SLAMF6,Starch and sucrose metabolism,,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
810,HMDB0000492,FOLR2,Starch and sucrose metabolism,WP176: Folate metabolism; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
811,HMDB0000492,TNFRSF10A,Starch and sucrose metabolism,WP1772: Apoptosis modulation and signaling,Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
812,HMDB0000492,ADGRE2,Starch and sucrose metabolism,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Chloride ion,"Blood,Cerebrospinal Fluid (CSF),Saliva,Sweat,Urine"
813,HMDB0000511,PPARG,Biosynthesis of unsaturated fatty acids,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Capric acid,"Blood,Breast Milk,Feces,Saliva,Sweat,Urine"
814,HMDB0000517,SLC38A4,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle",,L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
815,HMDB0000517,AVPR2,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle","WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5085: Vasopressin-regulated water reabsorption",L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
816,HMDB0000517,SLC7A2,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle",WP5355: Metabolic Epileptic Disorders,L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
817,HMDB0000517,GPRC6A,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle",,L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
818,HMDB0000517,SLC7A3,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle",,L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
819,HMDB0000517,SLC7A1,"Arginine and proline metabolism; Aspartate metabolism; Glycine, serine and threonine metabolism; Urea cycle","WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP2895: Differentiation of white and brown adipocyte; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4357: NRF2-ARE regulation; WP4963: p53 transcriptional gene network; WP5083: Neuroinflammation and glutamatergic signaling; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5213: Amino acid metabolism in triple-negative breast cancer cells",L-Arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
820,HMDB0000518,NR1H4,Primary bile acid biosynthesis,WP2289: Drug induction of bile acid pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4396: Nonalcoholic fatty liver disease; WP5238: Cholestasis,Chenodeoxycholic acid,"Bile,Blood,Feces,Urine"
821,HMDB0000538,P2RY4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
822,HMDB0000538,P2RY1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5360: KCNQ2-related epilepsies; WP80: Nucleotide GPCRs",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
823,HMDB0000538,P2RX6,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4657: 22q11.2 copy number variation syndrome; WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
824,HMDB0000538,ABCA1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
825,HMDB0000538,P2RY6,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
826,HMDB0000538,P2RY13,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
827,HMDB0000538,P2RX3,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
828,HMDB0000538,P2RX5,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
829,HMDB0000538,ABCC8,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
830,HMDB0000538,ABCA7,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
831,HMDB0000538,IL6R,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2848: Pluripotent stem cell differentiation pathway; WP364: IL6 signaling pathway; WP3646: Hepatitis C and hepatocellular carcinoma; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4396: Nonalcoholic fatty liver disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
832,HMDB0000538,P2RY12,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
833,HMDB0000538,P2RX2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
834,HMDB0000538,P2RX1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
835,HMDB0000538,ABCG1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP299: Nuclear receptors in lipid metabolism and toxicity; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
836,HMDB0000538,TRPV4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
837,HMDB0000538,ABCB1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
838,HMDB0000538,CLCN5,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP1981: Thyroxine (thyroid hormone) production,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
839,HMDB0000538,P2RY11,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
840,HMDB0000538,GRIN2B,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4754: IL-18 signaling pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
841,HMDB0000538,P2RX4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
842,HMDB0000538,ABCG2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
843,HMDB0000538,ABCC1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP229: Irinotecan pathway; WP5171: Leukotriene metabolic pathway; WP5300: TROP2 regulatory signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
844,HMDB0000538,P2RY2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP80: Nucleotide GPCRs",Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
845,HMDB0000538,TRPM4,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP5083: Neuroinflammation and glutamatergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
846,HMDB0000538,ABCB6,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
847,HMDB0000538,P2RX7,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Biotin metabolism; Butyrate metabolism; Citric acid cycle; Cysteine metabolism; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Tryptophan metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4900: Purinergic signaling,Adenosine triphosphate,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva"
848,HMDB0000547,ANTXR1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP5316: Primary ovarian insufficiency,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
849,HMDB0000547,TNFRSF14,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP5345: 1p36 copy number variation syndrome; WP5362: TAR syndrome,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
850,HMDB0000547,KIAA0319L,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
851,HMDB0000547,FGFR2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1539: Angiogenesis; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2795: Cardiac hypertrophic response; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2858: Ectoderm differentiation; WP382: MAPK signaling pathway; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4842: Mammalian disorder of sexual development; WP4872: MAP3K1 role in promoting and blocking gonadal determination; WP5053: Development of ureteric collection system; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
852,HMDB0000547,PTK2B,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP205: IL-7 signaling pathway; WP2263: Androgen receptor network in prostate cancer; WP2374: Oncostatin M signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP313: Hepatocyte growth factor receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3929: Chemokine signaling pathway; WP437: EGF/EGFR signaling pathway; WP4666: Hepatitis B infection; WP4747: Netrin-UNC5B signaling pathway; WP49: IL-2 signaling pathway; WP5097: CCL18 signaling pathway; WP5399: NPHP1 deletion syndrome; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP69: T-cell receptor signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
853,HMDB0000547,ABCA7,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
854,HMDB0000547,CALCRL,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
855,HMDB0000547,GHRHR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
856,HMDB0000547,RIPK2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP69: T-cell receptor signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
857,HMDB0000547,CHRNA3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1602: Nicotine effect on dopaminergic neurons; WP1603: Nicotine effect on chromaffin cells,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
858,HMDB0000547,ABCG1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP299: Nuclear receptors in lipid metabolism and toxicity; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
859,HMDB0000547,GABBR1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP4159: GABA receptor signaling; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
860,HMDB0000547,GRK2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3929: Chemokine signaling pathway; WP4249: Hedgehog signaling pathway; WP47: Hedgehog signaling pathway; WP5426: HDAC6 interactions in the central nervous system,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
861,HMDB0000547,ABCC8,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
862,HMDB0000547,MERTK,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
863,HMDB0000547,GRM2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
864,HMDB0000547,ABCB1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
865,HMDB0000547,CD300LF,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
866,HMDB0000547,TGFBR2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP366: TGF-beta signaling pathway; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP382: MAPK signaling pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4263: Pancreatic adenocarcinoma pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4666: Hepatitis B infection; WP4674: Head and neck squamous cell carcinoma; WP4816: TGF-beta receptor signaling in skeletal dysplasias; WP4904: LDLRAD4 and what we know about it; WP5036: Angiotensin II receptor type 1 pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5316: Primary ovarian insufficiency; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5382: TGFβ/Smad signaling pathway; WP5434: Pathways in cancer; WP560: TGF-beta receptor signaling,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
867,HMDB0000547,GRM7,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
868,HMDB0000547,KIT,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
869,HMDB0000547,CD160,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5345: 1p36 copy number variation syndrome; WP5362: TAR syndrome,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
870,HMDB0000547,TNK2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3933: Kennedy pathway from sphingolipids; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP437: EGF/EGFR signaling pathway; WP524: G13 signaling pathway",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
871,HMDB0000547,SNW1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP366: TGF-beta signaling pathway; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP4148: Splicing factor NOVA regulated synaptic proteins; WP61: Notch signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
872,HMDB0000547,ABCA1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
873,HMDB0000547,HTR2A,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
874,HMDB0000547,ARHGAP35,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP306: Focal adhesion; WP51: Regulation of actin cytoskeleton,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
875,HMDB0000547,ABCG2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
876,HMDB0000547,NECTIN2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP727: Monoamine transport,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
877,HMDB0000547,IGF1R,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
878,HMDB0000547,EPHA3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
879,HMDB0000547,GRM5,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
880,HMDB0000547,TFRC,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
881,HMDB0000547,ITGB7,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP306: Focal adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
882,HMDB0000547,BMPR2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1425: Bone morphogenic protein signaling and regulation; WP1591: Heart development; WP2857: Mesodermal commitment pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3931: Embryonic stem cell pluripotency pathways; WP4787: Osteoblast differentiation and related diseases; WP5053: Development of ureteric collection system; WP5205: Clock-controlled autophagy in bone metabolism; WP5316: Primary ovarian insufficiency,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
883,HMDB0000547,CELSR1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP4657: 22q11.2 copy number variation syndrome; WP5053: Development of ureteric collection system",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
884,HMDB0000547,RXRA,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
885,HMDB0000547,ESR1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
886,HMDB0000547,CSF1R,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
887,HMDB0000547,CASR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP501: GPCRs, class C metabotropic glutamate, pheromone",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
888,HMDB0000547,RACK1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP4630: Measles virus infection; WP5036: Angiotensin II receptor type 1 pathway; WP5300: TROP2 regulatory signaling; WP585: Interferon type I signaling pathways,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
889,HMDB0000547,ITGB1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
890,HMDB0000547,FGFR1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
891,HMDB0000547,ITGB2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
892,HMDB0000547,CLEC7A,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
893,HMDB0000547,LRP6,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
894,HMDB0000547,EPHB2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2038: Microtubule cytoskeleton regulation; WP288: Nod-like receptor (NLR) signaling pathway; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP4331: Neovascularization processes; WP4357: NRF2-ARE regulation; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
895,HMDB0000547,GRM3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
896,HMDB0000547,GRM1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP2636: Common pathways underlying drug addiction; WP3853: ERK pathway in Huntington's disease; WP3947: Serotonin and anxiety; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4875: Disruption of postsynaptic signaling by CNV; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
897,HMDB0000547,GABBR2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
898,HMDB0000547,ADGRL3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
899,HMDB0000547,ABCC1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP229: Irinotecan pathway; WP5171: Leukotriene metabolic pathway; WP5300: TROP2 regulatory signaling,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
900,HMDB0000547,NR3C1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
901,HMDB0000547,ABCB6,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
902,HMDB0000547,PIGR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
903,HMDB0000547,ANTXR2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
904,HMDB0000547,EPHA2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
905,HMDB0000547,TRAV24,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
906,HMDB0000547,TNFRSF1A,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP1772: Apoptosis modulation and signaling; WP2059: Alzheimer's disease and miRNA effects; WP231: TNF-alpha signaling pathway; WP2447: Amyotrophic lateral sclerosis (ALS); WP2513: Nanoparticle triggered regulated necrosis; WP254: Apoptosis; WP2795: Cardiac hypertrophic response; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4396: Nonalcoholic fatty liver disease; WP453: Inflammatory response pathway; WP4754: IL-18 signaling pathway; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5182: Pro-survival signaling of neuroprotectin D1; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5422: IL-19 signaling pathway",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
907,HMDB0000547,NR4A2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
908,HMDB0000547,FGFR3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2064: Neural crest differentiation; WP2828: Bladder cancer; WP3413: NOTCH1 regulation of endothelial cell calcification; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5365: 4p16.3 copy number variation; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
909,HMDB0000547,RIPK1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1772: Apoptosis modulation and signaling; WP2036: TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; WP231: TNF-alpha signaling pathway; WP2513: Nanoparticle triggered regulated necrosis; WP2516: ATM signaling pathway; WP254: Apoptosis; WP384: Apoptosis modulation by HSP70; WP3851: TLR4 signaling and tolerance; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP400: p38 MAPK signaling pathway; WP4655: Cytosolic DNA-sensing pathway; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5182: Pro-survival signaling of neuroprotectin D1; WP75: Toll-like receptor signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
910,HMDB0000547,GAB2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2018: RANKL/RANK signaling pathway; WP2037: Prolactin signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP23: B cell receptor signaling pathway; WP286: IL-3 signaling pathway; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3676: BDNF-TrkB signaling; WP395: IL-4 signaling pathway; WP4223: Ras signaling; WP437: EGF/EGFR signaling pathway; WP49: IL-2 signaling pathway; WP585: Interferon type I signaling pathways; WP69: T-cell receptor signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
911,HMDB0000547,EPHB4,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2877: Vitamin D receptor pathway; WP4331: Neovascularization processes; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
912,HMDB0000547,CNNM2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
913,HMDB0000547,TRPV4,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
914,HMDB0000547,P2RX3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4900: Purinergic signaling,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
915,HMDB0000547,GRIN2B,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4754: IL-18 signaling pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
916,HMDB0000547,NR1I2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
917,HMDB0000547,ITGAM,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
918,HMDB0000547,RPSA,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP477: Cytoplasmic ribosomal proteins; WP4906: 3q29 copy number variation syndrome,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
919,HMDB0000547,EPOR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
920,HMDB0000547,CD79B,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP23: B cell receptor signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
921,HMDB0000547,GRK5,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP289: Myometrial relaxation and contraction pathways; WP3929: Chemokine signaling pathway; WP536: Calcium regulation in cardiac cells,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
922,HMDB0000547,CYTH3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
923,HMDB0000547,NCOA1,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
924,HMDB0000547,EGFR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
925,HMDB0000547,ADRB2,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
926,HMDB0000547,ERBB3,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1591: Heart development; WP2261: Glioblastoma signaling pathways; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP4806: EGFR tyrosine kinase inhibitor resistance; WP673: ErbB signaling pathway,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
927,HMDB0000547,INSR,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
928,HMDB0000547,MARCO,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
929,HMDB0000547,RORC,"Amino sugar metabolism; Arachidonic acid metabolism; Aspartate metabolism; Biosynthesis of unsaturated fatty acids; Butyrate metabolism; Citric acid cycle; Fatty acid metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Phenylalanine and tyrosine metabolism; Phenylalanine metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Magnesium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
930,HMDB0000561,RARG,Retinol metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,beta-Carotene,"Blood,Breast Milk,Feces"
931,HMDB0000561,RARB,Retinol metabolism,WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,beta-Carotene,"Blood,Breast Milk,Feces"
932,HMDB0000561,RARA,Retinol metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,beta-Carotene,"Blood,Breast Milk,Feces"
933,HMDB0000573,SLC27A2,,WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5176: Disorders of bile acid synthesis and biliary transport; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Elaidic acid,"Blood,Feces"
934,HMDB0000574,IL6R,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",WP2848: Pluripotent stem cell differentiation pathway; WP364: IL6 signaling pathway; WP3646: Hepatitis C and hepatocellular carcinoma; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4396: Nonalcoholic fatty liver disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
935,HMDB0000574,SLC7A11,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism","WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4357: NRF2-ARE regulation; WP4963: p53 transcriptional gene network; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5213: Amino acid metabolism in triple-negative breast cancer cells",L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
936,HMDB0000574,ESR1,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism","WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
937,HMDB0000574,IFNGR2,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism","WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP619: Type II interferon signaling",L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
938,HMDB0000574,IL2RG,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",WP205: IL-7 signaling pathway; WP22: IL-9 signaling pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP395: IL-4 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5434: Pathways in cancer,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
939,HMDB0000574,IFNGR1,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism","WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP619: Type II interferon signaling",L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
940,HMDB0000574,SLC43A2,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
941,HMDB0000574,LEPR,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",WP1403: AMP-activated protein kinase signaling; WP2034: Leptin signaling pathway; WP3934: Leptin and adiponectin; WP3935: Leptin-insulin signaling overlap; WP4396: Nonalcoholic fatty liver disease; WP5400: 6q16 copy number variation,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
942,HMDB0000574,FCGRT,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
943,HMDB0000574,CD200R1,"Cysteine metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Methionine metabolism; Pantothenate and coa biosynthesis; Taurine and hypotaurine metabolism",,L-Cysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
944,HMDB0000586,PPARD,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
945,HMDB0000586,SLC1A1,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
946,HMDB0000586,FOLR2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP176: Folate metabolism; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
947,HMDB0000586,CYTH3,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
948,HMDB0000586,ABCC8,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
949,HMDB0000586,ANTXR2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
950,HMDB0000586,NR3C2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
951,HMDB0000586,DRD2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism","WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
952,HMDB0000586,CD40,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism","WP2328: Allograft rejection; WP2806: Complement system; WP2877: Vitamin D receptor pathway; WP288: Nod-like receptor (NLR) signaling pathway; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4298: Acute viral myocarditis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP453: Inflammatory response pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5078: T cell modulation in pancreatic cancer; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP75: Toll-like receptor signaling pathway",Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
953,HMDB0000586,FCGRT,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
954,HMDB0000586,LAIR1,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
955,HMDB0000586,ADORA2A,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism","WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
956,HMDB0000586,NR4A2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
957,HMDB0000586,MCOLN2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
958,HMDB0000586,RXRA,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism","WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
959,HMDB0000586,TYROBP,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
960,HMDB0000586,FOLR1,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
961,HMDB0000586,NCOR2,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP268: Notch signaling; WP4312: Rett syndrome; WP61: Notch signaling pathway,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
962,HMDB0000586,GRB7,"Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Methionine metabolism; Purine metabolism; Pyruvate metabolism",WP304: Kit receptor signaling pathway; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP5287: 17q12 copy number variation syndrome,Potassium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
963,HMDB0000588,TNFRSF11A,,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3594: Circadian rhythm genes; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP5187: mRNA vaccine activation of dendritic cell and induction of IFN-1; WP5205: Clock-controlled autophagy in bone metabolism,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
964,HMDB0000588,RTN4R,,WP2431: Spinal cord injury; WP4657: 22q11.2 copy number variation syndrome; WP5366: NF1 copy number variation syndrome ; WP5406: 13q12.12 copy number variation,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
965,HMDB0000588,SORT1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
966,HMDB0000588,HCRTR1,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
967,HMDB0000588,SLC5A3,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
968,HMDB0000588,LAIR1,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
969,HMDB0000588,TRPV4,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
970,HMDB0000588,LTB4R,,"WP117: GPCRs, other; WP2431: Spinal cord injury; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; WP80: Nucleotide GPCRs",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
971,HMDB0000588,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
972,HMDB0000588,LDLR,,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2846: PCSK9-mediated LDL receptor degradation; WP3408: Evolocumab mechanism to reduce LDL cholesterol; WP3601: Lipid particles composition; WP399: Wnt signaling pathway and pluripotency; WP430: Statin inhibition of cholesterol production; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4904: LDLRAD4 and what we know about it; WP5108: Familial  hyperlipidemia type 1; WP5109: Familial hyperlipidemia type 2; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5220: Metabolic reprogramming in pancreatic cancer; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5409: PAFAH1B1 copy number variation; WP710: DNA damage response (only ATM dependent)",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
973,HMDB0000588,CHRNA9,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
974,HMDB0000588,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
975,HMDB0000588,GRM2,,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
976,HMDB0000588,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
977,HMDB0000588,CHRNA3,,WP1602: Nicotine effect on dopaminergic neurons; WP1603: Nicotine effect on chromaffin cells,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
978,HMDB0000588,LEPR,,WP1403: AMP-activated protein kinase signaling; WP2034: Leptin signaling pathway; WP3934: Leptin and adiponectin; WP3935: Leptin-insulin signaling overlap; WP4396: Nonalcoholic fatty liver disease; WP5400: 6q16 copy number variation,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
979,HMDB0000588,P2RX3,,WP4900: Purinergic signaling,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
980,HMDB0000588,C5AR1,,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
981,HMDB0000588,CHRNB2,,WP1602: Nicotine effect on dopaminergic neurons; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
982,HMDB0000588,ITGB2,,WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
983,HMDB0000588,ESRRG,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
984,HMDB0000588,CD300LF,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
985,HMDB0000588,LTK,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
986,HMDB0000588,FLT1,,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
987,HMDB0000588,IL1R1,,WP1455: Serotonin transporter activity; WP1772: Apoptosis modulation and signaling; WP195: IL-1 signaling pathway; WP2431: Spinal cord injury; WP2637: Interleukin-1 (IL-1) structural pathway; WP2865: IL1 and megakaryocytes in obesity; WP382: MAPK signaling pathway; WP4496: Signal transduction through IL1R; WP5083: Neuroinflammation and glutamatergic signaling; WP516: Hypertrophy model; WP5222: 2q13 copy number variation syndrome; WP727: Monoamine transport,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
988,HMDB0000588,OPRD1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
989,HMDB0000588,TNFRSF9,,WP5078: T cell modulation in pancreatic cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
990,HMDB0000588,NTSR1,,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
991,HMDB0000588,TRAV26-1,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
992,HMDB0000588,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
993,HMDB0000588,CDH17,,WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5390: Pancreatic cancer subtypes,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
994,HMDB0000588,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
995,HMDB0000588,THRB,,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
996,HMDB0000588,SLC6A1,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
997,HMDB0000588,CELSR1,,"WP117: GPCRs, other; WP4657: 22q11.2 copy number variation syndrome; WP5053: Development of ureteric collection system",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
998,HMDB0000588,TRPM4,,WP5083: Neuroinflammation and glutamatergic signaling,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
999,HMDB0000588,HTR3A,,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1000,HMDB0000588,FCGRT,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1001,HMDB0000588,CALCR,,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1002,HMDB0000588,NR4A1,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP382: MAPK signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP5142: Calcium mediated T-cell apoptosis involved in inclusion body myositis,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1003,HMDB0000588,LRP6,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1004,HMDB0000588,GIPR,,"WP334: GPCRs, class B secretin-like",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1005,HMDB0000588,PTPRS,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1006,HMDB0000588,FCGR3A,,WP2806: Complement system; WP5092: Interactions of natural killer cells in pancreatic cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1007,HMDB0000588,NCOR1,,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1008,HMDB0000588,CSF1R,,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1009,HMDB0000588,TRPM8,,WP5224: 2q37 copy number variation syndrome,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1010,HMDB0000588,NTRK1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1011,HMDB0000588,CHRNB4,,WP1603: Nicotine effect on chromaffin cells; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1012,HMDB0000588,CCR7,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4542: Leukocyte-intrinsic Hippo pathway functions; WP455: GPCRs, class A rhodopsin-like; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1013,HMDB0000588,OSCAR,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1014,HMDB0000588,AGER,,WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1015,HMDB0000588,FGFR2,,WP1539: Angiogenesis; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2795: Cardiac hypertrophic response; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2858: Ectoderm differentiation; WP382: MAPK signaling pathway; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4842: Mammalian disorder of sexual development; WP4872: MAP3K1 role in promoting and blocking gonadal determination; WP5053: Development of ureteric collection system; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1016,HMDB0000588,GRB7,,WP304: Kit receptor signaling pathway; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP5287: 17q12 copy number variation syndrome,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1017,HMDB0000588,ADRB1,,"WP2197: Endothelin pathways; WP3298: Melatonin metabolism and effects; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1018,HMDB0000588,PTPRK,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1019,HMDB0000588,TFRC,,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1020,HMDB0000588,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1021,HMDB0000588,ACVRL1,,WP4331: Neovascularization processes; WP5300: TROP2 regulatory signaling,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1022,HMDB0000588,ANTXR2,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1023,HMDB0000588,F2R,,"WP117: GPCRs, other; WP127: IL-5 signaling pathway; WP2038: Microtubule cytoskeleton regulation; WP286: IL-3 signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2865: IL1 and megakaryocytes in obesity; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP51: Regulation of actin cytoskeleton; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5300: TROP2 regulatory signaling; WP5434: Pathways in cancer; WP558: Complement and coagulation cascades",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1024,HMDB0000588,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1025,HMDB0000588,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1026,HMDB0000588,TRPC4,,WP5158: Urotensin-II-mediated signaling pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1027,HMDB0000588,SLC5A1,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP5446: GLP-1 secretion from intestine to portal vein,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1028,HMDB0000588,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1029,HMDB0000588,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1030,HMDB0000588,SLC1A3,,WP2267: Synaptic vesicle pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5417: Cell lineage map for neuronal differentiation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1031,HMDB0000588,OPRK1,,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1032,HMDB0000588,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1033,HMDB0000588,TRPV1,,WP3947: Serotonin and anxiety; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1034,HMDB0000588,SLC26A9,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1035,HMDB0000588,HAVCR1,,WP4217: Ebola virus infection in host,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1036,HMDB0000588,MCOLN1,,WP2007: Iron metabolism in placenta,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1037,HMDB0000588,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1038,HMDB0000588,TRAV22,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1039,HMDB0000588,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1040,HMDB0000588,F2RL1,,"WP455: GPCRs, class A rhodopsin-like",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1041,HMDB0000588,FFAR1,,"WP3958: GPR40 pathway; WP455: GPCRs, class A rhodopsin-like",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1042,HMDB0000588,CD40,,"WP2328: Allograft rejection; WP2806: Complement system; WP2877: Vitamin D receptor pathway; WP288: Nod-like receptor (NLR) signaling pathway; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4298: Acute viral myocarditis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP453: Inflammatory response pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5078: T cell modulation in pancreatic cancer; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP75: Toll-like receptor signaling pathway",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1043,HMDB0000588,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1044,HMDB0000588,PTPN3,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1045,HMDB0000588,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1046,HMDB0000588,ITGAV,,WP1434: Osteopontin signaling; WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP306: Focal adhesion; WP322: Osteoblast signaling; WP3301: MFAP5-mediated ovarian cancer cell motility and invasiveness; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4541: Hippo-Merlin signaling dysregulation; WP4560: MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; WP4658: Small cell lung cancer; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5033: Genes associated with the development of rheumatoid arthritis; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5434: Pathways in cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1047,HMDB0000588,SLC1A1,,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1048,HMDB0000588,CYSLTR1,,"WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5424: Omega-6-fatty acids in senescence",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1049,HMDB0000588,TRGC1,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1050,HMDB0000588,TRBC1,,WP5078: T cell modulation in pancreatic cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1051,HMDB0000588,CALCRL,,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1052,HMDB0000588,SLC13A5,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1053,HMDB0000588,NR0B2,,WP138: Androgen receptor signaling pathway; WP2879: Farnesoid X receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1054,HMDB0000588,TRAC,,WP5078: T cell modulation in pancreatic cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1055,HMDB0000588,CD2,,"WP1530: miRNA regulation of DNA damage response; WP2263: Androgen receptor network in prostate cancer; WP23: B cell receptor signaling pathway; WP2328: Allograft rejection; WP2516: ATM signaling pathway; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2583: T cell receptor and co-stimulatory signaling; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP4016: DNA IR-damage and cellular response via ATR; WP411: mRNA processing; WP4204: Tumor suppressor activity of SMARCB1; WP4217: Ebola virus infection in host; WP4321: Thermogenesis; WP4352: Ciliary landscape; WP4484: Control of immune tolerance by vasoactive intestinal peptide; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP453: Inflammatory response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4582: Cancer immunotherapy by CTLA4 blockade; WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP4758: Nephrotic syndrome; WP4823: Genes controlling nephrogenesis; WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP5033: Genes associated with the development of rheumatoid arthritis; WP5063: FOXP3 in COVID-19; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5092: Interactions of natural killer cells in pancreatic cancer; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5351: Kleefstra syndrome; WP5362: TAR syndrome; WP5407: 15q11q13 copy number variation; WP5417: Cell lineage map for neuronal differentiation; WP69: T-cell receptor signaling pathway; WP707: DNA damage response",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1056,HMDB0000588,DRD4,,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1057,HMDB0000588,TRPC5,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1058,HMDB0000588,EPOR,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1059,HMDB0000588,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1060,HMDB0000588,PTPRM,,,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1061,HMDB0000588,RIPK1,,WP1772: Apoptosis modulation and signaling; WP2036: TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; WP231: TNF-alpha signaling pathway; WP2513: Nanoparticle triggered regulated necrosis; WP2516: ATM signaling pathway; WP254: Apoptosis; WP384: Apoptosis modulation by HSP70; WP3851: TLR4 signaling and tolerance; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP400: p38 MAPK signaling pathway; WP4655: Cytosolic DNA-sensing pathway; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5182: Pro-survival signaling of neuroprotectin D1; WP75: Toll-like receptor signaling pathway,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1062,HMDB0000588,SLC5A5,,WP1981: Thyroxine (thyroid hormone) production; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1063,HMDB0000588,HAVCR2,,WP4217: Ebola virus infection in host; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5078: T cell modulation in pancreatic cancer,Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1064,HMDB0000588,SLC1A5,,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1065,HMDB0000588,ADGRL3,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Sodium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1066,HMDB0000608,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Cobalt,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1067,HMDB0000608,SLC40A1,,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Cobalt,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1068,HMDB0000608,FLT1,,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Cobalt,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1069,HMDB0000608,RIPK2,,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP69: T-cell receptor signaling pathway,Cobalt,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1070,HMDB0000619,NCOA2,Primary bile acid biosynthesis,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Cholic acid,"Bile,Blood,Feces,Urine"
1071,HMDB0000619,ESRRG,Primary bile acid biosynthesis,,Cholic acid,"Bile,Blood,Feces,Urine"
1072,HMDB0000619,RORC,Primary bile acid biosynthesis,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Cholic acid,"Bile,Blood,Feces,Urine"
1073,HMDB0000630,SLC29A2,,,Cytosine,"Blood,Feces,Urine"
1074,HMDB0000637,CD300LF,Primary bile acid biosynthesis,,Chenodeoxycholic acid glycine conjugate,"Bile,Blood,Feces,Urine"
1075,HMDB0000638,HNF4A,Biosynthesis of unsaturated fatty acids,WP1403: AMP-activated protein kinase signaling; WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP5236: Markers of kidney cell lineage; WP5417: Cell lineage map for neuronal differentiation,Dodecanoic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1076,HMDB0000641,SLC38A1,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP2267: Synaptic vesicle pathway; WP4313: Ferroptosis; WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1077,HMDB0000641,SLC38A3,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1078,HMDB0000641,SLC38A2,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP474: Endochondral ossification; WP4808: Endochondral ossification with skeletal dysplasias; WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1079,HMDB0000641,SLC38A5,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP5083: Neuroinflammation and glutamatergic signaling,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1080,HMDB0000641,SLC7A7,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP3945: TYROBP causal network in microglia; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs),L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1081,HMDB0000641,SLC38A7,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1082,HMDB0000641,SLC6A14,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1083,HMDB0000641,SLC3A2,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,"WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1084,HMDB0000641,SLC7A6,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1085,HMDB0000641,SLC6A19,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1086,HMDB0000641,SLC7A5,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1087,HMDB0000641,SLC1A5,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1088,HMDB0000641,SLC43A1,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,WP5220: Metabolic reprogramming in pancreatic cancer,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1089,HMDB0000641,SLC38A8,Amino sugar metabolism; Aspartate metabolism; Glutamate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Phenylalanine metabolism; Purine metabolism; Pyrimidine metabolism; Urea cycle,,L-Glutamine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1090,HMDB0000653,NRIP1,,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP34: Ovarian infertility; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis,Cholesterol sulfate,"Blood,Urine"
1091,HMDB0000653,CD247,,WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP5362: TAR syndrome; WP69: T-cell receptor signaling pathway,Cholesterol sulfate,"Blood,Urine"
1092,HMDB0000653,RORA,,WP170: Nuclear receptors; WP236: Adipogenesis; WP3594: Circadian rhythm genes; WP3893: Development and heterogeneity of the ILC family; WP4149: White fat cell differentiation; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Cholesterol sulfate,"Blood,Urine"
1093,HMDB0000657,TNFRSF17,Beta-alanine metabolism; Histidine metabolism; Riboflavin metabolism; Tyrosine metabolism; Tyrosine metabolism,,Copper,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1094,HMDB0000657,FGFR3,Beta-alanine metabolism; Histidine metabolism; Riboflavin metabolism; Tyrosine metabolism; Tyrosine metabolism,WP2064: Neural crest differentiation; WP2828: Bladder cancer; WP3413: NOTCH1 regulation of endothelial cell calcification; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5365: 4p16.3 copy number variation; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Copper,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1095,HMDB0000657,FLT1,Beta-alanine metabolism; Histidine metabolism; Riboflavin metabolism; Tyrosine metabolism; Tyrosine metabolism,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Copper,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1096,HMDB0000660,SLC2A7,Amino sugar metabolism; Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Fructose,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1097,HMDB0000660,SLC2A5,Amino sugar metabolism; Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,D-Fructose,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1098,HMDB0000660,SLC2A8,Amino sugar metabolism; Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway,D-Fructose,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1099,HMDB0000660,SLC2A2,Amino sugar metabolism; Fructose and mannose metabolism; Galactose metabolism; Starch and sucrose metabolism,WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5446: GLP-1 secretion from intestine to portal vein,D-Fructose,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1100,HMDB0000670,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Homo-L-arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1101,HMDB0000673,SLC27A5,Alpha-linolenic acid metabolism,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Linoleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1102,HMDB0000673,TRPV4,Alpha-linolenic acid metabolism,,Linoleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1103,HMDB0000673,FFAR4,Alpha-linolenic acid metabolism,,Linoleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1104,HMDB0000674,TRPC5,Glycerolipid metabolism; Phospholipid biosynthesis,,PA(16:0/16:0),Blood
1105,HMDB0000674,TRPC4,Glycerolipid metabolism; Phospholipid biosynthesis,WP5158: Urotensin-II-mediated signaling pathway,PA(16:0/16:0),Blood
1106,HMDB0000687,SLC7A5,"Valine, leucine and isoleucine degradation","WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Leucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1107,HMDB0000687,SLC43A2,"Valine, leucine and isoleucine degradation",,L-Leucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1108,HMDB0000687,SLC3A2,"Valine, leucine and isoleucine degradation","WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",L-Leucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1109,HMDB0000687,SLC1A5,"Valine, leucine and isoleucine degradation","WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",L-Leucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1110,HMDB0000687,SLC43A1,"Valine, leucine and isoleucine degradation",WP5220: Metabolic reprogramming in pancreatic cancer,L-Leucine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1111,HMDB0000691,PPARG,Aspartate metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Malonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1112,HMDB0000691,NCOA1,Aspartate metabolism,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Malonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1113,HMDB0000691,GRB7,Aspartate metabolism,WP304: Kit receptor signaling pathway; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP5287: 17q12 copy number variation syndrome,Malonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1114,HMDB0000696,SLC43A1,"Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Methionine metabolism",WP5220: Metabolic reprogramming in pancreatic cancer,L-Methionine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1115,HMDB0000696,SLC7A5,"Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Methionine metabolism","WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",L-Methionine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1116,HMDB0000696,SLC43A2,"Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Methionine metabolism",,L-Methionine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1117,HMDB0000696,SLC6A19,"Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Methionine metabolism",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map,L-Methionine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1118,HMDB0000715,GPR35,Tryptophan metabolism,"WP455: GPCRs, class A rhodopsin-like; WP5224: 2q37 copy number variation syndrome",Kynurenic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1119,HMDB0000719,SLC43A1,Methionine metabolism,WP5220: Metabolic reprogramming in pancreatic cancer,L-Homoserine,"Blood,Feces,Urine"
1120,HMDB0000757,STBD1,Starch and sucrose metabolism,WP410: Exercise-induced circadian regulation,Glycogen,"Blood,Urine"
1121,HMDB0000761,GPBAR1,Primary bile acid biosynthesis,,Lithocholic acid,"Bile,Blood,Feces,Urine"
1122,HMDB0000761,VDR,Primary bile acid biosynthesis,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Lithocholic acid,"Bile,Blood,Feces,Urine"
1123,HMDB0000763,PPARG,Tryptophan metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",5-Hydroxyindoleacetic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1124,HMDB0000801,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Phytanic acid,"Blood,Feces"
1125,HMDB0000801,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Phytanic acid,"Blood,Feces"
1126,HMDB0000803,CD3G,,WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP69: T-cell receptor signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1127,HMDB0000803,ADGRL3,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1128,HMDB0000803,TNFRSF11A,,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3594: Circadian rhythm genes; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP5187: mRNA vaccine activation of dendritic cell and induction of IFN-1; WP5205: Clock-controlled autophagy in bone metabolism,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1129,HMDB0000803,GRIN2B,,WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4754: IL-18 signaling pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1130,HMDB0000803,CHRNA3,,WP1602: Nicotine effect on dopaminergic neurons; WP1603: Nicotine effect on chromaffin cells,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1131,HMDB0000803,CDH17,,WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5390: Pancreatic cancer subtypes,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1132,HMDB0000803,VSIR,,WP5078: T cell modulation in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1133,HMDB0000803,LGR4,,WP3594: Circadian rhythm genes,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1134,HMDB0000803,GLP1R,,"WP334: GPCRs, class B secretin-like",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1135,HMDB0000803,NECTIN2,,WP727: Monoamine transport,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1136,HMDB0000803,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1137,HMDB0000803,EPHB2,,WP2038: Microtubule cytoskeleton regulation; WP288: Nod-like receptor (NLR) signaling pathway; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP4331: Neovascularization processes; WP4357: NRF2-ARE regulation; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1138,HMDB0000803,PVR,,WP5078: T cell modulation in pancreatic cancer; WP5092: Interactions of natural killer cells in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1139,HMDB0000803,ACVR2A,,WP2857: Mesodermal commitment pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1140,HMDB0000803,PLAUR,,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2806: Complement system; WP3888: VEGFA-VEGFR2 signaling; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP558: Complement and coagulation cascades,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1141,HMDB0000803,HTR3A,,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1142,HMDB0000803,CHRNB3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1143,HMDB0000803,GRIN2D,,WP2059: Alzheimer's disease and miRNA effects; WP3944: Serotonin and anxiety-related events; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1144,HMDB0000803,NPR3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1145,HMDB0000803,CEACAM3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1146,HMDB0000803,GABBR1,,"WP4159: GABA receptor signaling; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1147,HMDB0000803,GFRA2,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1148,HMDB0000803,TNFRSF1A,,"WP1772: Apoptosis modulation and signaling; WP2059: Alzheimer's disease and miRNA effects; WP231: TNF-alpha signaling pathway; WP2447: Amyotrophic lateral sclerosis (ALS); WP2513: Nanoparticle triggered regulated necrosis; WP254: Apoptosis; WP2795: Cardiac hypertrophic response; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4396: Nonalcoholic fatty liver disease; WP453: Inflammatory response pathway; WP4754: IL-18 signaling pathway; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5182: Pro-survival signaling of neuroprotectin D1; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5422: IL-19 signaling pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1149,HMDB0000803,GRM2,,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1150,HMDB0000803,PLA2R1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1151,HMDB0000803,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1152,HMDB0000803,GABRA5,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1153,HMDB0000803,IL6ST,,WP1528: Physiological and pathological hypertrophy of the heart; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2332: Interleukin-11 signaling pathway; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP2815: Mammary gland development pathway - Involution (Stage 4 of 4); WP364: IL6 signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5036: Angiotensin II receptor type 1 pathway; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1154,HMDB0000803,IL7R,,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1155,HMDB0000803,IL10RA,,WP3945: TYROBP causal network in microglia; WP4495: IL-10 anti-inflammatory signaling pathway ; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1156,HMDB0000803,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1157,HMDB0000803,IL2RG,,WP205: IL-7 signaling pathway; WP22: IL-9 signaling pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP395: IL-4 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1158,HMDB0000803,NCR3LG1,,WP5092: Interactions of natural killer cells in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1159,HMDB0000803,MCOLN1,,WP2007: Iron metabolism in placenta,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1160,HMDB0000803,TFRC,,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1161,HMDB0000803,GRIN1,,WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2431: Spinal cord injury; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3676: BDNF-TrkB signaling; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1162,HMDB0000803,GABRG2,,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1163,HMDB0000803,GRIN2A,,WP2059: Alzheimer's disease and miRNA effects; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4685: Melanoma; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1164,HMDB0000803,LRP6,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1165,HMDB0000803,GABRA4,,WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1166,HMDB0000803,S1PR5,,WP26: S1P receptor signal transduction; WP5121: Sphingolipid metabolism in senescence,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1167,HMDB0000803,IL1RAP,,WP195: IL-1 signaling pathway; WP2637: Interleukin-1 (IL-1) structural pathway; WP4496: Signal transduction through IL1R; WP5222: 2q13 copy number variation syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1168,HMDB0000803,ITGB1,,WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1169,HMDB0000803,UNC5A,,WP5380: 5q35 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1170,HMDB0000803,ITGB2,,WP185: Integrin-mediated cell adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4298: Acute viral myocarditis; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5348: 11p11.2 copy number variation syndrome ,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1171,HMDB0000803,FCAR,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1172,HMDB0000803,CD200R1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1173,HMDB0000803,PTPRK,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1174,HMDB0000803,ERBB4,,WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3297: EV release from cardiac cells and their functional effects; WP3680: Physico-chemical features and toxicity-associated pathways; WP4685: Melanoma; WP5402: 10q22q23 copy number variation; WP673: ErbB signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1175,HMDB0000803,PDGFRB,,WP2261: Glioblastoma signaling pathways; WP2526: PDGF pathway; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3640: Imatinib and chronic myeloid leukemia; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3972: PDGFR-beta pathway; WP3981: miRNA regulation of prostate cancer signaling pathways; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5236: Markers of kidney cell lineage; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1176,HMDB0000803,GRM7,,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1177,HMDB0000803,TLR1,,WP2865: IL1 and megakaryocytes in obesity; WP3858: Toll-like receptor signaling related to MyD88; WP3877: MYD88 distinct input-output pathway; WP75: Toll-like receptor signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1178,HMDB0000803,GABRD,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5345: 1p36 copy number variation syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1179,HMDB0000803,ADGRB3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1180,HMDB0000803,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1181,HMDB0000803,GABRB3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1182,HMDB0000803,CASR,,"WP501: GPCRs, class C metabotropic glutamate, pheromone",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1183,HMDB0000803,CD3D,,WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5130: Th17 cell differentiation pathway; WP5362: TAR syndrome; WP69: T-cell receptor signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1184,HMDB0000803,TRPM4,,WP5083: Neuroinflammation and glutamatergic signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1185,HMDB0000803,FCGR2A,,WP2431: Spinal cord injury; WP4961: STING pathway in Kawasaki-like disease and COVID-19; WP5346: 8p23.1 copy number variation syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1186,HMDB0000803,CD36,,WP2586: Aryl hydrocarbon receptor pathway; WP3942: PPAR signaling pathway; WP4823: Genes controlling nephrogenesis; WP5061: Fatty acid transporters; WP5181: Roles of ceramides in development of insulin resistance; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1187,HMDB0000803,RIPK1,,WP1772: Apoptosis modulation and signaling; WP2036: TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; WP231: TNF-alpha signaling pathway; WP2513: Nanoparticle triggered regulated necrosis; WP2516: ATM signaling pathway; WP254: Apoptosis; WP384: Apoptosis modulation by HSP70; WP3851: TLR4 signaling and tolerance; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP400: p38 MAPK signaling pathway; WP4655: Cytosolic DNA-sensing pathway; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5182: Pro-survival signaling of neuroprotectin D1; WP75: Toll-like receptor signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1188,HMDB0000803,SORL1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1189,HMDB0000803,IL6R,,WP2848: Pluripotent stem cell differentiation pathway; WP364: IL6 signaling pathway; WP3646: Hepatitis C and hepatocellular carcinoma; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4396: Nonalcoholic fatty liver disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1190,HMDB0000803,IGF1R,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1191,HMDB0000803,TNFSF11,,WP12: Osteoclast signaling; WP2018: RANKL/RANK signaling pathway; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2848: Pluripotent stem cell differentiation pathway; WP2877: Vitamin D receptor pathway; WP322: Osteoblast signaling; WP4262: Breast cancer pathway; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4788: Autosomal recessive osteopetrosis pathways; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP5205: Clock-controlled autophagy in bone metabolism; WP5347: IL-26 signaling pathways; WP5402: 10q22q23 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1192,HMDB0000803,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1193,HMDB0000803,TRBC2,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1194,HMDB0000803,GLRA2,,WP5417: Cell lineage map for neuronal differentiation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1195,HMDB0000803,SLC3A2,,"WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1196,HMDB0000803,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1197,HMDB0000803,PTPRZ1,,WP2431: Spinal cord injury; WP3888: VEGFA-VEGFR2 signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1198,HMDB0000803,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1199,HMDB0000803,ADGRG1,,"WP117: GPCRs, other",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1200,HMDB0000803,TREM2,,WP3937: Microglia pathogen phagocytosis pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1201,HMDB0000803,PTPRM,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1202,HMDB0000803,TRGV4,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1203,HMDB0000803,ERBB2,,WP2034: Leptin signaling pathway; WP2037: Prolactin signaling pathway; WP2261: Glioblastoma signaling pathways; WP2571: Polycystic kidney disease pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3651: Pathways affected in adenoid cystic carcinoma; WP3680: Physico-chemical features and toxicity-associated pathways; WP4155: Endometrial cancer; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP437: EGF/EGFR signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5221: 2q11.2 copy number variation syndrome; WP5287: 17q12 copy number variation syndrome; WP5434: Pathways in cancer; WP673: ErbB signaling pathway; WP710: DNA damage response (only ATM dependent),beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1204,HMDB0000803,PKD2,,WP2571: Polycystic kidney disease pathway; WP4803: Ciliopathies; WP5234: Bardet-Biedl syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1205,HMDB0000803,SLC3A1,,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs),beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1206,HMDB0000803,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1207,HMDB0000803,TNFRSF14,,WP5345: 1p36 copy number variation syndrome; WP5362: TAR syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1208,HMDB0000803,RTN4R,,WP2431: Spinal cord injury; WP4657: 22q11.2 copy number variation syndrome; WP5366: NF1 copy number variation syndrome ; WP5406: 13q12.12 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1209,HMDB0000803,AGTR1,,"WP2328: Allograft rejection; WP24: Peptide GPCRs; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4883: SARS-CoV-2 and ACE2 receptor: molecular mechanisms; WP4969: RAS and bradykinin pathways in COVID-19; WP5036: Angiotensin II receptor type 1 pathway; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5076: Soluble ACE2-mediated cell entry of SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5158: Urotensin-II-mediated signaling pathway; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5360: KCNQ2-related epilepsies; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1210,HMDB0000803,CD22,,WP23: B cell receptor signaling pathway; WP5078: T cell modulation in pancreatic cancer; WP5092: Interactions of natural killer cells in pancreatic cancer; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1211,HMDB0000803,PIGR,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1212,HMDB0000803,TNFRSF21,,WP254: Apoptosis; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1213,HMDB0000803,IZUMO1R,,WP176: Folate metabolism,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1214,HMDB0000803,SLC7A8,,WP4917: Proximal tubule transport,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1215,HMDB0000803,CHRNA4,,WP1602: Nicotine effect on dopaminergic neurons; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1216,HMDB0000803,LRP8,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1217,HMDB0000803,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1218,HMDB0000803,LEPR,,WP1403: AMP-activated protein kinase signaling; WP2034: Leptin signaling pathway; WP3934: Leptin and adiponectin; WP3935: Leptin-insulin signaling overlap; WP4396: Nonalcoholic fatty liver disease; WP5400: 6q16 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1219,HMDB0000803,FCGR1A,,WP3937: Microglia pathogen phagocytosis pathway; WP5293: Acute myeloid leukemia,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1220,HMDB0000803,IFNGR2,,"WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP619: Type II interferon signaling",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1221,HMDB0000803,KREMEN1,,WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP5087: Pleural mesothelioma,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1222,HMDB0000803,TNFRSF9,,WP5078: T cell modulation in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1223,HMDB0000803,GLRA3,,WP5417: Cell lineage map for neuronal differentiation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1224,HMDB0000803,ABCA1,,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1225,HMDB0000803,PTPRS,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1226,HMDB0000803,TRPC3,,WP3676: BDNF-TrkB signaling; WP3888: VEGFA-VEGFR2 signaling; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5356: Affected pathways in Duchenne muscular dystrophy,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1227,HMDB0000803,S1PR1,,"WP117: GPCRs, other; WP247: Small ligand GPCRs; WP26: S1P receptor signal transduction; WP3888: VEGFA-VEGFR2 signaling; WP5121: Sphingolipid metabolism in senescence; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5316: Primary ovarian insufficiency",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1228,HMDB0000803,SLC1A5,,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1229,HMDB0000803,FCGR2B,,WP4630: Measles virus infection; WP5346: 8p23.1 copy number variation syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1230,HMDB0000803,CSF2RA,,WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1231,HMDB0000803,IL23R,,WP5098: T-cell activation SARS-CoV-2; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1232,HMDB0000803,IL2RB,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1233,HMDB0000803,ITGB7,,WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP306: Focal adhesion; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1234,HMDB0000803,GLRB,,WP5417: Cell lineage map for neuronal differentiation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1235,HMDB0000803,SLC7A5,,"WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP5087: Pleural mesothelioma; WP5220: Metabolic reprogramming in pancreatic cancer",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1236,HMDB0000803,FCGR3A,,WP2806: Complement system; WP5092: Interactions of natural killer cells in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1237,HMDB0000803,NPC1L1,,WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1238,HMDB0000803,P2RX3,,WP4900: Purinergic signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1239,HMDB0000803,TEX101,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1240,HMDB0000803,SCARA5,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1241,HMDB0000803,PLXNB1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1242,HMDB0000803,GABRR1,,WP3998: Prader-Willi and Angelman syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1243,HMDB0000803,GLRA1,,WP5417: Cell lineage map for neuronal differentiation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1244,HMDB0000803,CNTFR,,WP236: Adipogenesis; WP4538: Regulatory circuits of the STAT3 signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1245,HMDB0000803,GRID1,,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1246,HMDB0000803,IL4R,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP395: IL-4 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP453: Inflammatory response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5422: IL-19 signaling pathway; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1247,HMDB0000803,TRPA1,,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1248,HMDB0000803,EFNB2,,WP2431: Spinal cord injury; WP5205: Clock-controlled autophagy in bone metabolism,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1249,HMDB0000803,IFNAR1,,WP12: Osteoclast signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4197: Immune response to tuberculosis; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4912: SARS coronavirus and innate immunity; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5098: T-cell activation SARS-CoV-2; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5434: Pathways in cancer; WP585: Interferon type I signaling pathways; WP75: Toll-like receptor signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1250,HMDB0000803,GRM3,,"WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1251,HMDB0000803,RAMP3,,WP289: Myometrial relaxation and contraction pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1252,HMDB0000803,INSR,,WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1253,HMDB0000803,SLC6A19,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1254,HMDB0000803,GRM8,,"WP117: GPCRs, other; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1255,HMDB0000803,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1256,HMDB0000803,SLC6A1,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1257,HMDB0000803,ADGRB2,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1258,HMDB0000803,CD79A,,WP23: B cell receptor signaling pathway; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1259,HMDB0000803,TLR2,,"WP2806: Complement system; WP2865: IL1 and megakaryocytes in obesity; WP3858: Toll-like receptor signaling related to MyD88; WP3877: MYD88 distinct input-output pathway; WP3926: ApoE and miR-146 in inflammation and atherosclerosis; WP4172: PI3K-Akt signaling pathway; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4478: LTF danger signal response pathway; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5346: 8p23.1 copy number variation syndrome; WP75: Toll-like receptor signaling pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1260,HMDB0000803,IL17RC,,WP2112: IL-17 signaling pathway; WP5256: COVID-19 and endothelial cell senescence,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1261,HMDB0000803,LINGO1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP5406: 13q12.12 copy number variation,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1262,HMDB0000803,ACVRL1,,WP4331: Neovascularization processes; WP5300: TROP2 regulatory signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1263,HMDB0000803,FCGR2C,,WP5346: 8p23.1 copy number variation syndrome,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1264,HMDB0000803,NTRK1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1265,HMDB0000803,TSHR,,WP1981: Thyroxine (thyroid hormone) production; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP24: Peptide GPCRs; WP4746: Thyroid hormones production and peripheral downstream signaling effects,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1266,HMDB0000803,LILRB1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1267,HMDB0000803,ADGRL1,,"WP334: GPCRs, class B secretin-like",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1268,HMDB0000803,ADGRF1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1269,HMDB0000803,NECTIN3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1270,HMDB0000803,FLT4,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1271,HMDB0000803,IL22RA1,,WP4538: Regulatory circuits of the STAT3 signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1272,HMDB0000803,HCAR2,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1273,HMDB0000803,TEK,,WP1539: Angiogenesis; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1274,HMDB0000803,IL17RA,,WP2112: IL-17 signaling pathway; WP5256: COVID-19 and endothelial cell senescence,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1275,HMDB0000803,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1276,HMDB0000803,CR2,,"WP117: GPCRs, other; WP23: B cell receptor signaling pathway; WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP2806: Complement system; WP2877: Vitamin D receptor pathway; WP3624: Lung fibrosis; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3929: Chemokine signaling pathway; WP3941: Oxidative damage response; WP4217: Ebola virus infection in host; WP4290: Metabolic reprogramming in colon cancer; WP4312: Rett syndrome; WP4397: Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP4804: Cholesterol biosynthesis with skeletal dysplasias; WP4950: 16p11.2 distal deletion syndrome; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5055: Burn wound healing; WP5078: T cell modulation in pancreatic cancer; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5171: Leukotriene metabolic pathway; WP5193: Cholesterol synthesis disorders; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5304: Cholesterol metabolism; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP558: Complement and coagulation cascades",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1277,HMDB0000803,IL1RAPL1,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1278,HMDB0000803,ABCA7,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1279,HMDB0000803,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1280,HMDB0000803,CLEC2D,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1281,HMDB0000803,ERBB3,,WP1591: Heart development; WP2261: Glioblastoma signaling pathways; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP4806: EGFR tyrosine kinase inhibitor resistance; WP673: ErbB signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1282,HMDB0000803,TRAC,,WP5078: T cell modulation in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1283,HMDB0000803,TLR4,,"WP2272: Pathogenic Escherichia coli infection; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3851: TLR4 signaling and tolerance; WP3858: Toll-like receptor signaling related to MyD88; WP3877: MYD88 distinct input-output pathway; WP3890: Nanomaterial-induced inflammasome activation; WP3926: ApoE and miR-146 in inflammation and atherosclerosis; WP4136: Fibrin complement receptor 3 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4298: Acute viral myocarditis; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4329: miRNA role in immune response in sepsis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4478: LTF danger signal response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4919: Neuroinflammation; WP5044: Kynurenine pathway and links to cell senescence; WP5055: Burn wound healing; WP5093: Opioid receptor pathways; WP5198: Inflammatory bowel disease signaling; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5256: COVID-19 and endothelial cell senescence; WP5272: LDL- influence on CD14 and TLR4; WP5336: Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ; WP5346: 8p23.1 copy number variation syndrome; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP75: Toll-like receptor signaling pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1284,HMDB0000803,TRBC1,,WP5078: T cell modulation in pancreatic cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1285,HMDB0000803,CALCR,,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1286,HMDB0000803,OSCAR,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1287,HMDB0000803,TRAV21,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1288,HMDB0000803,SORCS2,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1289,HMDB0000803,GRM5,,"WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1290,HMDB0000803,PTPRC,,WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5098: T-cell activation SARS-CoV-2; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP581: EPO receptor signaling; WP585: Interferon type I signaling pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1291,HMDB0000803,IL18RAP,,WP4754: IL-18 signaling pathway; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5198: Inflammatory bowel disease signaling,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1292,HMDB0000803,SELL,,WP2806: Complement system; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1293,HMDB0000803,TRAV12-3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1294,HMDB0000803,MCOLN3,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1295,HMDB0000803,PLXNA1,,WP5144: NRP1-triggered signaling pathways in pancreatic cancer ,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1296,HMDB0000803,CSF1R,,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1297,HMDB0000803,FOLR2,,WP176: Folate metabolism; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1298,HMDB0000803,ABCB1,,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1299,HMDB0000803,ITGAV,,WP1434: Osteopontin signaling; WP185: Integrin-mediated cell adhesion; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP306: Focal adhesion; WP322: Osteoblast signaling; WP3301: MFAP5-mediated ovarian cancer cell motility and invasiveness; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4541: Hippo-Merlin signaling dysregulation; WP4560: MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement; WP4658: Small cell lung cancer; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5033: Genes associated with the development of rheumatoid arthritis; WP5087: Pleural mesothelioma; WP5090: Complement system in neuronal development and plasticity; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1300,HMDB0000803,CHRNA9,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1301,HMDB0000803,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1302,HMDB0000803,SORT1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1303,HMDB0000803,GRM1,,"WP117: GPCRs, other; WP2636: Common pathways underlying drug addiction; WP3853: ERK pathway in Huntington's disease; WP3947: Serotonin and anxiety; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP4875: Disruption of postsynaptic signaling by CNV; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1304,HMDB0000803,KIR2DL4,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1305,HMDB0000803,GCGR,,"WP334: GPCRs, class B secretin-like",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1306,HMDB0000803,CCR8,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP5097: CCL18 signaling pathway",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1307,HMDB0000803,FCER1A,,WP2865: IL1 and megakaryocytes in obesity,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1308,HMDB0000803,GRIA2,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1309,HMDB0000803,SLC13A5,,,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1310,HMDB0000803,CD2,,"WP1530: miRNA regulation of DNA damage response; WP2263: Androgen receptor network in prostate cancer; WP23: B cell receptor signaling pathway; WP2328: Allograft rejection; WP2516: ATM signaling pathway; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2583: T cell receptor and co-stimulatory signaling; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP4016: DNA IR-damage and cellular response via ATR; WP411: mRNA processing; WP4204: Tumor suppressor activity of SMARCB1; WP4217: Ebola virus infection in host; WP4321: Thermogenesis; WP4352: Ciliary landscape; WP4484: Control of immune tolerance by vasoactive intestinal peptide; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP453: Inflammatory response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4582: Cancer immunotherapy by CTLA4 blockade; WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP4758: Nephrotic syndrome; WP4823: Genes controlling nephrogenesis; WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP5033: Genes associated with the development of rheumatoid arthritis; WP5063: FOXP3 in COVID-19; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5092: Interactions of natural killer cells in pancreatic cancer; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5351: Kleefstra syndrome; WP5362: TAR syndrome; WP5407: 15q11q13 copy number variation; WP5417: Cell lineage map for neuronal differentiation; WP69: T-cell receptor signaling pathway; WP707: DNA damage response",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1311,HMDB0000803,GABBR2,,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1312,HMDB0000803,LGR5,,WP2840: Hair follicle development: cytodifferentiation - part 3 of 3,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1313,HMDB0000803,CHRNB4,,WP1603: Nicotine effect on chromaffin cells; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1314,HMDB0000803,EPHA4,,WP2431: Spinal cord injury; WP2854: Gene regulatory network modeling somitogenesis ; WP4549: Fragile X syndrome; WP4785: Somitogenesis in the context of spondylocostal dysostosis,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1315,HMDB0000803,FOLR1,,WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1316,HMDB0000803,LIFR,,WP1528: Physiological and pathological hypertrophy of the heart; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4538: Regulatory circuits of the STAT3 signaling pathway,beta-N-Acetylglucosamine,"Blood,Feces,Saliva,Urine"
1317,HMDB0000806,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1318,HMDB0000806,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1319,HMDB0000806,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1320,HMDB0000806,PVR,,WP5078: T cell modulation in pancreatic cancer; WP5092: Interactions of natural killer cells in pancreatic cancer,Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1321,HMDB0000806,SLC27A2,,WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5176: Disorders of bile acid synthesis and biliary transport; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1322,HMDB0000806,HNF4A,,WP1403: AMP-activated protein kinase signaling; WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP5236: Markers of kidney cell lineage; WP5417: Cell lineage map for neuronal differentiation,Myristic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1323,HMDB0000820,EPHA4,Sulfur metabolism,WP2431: Spinal cord injury; WP2854: Gene regulatory network modeling somitogenesis ; WP4549: Fragile X syndrome; WP4785: Somitogenesis in the context of spondylocostal dysostosis,Propyl alcohol,"Blood,Feces,Saliva"
1324,HMDB0000826,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Pentadecanoic acid,"Blood,Feces,Saliva,Sweat,Urine"
1325,HMDB0000826,NR1I3,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2875: Constitutive androstane receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5238: Cholestasis; WP5351: Kleefstra syndrome,Pentadecanoic acid,"Blood,Feces,Saliva,Sweat,Urine"
1326,HMDB0000827,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Stearic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1327,HMDB0000827,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Stearic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1328,HMDB0000827,SLC27A5,,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Stearic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1329,HMDB0000847,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Pelargonic acid,"Blood,Feces,Saliva,Sweat,Urine"
1330,HMDB0000863,LILRB2,,,Isopropyl alcohol,"Blood,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1331,HMDB0000863,PILRA,,,Isopropyl alcohol,"Blood,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1332,HMDB0000863,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,Isopropyl alcohol,"Blood,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1333,HMDB0000863,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Isopropyl alcohol,"Blood,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1334,HMDB0000870,GABRB3,Histidine metabolism,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1335,HMDB0000870,GABRD,Histidine metabolism,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5345: 1p36 copy number variation syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1336,HMDB0000870,HRH4,Histidine metabolism,"WP117: GPCRs, other",Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1337,HMDB0000870,HRH2,Histidine metabolism,"WP2597: Secretion of hydrochloric acid in parietal cells; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1338,HMDB0000870,SLC22A3,Histidine metabolism,WP2267: Synaptic vesicle pathway,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1339,HMDB0000870,SLC22A2,Histidine metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1340,HMDB0000870,HRH3,Histidine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP727: Monoamine transport",Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1341,HMDB0000870,GABRA1,Histidine metabolism,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1342,HMDB0000870,SLC22A5,Histidine metabolism,WP5123: Mitochondrial fatty acid oxidation disorders,Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1343,HMDB0000870,HRH1,Histidine metabolism,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Histamine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1344,HMDB0000876,VDR,Steroid biosynthesis,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Vitamin D3,"Blood,Saliva,Urine"
1345,HMDB0000876,GOT2,Steroid biosynthesis,WP106: Alanine and aspartate metabolism; WP3925: Amino acid metabolism; WP4290: Metabolic reprogramming in colon cancer; WP4595: Urea cycle and associated pathways; WP465: Tryptophan metabolism; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5166: Glyoxylate metabolism; WP5220: Metabolic reprogramming in pancreatic cancer; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5414: IDO metabolic pathway; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Vitamin D3,"Blood,Saliva,Urine"
1346,HMDB0000876,CD36,Steroid biosynthesis,WP2586: Aryl hydrocarbon receptor pathway; WP3942: PPAR signaling pathway; WP4823: Genes controlling nephrogenesis; WP5061: Fatty acid transporters; WP5181: Roles of ceramides in development of insulin resistance; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,Vitamin D3,"Blood,Saliva,Urine"
1347,HMDB0000879,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Tetrahydrodeoxycorticosterone,"Blood,Feces,Urine"
1348,HMDB0000883,SLC43A1,"Propanoate metabolism; Valine, leucine and isoleucine degradation",WP5220: Metabolic reprogramming in pancreatic cancer,L-Valine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1349,HMDB0000883,SLC43A2,"Propanoate metabolism; Valine, leucine and isoleucine degradation",,L-Valine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1350,HMDB0000895,CHRNA7,Phospholipid biosynthesis,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1351,HMDB0000895,CHRM4,Phospholipid biosynthesis,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1352,HMDB0000895,CHRFAM7A,Phospholipid biosynthesis,WP4942: 15q13.3 copy number variation syndrome,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1353,HMDB0000895,CHRM3,Phospholipid biosynthesis,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4874: CAMKK2 pathway; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1354,HMDB0000895,CHRM5,Phospholipid biosynthesis,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1355,HMDB0000895,CHRM2,Phospholipid biosynthesis,"WP117: GPCRs, other; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1356,HMDB0000895,CHRM1,Phospholipid biosynthesis,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1357,HMDB0000895,SLC22A1,Phospholipid biosynthesis,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1358,HMDB0000895,CHRNA4,Phospholipid biosynthesis,WP1602: Nicotine effect on dopaminergic neurons; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1359,HMDB0000895,CHRNA2,Phospholipid biosynthesis,,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1360,HMDB0000895,CHRNA1,Phospholipid biosynthesis,,Acetylcholine,"Cerebrospinal Fluid (CSF),Saliva"
1361,HMDB0000925,TNFRSF9,,WP5078: T cell modulation in pancreatic cancer,Trimethylamine N-oxide,"Blood,Feces,Saliva,Urine"
1362,HMDB0000929,GPR142,Tryptophan metabolism,,L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1363,HMDB0000929,SLC36A4,Tryptophan metabolism,,L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1364,HMDB0000929,SLC16A10,Tryptophan metabolism,WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport,L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1365,HMDB0000929,HTR3A,Tryptophan metabolism,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1366,HMDB0000929,CASR,Tryptophan metabolism,"WP501: GPCRs, class C metabotropic glutamate, pheromone",L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1367,HMDB0000929,SLC3A2,Tryptophan metabolism,"WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",L-Tryptophan,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1368,HMDB0000939,FLT1,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Tryptophan metabolism; Tyrosine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis",WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,S-Adenosylhomocysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1369,HMDB0000939,ESR1,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Tryptophan metabolism; Tyrosine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis","WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",S-Adenosylhomocysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1370,HMDB0000939,TGS1,"Arginine and proline metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Tryptophan metabolism; Tyrosine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis","WP15: Selenium micronutrient network; WP167: Eicosanoid synthesis; WP3287: Overview of nanoparticle effects; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5155: Arachidonic acid (AA, ARA) oxylipin metabolism; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5324: Octadecanoid formation from linoleic acid; WP5424: Omega-6-fatty acids in senescence; WP5444: Acetaminophen in analgesia and antipyresis; WP98: Prostaglandin synthesis and regulation",S-Adenosylhomocysteine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1371,HMDB0000956,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Tartaric acid,"Blood,Feces,Urine"
1372,HMDB0000956,TREM1,,WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP4478: LTF danger signal response pathway,Tartaric acid,"Blood,Feces,Urine"
1373,HMDB0000956,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Tartaric acid,"Blood,Feces,Urine"
1374,HMDB0000956,GCGR,,"WP334: GPCRs, class B secretin-like",Tartaric acid,"Blood,Feces,Urine"
1375,HMDB0000956,OPRD1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Tartaric acid,"Blood,Feces,Urine"
1376,HMDB0000956,CYSLTR2,,"WP3624: Lung fibrosis; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX)",Tartaric acid,"Blood,Feces,Urine"
1377,HMDB0000956,C5AR1,,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,Tartaric acid,"Blood,Feces,Urine"
1378,HMDB0000990,ITGAM,Pyruvate metabolism,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Acetaldehyde,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1379,HMDB0001032,GABRA1,Androgen and estrogen metabolism,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Dehydroepiandrosterone sulfate,"Blood,Feces,Urine"
1380,HMDB0001039,PTH1R,,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Hydroxide,
1381,HMDB0001043,PPARA,Alpha-linolenic acid metabolism; Arachidonic acid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Arachidonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1382,HMDB0001043,SLC27A5,Alpha-linolenic acid metabolism; Arachidonic acid metabolism,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Arachidonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1383,HMDB0001043,PPARG,Alpha-linolenic acid metabolism; Arachidonic acid metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Arachidonic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1384,HMDB0001085,PPARA,Arachidonic acid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Leukotriene B4,"Blood,Cerebrospinal Fluid (CSF),Urine"
1385,HMDB0001085,LTB4R,Arachidonic acid metabolism,"WP117: GPCRs, other; WP2431: Spinal cord injury; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; WP80: Nucleotide GPCRs",Leukotriene B4,"Blood,Cerebrospinal Fluid (CSF),Urine"
1386,HMDB0001139,SLC22A2,Arachidonic acid metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Prostaglandin F2a,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1387,HMDB0001139,SLC22A1,Arachidonic acid metabolism,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Prostaglandin F2a,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1388,HMDB0001149,TSPO2,"Glycine, serine and threonine metabolism; Porphyrin metabolism",,5-Aminolevulinic acid,"Blood,Urine"
1389,HMDB0001178,CD38,Glutamate metabolism; Nicotinate and nicotinamide metabolism; Purine metabolism,WP2889: Oxytocin signaling; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP4962: Airway smooth muscle cell contraction,Adenosine diphosphate ribose,
1390,HMDB0001178,TRPM2,Glutamate metabolism; Nicotinate and nicotinamide metabolism; Purine metabolism,WP2858: Ectoderm differentiation; WP5115: Network map of SARS-CoV-2 signaling pathway,Adenosine diphosphate ribose,
1391,HMDB0001201,TRPV4,Aspartate metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Purine metabolism; Pyruvate metabolism,,Guanosine diphosphate,"Blood,Cerebrospinal Fluid (CSF)"
1392,HMDB0001220,PTGER3,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP4483: Relationship between inflammation, COX-2 and EGFR; WP455: GPCRs, class A rhodopsin-like; WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1393,HMDB0001220,SLC22A2,Arachidonic acid metabolism,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1394,HMDB0001220,PTGER2,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP34: Ovarian infertility; WP4483: Relationship between inflammation, COX-2 and EGFR; WP455: GPCRs, class A rhodopsin-like; WP5088: Prostaglandin signaling; WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1395,HMDB0001220,SLC22A1,Arachidonic acid metabolism,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1396,HMDB0001220,PTGER1,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP4483: Relationship between inflammation, COX-2 and EGFR; WP455: GPCRs, class A rhodopsin-like; WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1397,HMDB0001220,PTGER4,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP2877: Vitamin D receptor pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP455: GPCRs, class A rhodopsin-like; WP5088: Prostaglandin signaling; WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Prostaglandin E2,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1398,HMDB0001251,HRH2,Steroid biosynthesis,"WP2597: Secretion of hydrochloric acid in parietal cells; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Lanosterol,"Blood,Feces"
1399,HMDB0001256,SLC22A1,,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Spermine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1400,HMDB0001256,SLC22A4,,WP5033: Genes associated with the development of rheumatoid arthritis; WP5362: TAR syndrome,Spermine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1401,HMDB0001257,TAAR9,Methionine metabolism,,Spermidine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1402,HMDB0001264,SLC2A1,Tyrosine metabolism; Tyrosine metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,Dehydroascorbic acid,"Blood,Urine"
1403,HMDB0001264,SLC2A4,Tyrosine metabolism; Tyrosine metabolism,WP1403: AMP-activated protein kinase signaling; WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP236: Adipogenesis; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4030: SCFA and skeletal muscle substrate metabolism; WP4657: 22q11.2 copy number variation syndrome; WP481: Insulin signaling; WP4844: Influence of laminopathies on Wnt signaling; WP4970: Galanin receptor pathway; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5094: Orexin receptor pathway; WP5181: Roles of ceramides in development of insulin resistance; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP534: Glycolysis and gluconeogenesis; WP5346: 8p23.1 copy number variation syndrome; WP5355: Metabolic Epileptic Disorders,Dehydroascorbic acid,"Blood,Urine"
1404,HMDB0001264,SLC2A3,Tyrosine metabolism; Tyrosine metabolism,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP5083: Neuroinflammation and glutamatergic signaling; WP5283: Chronic hyperglycemia impairment of neuron function; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders,Dehydroascorbic acid,"Blood,Urine"
1405,HMDB0001273,CYTH3,Aspartate metabolism; Citric acid cycle; Fructose and mannose metabolism; Glycolysis_gluconeogenesis; Pterine biosynthesis; Purine metabolism; Pyruvate metabolism,WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,Guanosine triphosphate,"Blood,Cerebrospinal Fluid (CSF)"
1406,HMDB0001311,SLC16A1,Pyruvate metabolism,WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP4549: Fragile X syndrome; WP4742: Ketogenesis and ketolysis; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4917: Proximal tubule transport; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells,D-Lactic acid,"Blood,Cerebrospinal Fluid (CSF),Urine"
1407,HMDB0001311,HCAR1,Pyruvate metabolism,"WP455: GPCRs, class A rhodopsin-like",D-Lactic acid,"Blood,Cerebrospinal Fluid (CSF),Urine"
1408,HMDB0001327,SLC1A3,,WP2267: Synaptic vesicle pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5417: Cell lineage map for neuronal differentiation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Rubidium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1409,HMDB0001327,SLC1A5,,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",Rubidium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1410,HMDB0001333,ERBB4,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3297: EV release from cardiac cells and their functional effects; WP3680: Physico-chemical features and toxicity-associated pathways; WP4685: Melanoma; WP5402: 10q22q23 copy number variation; WP673: ErbB signaling pathway,Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1411,HMDB0001333,ITGAM,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1412,HMDB0001333,INSR,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1413,HMDB0001333,TNFRSF9,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",WP5078: T cell modulation in pancreatic cancer,Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1414,HMDB0001333,ITGB1,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1415,HMDB0001333,ANTXR2,"Alanine, aspartate and glutamate metabolism; Arginine and proline metabolism; Citric acid cycle; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Phosphatidylinositol phosphate metabolism; Phospholipid biosynthesis; Propanoate metabolism; Pyruvate metabolism; Urea cycle",,Manganese,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1416,HMDB0001341,P2RY12,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1417,HMDB0001341,TGS1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP15: Selenium micronutrient network; WP167: Eicosanoid synthesis; WP3287: Overview of nanoparticle effects; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5155: Arachidonic acid (AA, ARA) oxylipin metabolism; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5324: Octadecanoid formation from linoleic acid; WP5424: Omega-6-fatty acids in senescence; WP5444: Acetaminophen in analgesia and antipyresis; WP98: Prostaglandin synthesis and regulation",ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1418,HMDB0001341,P2RY1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5360: KCNQ2-related epilepsies; WP80: Nucleotide GPCRs",ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1419,HMDB0001341,ABCC8,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1420,HMDB0001341,BMPR2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP1425: Bone morphogenic protein signaling and regulation; WP1591: Heart development; WP2857: Mesodermal commitment pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3931: Embryonic stem cell pluripotency pathways; WP4787: Osteoblast differentiation and related diseases; WP5053: Development of ureteric collection system; WP5205: Clock-controlled autophagy in bone metabolism; WP5316: Primary ovarian insufficiency,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1421,HMDB0001341,EPHB1,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1422,HMDB0001341,EPHB2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2038: Microtubule cytoskeleton regulation; WP288: Nod-like receptor (NLR) signaling pathway; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP3888: VEGFA-VEGFR2 signaling; WP4331: Neovascularization processes; WP4357: NRF2-ARE regulation; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1423,HMDB0001341,ABCB6,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1424,HMDB0001341,CNNM2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1425,HMDB0001341,CLCN5,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP1981: Thyroxine (thyroid hormone) production,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1426,HMDB0001341,KIT,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1427,HMDB0001341,ALK,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1428,HMDB0001341,EGFR,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1429,HMDB0001341,P2RY13,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1430,HMDB0001341,MERTK,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Biosynthesis of unsaturated fatty acids; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; Nucleotide sugars metabolism; One carbon pool by folate; Oxidative phosphorylation; Pantothenate and coa biosynthesis; Phosphatidylinositol phosphate metabolism; Primary bile acid biosynthesis; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation",WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,ADP,"Blood,Cellular Cytoplasm,Cerebrospinal Fluid (CSF),Saliva,Urine"
1431,HMDB0001358,RXRA,Retinol metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Retinal,"Blood,Urine"
1432,HMDB0001358,RXRB,Retinol metabolism,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Retinal,"Blood,Urine"
1433,HMDB0001358,RARB,Retinol metabolism,WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Retinal,"Blood,Urine"
1434,HMDB0001358,RARG,Retinol metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,Retinal,"Blood,Urine"
1435,HMDB0001358,RARA,Retinol metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Retinal,"Blood,Urine"
1436,HMDB0001358,RXRG,Retinol metabolism,"WP170: Nuclear receptors; WP236: Adipogenesis; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Retinal,"Blood,Urine"
1437,HMDB0001358,STRA6,Retinol metabolism,,Retinal,"Blood,Urine"
1438,HMDB0001372,SLC19A1,"Citric acid cycle; Lysine degradation; Propanoate metabolism; Pyruvate metabolism; Thiamine metabolism; Valine, leucine and isoleucine degradation",WP176: Folate metabolism; WP3996: Ethanol effects on histone modifications; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Thiamine pyrophosphate,"Blood,Cerebrospinal Fluid (CSF)"
1439,HMDB0001388,SLC27A5,Alpha-linolenic acid metabolism,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,alpha-Linolenic acid,"Blood,Feces,Saliva,Urine"
1440,HMDB0001389,MTNR1B,Tryptophan metabolism,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Melatonin,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1441,HMDB0001389,MTNR1A,Tryptophan metabolism,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Melatonin,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1442,HMDB0001392,ADGRB1,,WP4963: p53 transcriptional gene network,p-Aminobenzoic acid,"Blood,Feces,Urine"
1443,HMDB0001396,FOLR1,"Glycine, serine and threonine metabolism; Methionine metabolism; One carbon pool by folate",WP176: Folate metabolism; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,5-Methyltetrahydrofolic acid,"Blood,Cerebrospinal Fluid (CSF),Urine"
1444,HMDB0001403,PTGDR,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP3591: Sleep regulation; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Prostaglandin D2,"Blood,Cerebrospinal Fluid (CSF),Urine"
1445,HMDB0001403,PTGDR2,Arachidonic acid metabolism,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",Prostaglandin D2,"Blood,Cerebrospinal Fluid (CSF),Urine"
1446,HMDB0001414,SLC22A4,Methionine metabolism,WP5033: Genes associated with the development of rheumatoid arthritis; WP5362: TAR syndrome,Putrescine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1447,HMDB0001429,SLC20A2,"Alanine, aspartate and glutamate metabolism; Amino sugar metabolism; Arginine and proline metabolism; Aspartate metabolism; Citric acid cycle; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycerolipid metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Glycolysis_gluconeogenesis; Glycolysis_gluconeogenesis; Histidine metabolism; Inositol phosphate metabolism; Inositol phosphate metabolism; Methionine metabolism; Nicotinate and nicotinamide metabolism; Nitrogen metabolism; One carbon pool by folate; Oxidative phosphorylation; Phosphatidylinositol phosphate metabolism; Propanoate metabolism; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Riboflavin metabolism; Selenocompound metabolism; Starch and sucrose metabolism; Starch and sucrose metabolism; Steroid biosynthesis; Sulfur metabolism; Thiamine metabolism; Urea cycle; Valine, leucine and isoleucine degradation; Vitamin b6 metabolism",WP4917: Proximal tubule transport,Phosphate,"Blood,Feces,Saliva,Sweat,Urine"
1448,HMDB0001449,GABRA3,,WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Allopregnanolone,"Blood,Cerebrospinal Fluid (CSF)"
1449,HMDB0001449,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Allopregnanolone,"Blood,Cerebrospinal Fluid (CSF)"
1450,HMDB0001449,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Allopregnanolone,"Blood,Cerebrospinal Fluid (CSF)"
1451,HMDB0001449,GABRG2,,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Allopregnanolone,"Blood,Cerebrospinal Fluid (CSF)"
1452,HMDB0001452,TBXA2R,Arachidonic acid metabolism,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Thromboxane A2,"Blood,Cerebrospinal Fluid (CSF),Urine"
1453,HMDB0001453,ADORA2A,Cysteine metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Thiocyanate,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1454,HMDB0001453,NCOA2,Cysteine metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Thiocyanate,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1455,HMDB0001488,HCAR2,Nicotinate and nicotinamide metabolism,,Nicotinic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1456,HMDB0001514,SLC2A2,Amino sugar metabolism,WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4917: Proximal tubule transport; WP5173: Disorders of galactose metabolism ; WP5178: Disorders of fructose metabolism; WP534: Glycolysis and gluconeogenesis; WP5355: Metabolic Epileptic Disorders; WP5446: GLP-1 secretion from intestine to portal vein,Glucosamine,"Blood,Feces,Saliva,Urine"
1457,HMDB0001514,SLC2A1,Amino sugar metabolism,WP1946: Cori cycle; WP2456: HIF1A and PPARG regulation of glycolysis; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4241: Type 2 papillary renal cell carcinoma; WP4290: Metabolic reprogramming in colon cancer; WP4629: Aerobic glycolysis; WP4742: Ketogenesis and ketolysis; WP481: Insulin signaling; WP4917: Proximal tubule transport; WP4963: p53 transcriptional gene network; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5211: Glucose metabolism in triple-negative breast cancer cells; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5220: Metabolic reprogramming in pancreatic cancer; WP5283: Chronic hyperglycemia impairment of neuron function; WP5312: Metabolic pathways of fibroblasts; WP5314: Lactate shuttle in glial cells; WP534: Glycolysis and gluconeogenesis; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5390: Pancreatic cancer subtypes; WP5408: 15q25 copy number variation; WP5434: Pathways in cancer,Glucosamine,"Blood,Feces,Saliva,Urine"
1458,HMDB0001514,SLC2A4,Amino sugar metabolism,WP1403: AMP-activated protein kinase signaling; WP1584: Type II diabetes mellitus; WP1946: Cori cycle; WP236: Adipogenesis; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4030: SCFA and skeletal muscle substrate metabolism; WP4657: 22q11.2 copy number variation syndrome; WP481: Insulin signaling; WP4844: Influence of laminopathies on Wnt signaling; WP4970: Galanin receptor pathway; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5094: Orexin receptor pathway; WP5181: Roles of ceramides in development of insulin resistance; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP534: Glycolysis and gluconeogenesis; WP5346: 8p23.1 copy number variation syndrome; WP5355: Metabolic Epileptic Disorders,Glucosamine,"Blood,Feces,Saliva,Urine"
1459,HMDB0001520,GRM2,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Flavin mononucleotide,"Blood,Feces"
1460,HMDB0001520,GPR52,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP455: GPCRs, class A rhodopsin-like",Flavin mononucleotide,"Blood,Feces"
1461,HMDB0001520,CNR1,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Flavin mononucleotide,"Blood,Feces"
1462,HMDB0001520,PTAFR,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like",Flavin mononucleotide,"Blood,Feces"
1463,HMDB0001520,NPY2R,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Flavin mononucleotide,"Blood,Feces"
1464,HMDB0001520,LTB4R,Arginine and proline metabolism; Beta-alanine metabolism; Pantothenate and coa biosynthesis; Pyrimidine metabolism; Riboflavin metabolism; Vitamin b6 metabolism,"WP117: GPCRs, other; WP2431: Spinal cord injury; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; WP80: Nucleotide GPCRs",Flavin mononucleotide,"Blood,Feces"
1465,HMDB0001547,NR3C2,Steroidogenesis,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Corticosterone,"Blood,Urine"
1466,HMDB0001547,SLC22A3,Steroidogenesis,WP2267: Synaptic vesicle pathway,Corticosterone,"Blood,Urine"
1467,HMDB0001547,NR3C1,Steroidogenesis,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Corticosterone,"Blood,Urine"
1468,HMDB0001565,CD300LF,Phospholipid biosynthesis; Starch and sucrose metabolism,,Phosphorylcholine,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1469,HMDB0001830,PGR,Steroidogenesis,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Progesterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
1470,HMDB0001830,NR3C2,Steroidogenesis,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Progesterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
1471,HMDB0001847,ADORA2A,Caffeine metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Caffeine,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1472,HMDB0001852,RXRB,Retinol metabolism,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",all-trans-Retinoic acid,"Blood,Urine"
1473,HMDB0001852,NR1H3,Retinol metabolism,WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2878: PPAR-alpha pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4396: Nonalcoholic fatty liver disease; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,all-trans-Retinoic acid,"Blood,Urine"
1474,HMDB0001852,RARG,Retinol metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,all-trans-Retinoic acid,"Blood,Urine"
1475,HMDB0001852,RXRA,Retinol metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",all-trans-Retinoic acid,"Blood,Urine"
1476,HMDB0001852,RARB,Retinol metabolism,WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,all-trans-Retinoic acid,"Blood,Urine"
1477,HMDB0001852,RXRG,Retinol metabolism,"WP170: Nuclear receptors; WP236: Adipogenesis; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",all-trans-Retinoic acid,"Blood,Urine"
1478,HMDB0001852,NCOA2,Retinol metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,all-trans-Retinoic acid,"Blood,Urine"
1479,HMDB0001852,RARA,Retinol metabolism,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,all-trans-Retinoic acid,"Blood,Urine"
1480,HMDB0001870,HAVCR2,,WP4217: Ebola virus infection in host; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5078: T cell modulation in pancreatic cancer,Benzoic acid,"Blood,Breath,Feces,Saliva,Sweat,Urine"
1481,HMDB0001870,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Benzoic acid,"Blood,Breath,Feces,Saliva,Sweat,Urine"
1482,HMDB0001870,GAB2,,WP2018: RANKL/RANK signaling pathway; WP2037: Prolactin signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP23: B cell receptor signaling pathway; WP286: IL-3 signaling pathway; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3676: BDNF-TrkB signaling; WP395: IL-4 signaling pathway; WP4223: Ras signaling; WP437: EGF/EGFR signaling pathway; WP49: IL-2 signaling pathway; WP585: Interferon type I signaling pathways; WP69: T-cell receptor signaling pathway,Benzoic acid,"Blood,Breath,Feces,Saliva,Sweat,Urine"
1483,HMDB0001881,TGS1,Pyruvate metabolism,"WP15: Selenium micronutrient network; WP167: Eicosanoid synthesis; WP3287: Overview of nanoparticle effects; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5155: Arachidonic acid (AA, ARA) oxylipin metabolism; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5324: Octadecanoid formation from linoleic acid; WP5424: Omega-6-fatty acids in senescence; WP5444: Acetaminophen in analgesia and antipyresis; WP98: Prostaglandin synthesis and regulation",Propylene glycol,"Blood,Breath,Cerebrospinal Fluid (CSF),Feces,Saliva,Sweat,Urine"
1484,HMDB0001888,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,"N,N-Dimethylformamide","Blood,Saliva,Urine"
1485,HMDB0001889,ADORA2A,Caffeine metabolism,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Theophylline,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1486,HMDB0001893,SCARB1,,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4846: SARS-CoV-2 and COVID-19 pathway; WP5110: Familial hyperlipidemia type 3; WP5238: Cholestasis; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP716: Vitamin A and carotenoid metabolism",alpha-Tocopherol,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1487,HMDB0001893,NPC1L1,,WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,alpha-Tocopherol,"Blood,Breast Milk,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1488,HMDB0001901,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Aminocaproic acid,"Blood,Feces"
1489,HMDB0001901,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Aminocaproic acid,"Blood,Feces"
1490,HMDB0001903,VDR,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Calcitriol,"Blood,Feces"
1491,HMDB0001917,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Digoxin,Blood
1492,HMDB0001921,SLC22A1,,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,"1,1-Dimethylbiguanide","Blood,Feces,Urine"
1493,HMDB0001926,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,17a-Ethynylestradiol,"Blood,Urine"
1494,HMDB0001927,SLC22A1,,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Diphenhydramine,Blood
1495,HMDB0001934,CHRNA3,,WP1602: Nicotine effect on dopaminergic neurons; WP1603: Nicotine effect on chromaffin cells,Nicotine,"Blood,Saliva,Urine"
1496,HMDB0001934,CHRNB2,,WP1602: Nicotine effect on dopaminergic neurons; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Nicotine,"Blood,Saliva,Urine"
1497,HMDB0001934,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Nicotine,"Blood,Saliva,Urine"
1498,HMDB0001934,CHRNA4,,WP1602: Nicotine effect on dopaminergic neurons; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Nicotine,"Blood,Saliva,Urine"
1499,HMDB0001999,FFAR4,Alpha-linolenic acid metabolism,,Eicosapentaenoic acid,"Blood,Feces,Sweat,Urine"
1500,HMDB0001999,PPARD,Alpha-linolenic acid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Eicosapentaenoic acid,"Blood,Feces,Sweat,Urine"
1501,HMDB0001999,PPARA,Alpha-linolenic acid metabolism,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Eicosapentaenoic acid,"Blood,Feces,Sweat,Urine"
1502,HMDB0002003,SLC27A2,Biosynthesis of unsaturated fatty acids,WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5176: Disorders of bile acid synthesis and biliary transport; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Tetracosanoic acid,"Blood,Feces"
1503,HMDB0002086,AMN,"Propanoate metabolism; Valine, leucine and isoleucine degradation",WP4271: Vitamin B12 disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Adenosylcobalamin,
1504,HMDB0002086,CUBN,"Propanoate metabolism; Valine, leucine and isoleucine degradation",WP1533: Vitamin B12 metabolism; WP4271: Vitamin B12 disorders; WP4758: Nephrotic syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Adenosylcobalamin,
1505,HMDB0002096,TRBC1,,WP5078: T cell modulation in pancreatic cancer,3-Indolebutyric acid,Blood
1506,HMDB0002103,ESR1,Primary bile acid biosynthesis,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",27-Hydroxycholesterol,"Blood,Cerebrospinal Fluid (CSF)"
1507,HMDB0002151,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1508,HMDB0002151,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1509,HMDB0002151,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1510,HMDB0002151,TREM2,,WP3937: Microglia pathogen phagocytosis pathway,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1511,HMDB0002151,LILRB2,,,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1512,HMDB0002151,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1513,HMDB0002151,FGFR4,,WP3651: Pathways affected in adenoid cystic carcinoma; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4787: Osteoblast differentiation and related diseases; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5428: FGFR4 p.G388R signaling pathway; WP5434: Pathways in cancer,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1514,HMDB0002151,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1515,HMDB0002151,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1516,HMDB0002151,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1517,HMDB0002151,FFAR1,,"WP3958: GPR40 pathway; WP455: GPCRs, class A rhodopsin-like",Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1518,HMDB0002151,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1519,HMDB0002151,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1520,HMDB0002151,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1521,HMDB0002151,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Dimethyl sulfoxide,"Cerebrospinal Fluid (CSF),Feces"
1522,HMDB0002183,PPARG,Alpha-linolenic acid metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Docosahexaenoic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1523,HMDB0002183,RXRA,Alpha-linolenic acid metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Docosahexaenoic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1524,HMDB0002183,FFAR4,Alpha-linolenic acid metabolism,,Docosahexaenoic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1525,HMDB0002326,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Coumesterol,"Blood,Urine"
1526,HMDB0002338,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Biochanin A,"Blood,Urine"
1527,HMDB0002369,RXRG,Retinol metabolism,"WP170: Nuclear receptors; WP236: Adipogenesis; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",9-cis-Retinoic acid,Blood
1528,HMDB0002369,PPARG,Retinol metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",9-cis-Retinoic acid,Blood
1529,HMDB0002369,RXRA,Retinol metabolism,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",9-cis-Retinoic acid,Blood
1530,HMDB0002369,RXRB,Retinol metabolism,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",9-cis-Retinoic acid,Blood
1531,HMDB0002369,RARG,Retinol metabolism,WP170: Nuclear receptors; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5053: Development of ureteric collection system; WP5397: Vitamin A1 and A5/X pathways; WP716: Vitamin A and carotenoid metabolism,9-cis-Retinoic acid,Blood
1532,HMDB0002369,RARB,Retinol metabolism,WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,9-cis-Retinoic acid,Blood
1533,HMDB0002369,NCOA2,Retinol metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,9-cis-Retinoic acid,Blood
1534,HMDB0002369,NCOA1,Retinol metabolism,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,9-cis-Retinoic acid,Blood
1535,HMDB0002369,VDR,Retinol metabolism,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",9-cis-Retinoic acid,Blood
1536,HMDB0002369,NR1H2,Retinol metabolism,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,9-cis-Retinoic acid,Blood
1537,HMDB0002395,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Ursolic acid,Feces
1538,HMDB0002457,PTPRJ,,WP3888: VEGFA-VEGFR2 signaling,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1539,HMDB0002457,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1540,HMDB0002457,GLRA1,,WP5417: Cell lineage map for neuronal differentiation,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1541,HMDB0002457,OLR1,,WP176: Folate metabolism; WP3942: PPAR signaling pathway; WP4022: Pyrimidine metabolism; WP405: Eukaryotic transcription initiation; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP4655: Cytosolic DNA-sensing pathway; WP5222: 2q13 copy number variation syndrome; WP5367: Rubinstein-Taybi syndrome 1; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1542,HMDB0002457,IGF1R,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1543,HMDB0002457,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1544,HMDB0002457,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1545,HMDB0002457,ACVRL1,,WP4331: Neovascularization processes; WP5300: TROP2 regulatory signaling,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1546,HMDB0002457,AXL,,WP4217: Ebola virus infection in host; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5090: Complement system in neuronal development and plasticity,Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1547,HMDB0002457,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1548,HMDB0002457,RXRB,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Nickel,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1549,HMDB0002500,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Bromide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1550,HMDB0002500,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Bromide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1551,HMDB0002500,PTPRZ1,,WP2431: Spinal cord injury; WP3888: VEGFA-VEGFR2 signaling,Bromide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1552,HMDB0002500,NR4A2,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Bromide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1553,HMDB0002500,PTPN3,,,Bromide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1554,HMDB0002656,NR4A2,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Prostaglandin A1,Blood
1555,HMDB0002719,RORC,Steroid biosynthesis,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Desmosterol,"Blood,Semen"
1556,HMDB0002752,NR4A2,Arachidonic acid metabolism,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Prostaglandin A2,Blood
1557,HMDB0002878,HCRTR2,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1558,HMDB0002878,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1559,HMDB0002878,IL2RG,,WP205: IL-7 signaling pathway; WP22: IL-9 signaling pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP395: IL-4 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP453: Inflammatory response pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP49: IL-2 signaling pathway; WP5063: FOXP3 in COVID-19; WP5174: Ulcerative colitis signaling; WP5198: Inflammatory bowel disease signaling; WP5434: Pathways in cancer,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1560,HMDB0002878,ROR2,,WP2406: Cardiac progenitor differentiation; WP2858: Ectoderm differentiation; WP363: Wnt signaling pathway; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP5087: Pleural mesothelioma,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1561,HMDB0002878,CCR5,,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP4298: Acute viral myocarditis; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5431: FLT3 p.Gln640SerfsTer8 signaling pathway",Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1562,HMDB0002878,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1563,HMDB0002878,EPHA1,,,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1564,HMDB0002878,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1565,HMDB0002878,HAVCR1,,WP4217: Ebola virus infection in host,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1566,HMDB0002878,GABRG2,,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1567,HMDB0002878,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Nitrate,"Blood,Cerebrospinal Fluid (CSF),Urine"
1568,HMDB0002925,SLC27A5,Alpha-linolenic acid metabolism,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,Dihomo-gamma-linolenic acid,"Blood,Feces,Saliva"
1569,HMDB0002961,GLP1R,Androgen and estrogen metabolism,"WP334: GPCRs, class B secretin-like",Dihydrotestosterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
1570,HMDB0002961,NCOA2,Androgen and estrogen metabolism,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Dihydrotestosterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
1571,HMDB0002961,AR,Androgen and estrogen metabolism,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Dihydrotestosterone,"Blood,Cerebrospinal Fluid (CSF),Urine"
1572,HMDB0003073,SLC27A5,Alpha-linolenic acid metabolism,WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5066: FOXA2 pathway; WP5176: Disorders of bile acid synthesis and biliary transport,gamma-Linolenic acid,"Blood,Feces"
1573,HMDB0003125,TRPM2,"Arachidonic acid metabolism; Arginine and proline metabolism; Aspartate metabolism; Beta-alanine metabolism; Caffeine metabolism; D-arginine and d-ornithine metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Lysine degradation; Methionine metabolism; Nicotinate and nicotinamide metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Purine metabolism; Riboflavin metabolism; Sulfur metabolism; Tryptophan metabolism; Tyrosine metabolism; Valine, leucine and isoleucine degradation; Vitamin b6 metabolism",WP2858: Ectoderm differentiation; WP5115: Network map of SARS-CoV-2 signaling pathway,Hydrogen peroxide,"Blood,Urine"
1574,HMDB0003178,ABCB6,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,,Heme,"Feces,Saliva"
1575,HMDB0003178,NR1D2,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP410: Exercise-induced circadian regulation; WP5205: Clock-controlled autophagy in bone metabolism,Heme,"Feces,Saliva"
1576,HMDB0003178,TRPV6,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,WP2877: Vitamin D receptor pathway,Heme,"Feces,Saliva"
1577,HMDB0003178,TLR4,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,"WP2272: Pathogenic Escherichia coli infection; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3851: TLR4 signaling and tolerance; WP3858: Toll-like receptor signaling related to MyD88; WP3877: MYD88 distinct input-output pathway; WP3890: Nanomaterial-induced inflammasome activation; WP3926: ApoE and miR-146 in inflammation and atherosclerosis; WP4136: Fibrin complement receptor 3 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4298: Acute viral myocarditis; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4329: miRNA role in immune response in sepsis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4478: LTF danger signal response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4919: Neuroinflammation; WP5044: Kynurenine pathway and links to cell senescence; WP5055: Burn wound healing; WP5093: Opioid receptor pathways; WP5198: Inflammatory bowel disease signaling; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5256: COVID-19 and endothelial cell senescence; WP5272: LDL- influence on CD14 and TLR4; WP5336: Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ; WP5346: 8p23.1 copy number variation syndrome; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP75: Toll-like receptor signaling pathway",Heme,"Feces,Saliva"
1578,HMDB0003178,NR1D1,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,WP3594: Circadian rhythm genes; WP5130: Th17 cell differentiation pathway,Heme,"Feces,Saliva"
1579,HMDB0003178,LRP1,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2059: Alzheimer's disease and miRNA effects; WP3664: Regulation of Wnt / B-catenin signaling by small molecule compounds; WP430: Statin inhibition of cholesterol production; WP5108: Familial  hyperlipidemia type 1; WP5110: Familial hyperlipidemia type 3; WP5111: Familial hyperlipidemia type 4; WP5112: Familial hyperlipidemia type 5; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5145: COVID-19 structural coverage map; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Heme,"Feces,Saliva"
1580,HMDB0003178,SLC46A1,Androgen and estrogen metabolism; Arachidonic acid metabolism; Arginine and proline metabolism; Caffeine metabolism; Oxidative phosphorylation; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Retinol metabolism; Steroid biosynthesis; Steroidogenesis; Sulfur metabolism; Tryptophan metabolism,WP176: Folate metabolism; WP4259: Disorders of folate metabolism and transport; WP4673: Male infertility; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Heme,"Feces,Saliva"
1581,HMDB0003217,ESR2,,WP170: Nuclear receptors; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP5316: Primary ovarian insufficiency; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Genistein,"Blood,Feces,Urine"
1582,HMDB0003217,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Genistein,"Blood,Feces,Urine"
1583,HMDB0003217,TRPV6,,WP2877: Vitamin D receptor pathway,Genistein,"Blood,Feces,Urine"
1584,HMDB0003229,SLC27A2,,WP3942: PPAR signaling pathway; WP4545: Oxysterols derived from cholesterol; WP5064: 7-oxo-C and 7-beta-HC pathways; WP5176: Disorders of bile acid synthesis and biliary transport; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Palmitoleic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1585,HMDB0003276,CD36,Cysteine metabolism,WP2586: Aryl hydrocarbon receptor pathway; WP3942: PPAR signaling pathway; WP4823: Genes controlling nephrogenesis; WP5061: Fatty acid transporters; WP5181: Roles of ceramides in development of insulin resistance; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,Hydrogen sulfide,"Blood,Feces"
1586,HMDB0003406,GRIN1,"Glycine, serine and threonine metabolism",WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2431: Spinal cord injury; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP3676: BDNF-TrkB signaling; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4288: MTHFR deficiency; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,D-Serine,"Blood,Saliva,Urine"
1587,HMDB0003406,GRID1,"Glycine, serine and threonine metabolism",WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,D-Serine,"Blood,Saliva,Urine"
1588,HMDB0003474,SLC3A2,Tyrosine metabolism,"WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma","3,5-Diiodo-L-tyrosine","Blood,Urine"
1589,HMDB0003502,SNW1,Inositol phosphate metabolism; Inositol phosphate metabolism,WP366: TGF-beta signaling pathway; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP4148: Splicing factor NOVA regulated synaptic proteins; WP61: Notch signaling pathway,myo-Inositol hexakisphosphate,"Blood,Urine"
1590,HMDB0003502,TRPA1,Inositol phosphate metabolism; Inositol phosphate metabolism,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,myo-Inositol hexakisphosphate,"Blood,Urine"
1591,HMDB0003550,GC,,"WP100: Glutathione metabolism; WP1403: AMP-activated protein kinase signaling; WP1422: Sphingolipid pathway; WP143: Fatty acid beta-oxidation; WP1471: Target of rapamycin signaling; WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP197: Cholesterol biosynthesis pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2291: Deregulation of Rab and Rab effector genes in bladder cancer; WP2333: Trans-sulfuration pathway; WP2338: miRNA biogenesis; WP236: Adipogenesis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2586: Aryl hydrocarbon receptor pathway; WP2596: Gastric acid production; WP2805: exRNA mechanism of action and biogenesis; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP2895: Differentiation of white and brown adipocyte; WP2942: DDX1 as a regulatory component of the Drosha microprocessor; WP3: Transcriptional activation by NRF2 in response to phytochemicals; WP311: Ketone bodies synthesis and degradation; WP334: GPCRs, class B secretin-like; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP363: Wnt signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3940: One-carbon metabolism and related pathways; WP3942: PPAR signaling pathway; WP3963: Mevalonate pathway; WP3998: Prader-Willi and Angelman syndrome; WP4030: SCFA and skeletal muscle substrate metabolism; WP408: Oxidative stress response; WP4142: Metabolism of sphingolipids in ER and Golgi apparatus; WP4156: Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine; WP4189: Mevalonate arm of cholesterol biosynthesis pathway with inhibitors; WP4190: Mevalonate arm of cholesterol biosynthesis pathway; WP4191: Caloric restriction and aging; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4313: Ferroptosis; WP4321: Thermogenesis; WP4357: NRF2-ARE regulation; WP4504: Cysteine and methionine catabolism; WP4518: Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases; WP4519: Cerebral organic acidurias, including diseases; WP465: Tryptophan metabolism; WP4657: 22q11.2 copy number variation syndrome; WP4686: Leucine, isoleucine and valine metabolism; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP4725: Sphingolipid metabolism overview; WP4726: Sphingolipid metabolism: integrated pathway; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4808: Endochondral ossification with skeletal dysplasias; WP4940: 15q11.2 copy number variation syndrome; WP5028: Glycine metabolism, including IMDs; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5094: Orexin receptor pathway; WP5111: Familial hyperlipidemia type 4; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5121: Sphingolipid metabolism in senescence; WP5175: Disorders in ketone body synthesis; WP5186: Vitamin K metabolism and activation of dependent proteins; WP5193: Cholesterol synthesis disorders; WP5194: Synthesis of ceramides and 1-deoxyceramides; WP5195: Disorders in ketolysis; WP5220: Metabolic reprogramming in pancreatic cancer; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5238: Cholestasis; WP5292: Glycosphingolipid metabolism; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP534: Glycolysis and gluconeogenesis; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5343: Abnormal calcium handling and its effects on muscle contraction in DMD; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5394: UDP-derived sugars synthesis in fibroblasts; WP5406: 13q12.12 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5445: Hunger and satiety; WP5446: GLP-1 secretion from intestine to portal vein; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Calcidiol,"Blood,Urine"
1592,HMDB0003550,VDR,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Calcidiol,"Blood,Urine"
1593,HMDB0003550,CUBN,,WP1533: Vitamin B12 metabolism; WP4271: Vitamin B12 disorders; WP4758: Nephrotic syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Calcidiol,"Blood,Urine"
1594,HMDB0003550,LRP2,,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP1533: Vitamin B12 metabolism; WP2806: Complement system; WP4249: Hedgehog signaling pathway,Calcidiol,"Blood,Urine"
1595,HMDB0003625,PTPRC,,WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5098: T-cell activation SARS-CoV-2; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP581: EPO receptor signaling; WP585: Interferon type I signaling pathways,Mercury,"Blood,Cerebrospinal Fluid (CSF),Urine"
1596,HMDB0003625,SLC1A1,,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,Mercury,"Blood,Cerebrospinal Fluid (CSF),Urine"
1597,HMDB0003625,CHRM2,,"WP117: GPCRs, other; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Mercury,"Blood,Cerebrospinal Fluid (CSF),Urine"
1598,HMDB0003625,FCGR3B,,,Mercury,"Blood,Cerebrospinal Fluid (CSF),Urine"
1599,HMDB0003638,IGF1R,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1600,HMDB0003638,ZP3,,WP34: Ovarian infertility; WP5316: Primary ovarian insufficiency; WP5401: 7q11.23 distal copy number variation,Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1601,HMDB0003638,FAS,,WP1403: AMP-activated protein kinase signaling; WP1530: miRNA regulation of DNA damage response; WP1772: Apoptosis modulation and signaling; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2059: Alzheimer's disease and miRNA effects; WP2328: Allograft rejection; WP236: Adipogenesis; WP2507: Nanomaterial induced apoptosis; WP254: Apoptosis; WP2874: Liver X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP357: Fatty acid biosynthesis; WP3594: Circadian rhythm genes; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3646: Hepatitis C and hepatocellular carcinoma; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3965: Lipid metabolism pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4290: Metabolic reprogramming in colon cancer; WP4396: Nonalcoholic fatty liver disease; WP4484: Control of immune tolerance by vasoactive intestinal peptide; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP4724: Omega-9 fatty acid synthesis; WP4754: IL-18 signaling pathway; WP4864: Host-pathogen interaction of human coronaviruses - apoptosis; WP4932: 7q11.23 copy number variation syndrome; WP4963: p53 transcriptional gene network; WP5066: FOXA2 pathway; WP5078: T cell modulation in pancreatic cancer; WP5090: Complement system in neuronal development and plasticity; WP5111: Familial hyperlipidemia type 4; WP5124: Alzheimer's disease; WP5220: Metabolic reprogramming in pancreatic cancer; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer; WP707: DNA damage response; WP710: DNA damage response (only ATM dependent),Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1602,HMDB0003638,PLXNB1,,,Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1603,HMDB0003638,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1604,HMDB0003638,NECTIN2,,WP727: Monoamine transport,Cadmium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1605,HMDB0003642,ADGRE2,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Strontium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1606,HMDB0003747,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Resveratrol,"Blood,Urine"
1607,HMDB0003747,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Resveratrol,"Blood,Urine"
1608,HMDB0004035,RORC,Steroidogenesis,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,22b-Hydroxycholesterol,
1609,HMDB0004080,CNR2,,"WP247: Small ligand GPCRs; WP3869: Cannabinoid receptor signaling; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Anandamide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1610,HMDB0004080,TRPV1,,WP3947: Serotonin and anxiety; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,Anandamide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1611,HMDB0004080,CNR1,,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Anandamide,"Blood,Cerebrospinal Fluid (CSF),Urine"
1612,HMDB0004138,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Gold,"Blood,Cerebrospinal Fluid (CSF),Urine"
1613,HMDB0004142,SLC1A3,,WP2267: Synaptic vesicle pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5417: Cell lineage map for neuronal differentiation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Barium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1614,HMDB0004142,SLC1A5,,"WP3945: TYROBP causal network in microglia; WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4290: Metabolic reprogramming in colon cancer; WP4313: Ferroptosis; WP5213: Amino acid metabolism in triple-negative breast cancer cells; WP5220: Metabolic reprogramming in pancreatic cancer; WP5312: Metabolic pathways of fibroblasts; WP5355: Metabolic Epileptic Disorders",Barium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1615,HMDB0004142,ADGRE2,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Barium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1616,HMDB0004327,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,1-Butanol,"Blood,Feces,Saliva"
1617,HMDB0004385,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Lipoxin A4,Blood
1618,HMDB0004620,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,N-a-Acetyl-L-arginine,"Blood,Cerebrospinal Fluid (CSF),Feces,Urine"
1619,HMDB0004626,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Tetrahydrogestrinone,
1620,HMDB0004667,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",13-HODE,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1621,HMDB0004670,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",alpha-Dimorphecolic acid,"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva"
1622,HMDB0005010,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Sertraline,"Blood,Urine"
1623,HMDB0005028,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Escitalopram,"Blood,Feces"
1624,HMDB0005049,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",10-Nitrolinoleic acid,Blood
1625,HMDB0005079,PPARG,Arachidonic acid metabolism,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation","15-Deoxy-d-12,14-PGJ2","Blood,Urine"
1626,HMDB0005800,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Luteolin,"Blood,Feces,Urine"
1627,HMDB0005843,TRPM8,,WP5224: 2q37 copy number variation syndrome,Allyl isothiocyanate,"Blood,Feces,Saliva"
1628,HMDB0005935,NR1I3,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2875: Constitutive androstane receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5238: Cholestasis; WP5351: Kleefstra syndrome,Androstenol,
1629,HMDB0005949,TRAC,,WP5078: T cell modulation in pancreatic cancer,Lithium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1630,HMDB0005949,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Lithium,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1631,HMDB0006111,GPR31,,"WP455: GPCRs, class A rhodopsin-like",12-HETE,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1632,HMDB0006216,NR2F2,Retinol metabolism,WP170: Nuclear receptors; WP2858: Ectoderm differentiation; WP4149: White fat cell differentiation,11-cis-Retinol,
1633,HMDB0006219,RXRB,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",13-cis-Retinoic acid,Blood
1634,HMDB0006219,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",13-cis-Retinoic acid,Blood
1635,HMDB0006219,RXRG,,"WP170: Nuclear receptors; WP236: Adipogenesis; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",13-cis-Retinoic acid,Blood
1636,HMDB0006247,ABCA1,Primary bile acid biosynthesis,"WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP176: Folate metabolism; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2877: Vitamin D receptor pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP430: Statin inhibition of cholesterol production; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5333: Enterocyte cholesterol metabolism",25-Hydroxycholesterol,"Blood,Urine"
1637,HMDB0006247,ESR1,Primary bile acid biosynthesis,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",25-Hydroxycholesterol,"Blood,Urine"
1638,HMDB0006247,NR1H3,Primary bile acid biosynthesis,WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2878: PPAR-alpha pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4396: Nonalcoholic fatty liver disease; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,25-Hydroxycholesterol,"Blood,Urine"
1639,HMDB0006280,GPR183,Primary bile acid biosynthesis,"WP117: GPCRs, other; WP4545: Oxysterols derived from cholesterol; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2","7-a,25-Dihydroxycholesterol",
1640,HMDB0006283,RORC,Steroidogenesis,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,20alpha-Hydroxycholesterol,
1641,HMDB0006543,SLC22A2,,WP4917: Proximal tubule transport; WP5229: Nephrotoxcicity adverse outcome pathway,Debrisoquine,Blood
1642,HMDB0007158,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",DG(18:0/18:0/0:0),Blood
1643,HMDB0007214,TRPC5,,,DG(18:1(9Z)/16:0/0:0),Blood
1644,HMDB0007972,TRPA1,,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,PC(16:0/18:1(9Z)),"Blood,Feces,Saliva,Urine"
1645,HMDB0008036,TRPA1,,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,PC(18:0/18:0),"Blood,Feces,Urine"
1646,HMDB0008036,SLC1A1,,WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5083: Neuroinflammation and glutamatergic signaling,PC(18:0/18:0),"Blood,Feces,Urine"
1647,HMDB0008036,SLC1A2,,WP2447: Amyotrophic lateral sclerosis (ALS); WP5083: Neuroinflammation and glutamatergic signaling; WP5094: Orexin receptor pathway; WP5314: Lactate shuttle in glial cells; WP5417: Cell lineage map for neuronal differentiation,PC(18:0/18:0),"Blood,Feces,Urine"
1648,HMDB0008302,GABBR2,,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",PC(20:1(11Z)/18:1(9Z)),
1649,HMDB0008899,SLC14A1,,,PE(15:0/20:0),
1650,HMDB0008899,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,PE(15:0/20:0),
1651,HMDB0008899,TRPC5,,,PE(15:0/20:0),
1652,HMDB0008923,NCOA2,Phospholipid biosynthesis,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,PE(16:0/16:0),Feces
1653,HMDB0008923,NR5A1,Phospholipid biosynthesis,WP170: Nuclear receptors; WP34: Ovarian infertility; WP4814: Somatic sex determination; WP4842: Mammalian disorder of sexual development; WP5316: Primary ovarian insufficiency,PE(16:0/16:0),Feces
1654,HMDB0008927,TRPA1,,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,PE(16:0/18:1(9Z)),Feces
1655,HMDB0008991,MCOLN1,,WP2007: Iron metabolism in placenta,PE(18:0/18:0),
1656,HMDB0008991,ABCB1,,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,PE(18:0/18:0),
1657,HMDB0009059,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,PE(18:1(9Z)/18:1(9Z)),Feces
1658,HMDB0009059,ABCG1,,WP299: Nuclear receptors in lipid metabolism and toxicity; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes,PE(18:1(9Z)/18:1(9Z)),Feces
1659,HMDB0009059,GPR158,,,PE(18:1(9Z)/18:1(9Z)),Feces
1660,HMDB0009389,GABBR2,,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation","PE(20:4(5Z,8Z,11Z,14Z)/18:1(9Z))",
1661,HMDB0010169,ABCG1,,WP299: Nuclear receptors in lipid metabolism and toxicity; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes,SM(d18:1/16:0),"Blood,Cerebrospinal Fluid (CSF),Feces,Saliva,Urine"
1662,HMDB0010574,CRHR1,,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",PG(16:0/18:1(9Z)),"Blood,Feces"
1663,HMDB0010574,HCRTR1,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",PG(16:0/18:1(9Z)),"Blood,Feces"
1664,HMDB0010731,TLR4,,"WP2272: Pathogenic Escherichia coli infection; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3851: TLR4 signaling and tolerance; WP3858: Toll-like receptor signaling related to MyD88; WP3877: MYD88 distinct input-output pathway; WP3890: Nanomaterial-induced inflammasome activation; WP3926: ApoE and miR-146 in inflammation and atherosclerosis; WP4136: Fibrin complement receptor 3 signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4298: Acute viral myocarditis; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4329: miRNA role in immune response in sepsis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4462: Platelet-mediated interactions with vascular and circulating cells; WP4478: LTF danger signal response pathway; WP4559: Interactions between immune cells and microRNAs in tumor microenvironment; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4919: Neuroinflammation; WP5044: Kynurenine pathway and links to cell senescence; WP5055: Burn wound healing; WP5093: Opioid receptor pathways; WP5198: Inflammatory bowel disease signaling; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5256: COVID-19 and endothelial cell senescence; WP5272: LDL- influence on CD14 and TLR4; WP5336: Induction of autophagy and toll-like receptor signaling pathways by graphene oxide ; WP5346: 8p23.1 copy number variation syndrome; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP75: Toll-like receptor signaling pathway",(R)-3-Hydroxy-tetradecanoic acid,
1665,HMDB0011567,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1666,HMDB0011567,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1667,HMDB0011567,HTR1B,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP722: Serotonin HTR1 group and FOS pathway",MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1668,HMDB0011567,OPRL1,,"WP24: Peptide GPCRs; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways",MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1669,HMDB0011567,ADIPOR1,,WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1670,HMDB0011567,ADIPOR2,,WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1671,HMDB0011567,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",MG(18:1(9Z)/0:0/0:0),"Blood,Feces,Urine"
1672,HMDB0011733,SLC15A1,,,Glycyl-glycine,"Blood,Feces,Saliva,Sweat,Urine"
1673,HMDB0012238,ANTXR2,,,Iodide,"Blood,Urine"
1674,HMDB0012238,RIPK1,,WP1772: Apoptosis modulation and signaling; WP2036: TNF-related weak inducer of apoptosis (TWEAK) signaling pathway; WP231: TNF-alpha signaling pathway; WP2513: Nanoparticle triggered regulated necrosis; WP2516: ATM signaling pathway; WP254: Apoptosis; WP384: Apoptosis modulation by HSP70; WP3851: TLR4 signaling and tolerance; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP400: p38 MAPK signaling pathway; WP4655: Cytosolic DNA-sensing pathway; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5182: Pro-survival signaling of neuroprotectin D1; WP75: Toll-like receptor signaling pathway,Iodide,"Blood,Urine"
1675,HMDB0012238,PTPRS,,,Iodide,"Blood,Urine"
1676,HMDB0012238,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Iodide,"Blood,Urine"
1677,HMDB0012238,NR4A2,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Iodide,"Blood,Urine"
1678,HMDB0012238,ESRRA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP3527: Pre-implantation embryo; WP391: Mitochondrial gene expression; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Iodide,"Blood,Urine"
1679,HMDB0012238,SORT1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,Iodide,"Blood,Urine"
1680,HMDB0012238,LILRB1,,,Iodide,"Blood,Urine"
1681,HMDB0012238,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Iodide,"Blood,Urine"
1682,HMDB0012238,SLC5A8,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4917: Proximal tubule transport,Iodide,"Blood,Urine"
1683,HMDB0012238,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Iodide,"Blood,Urine"
1684,HMDB0012238,PTPN3,,,Iodide,"Blood,Urine"
1685,HMDB0012238,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Iodide,"Blood,Urine"
1686,HMDB0012238,TREM2,,WP3937: Microglia pathogen phagocytosis pathway,Iodide,"Blood,Urine"
1687,HMDB0012238,GRM3,,"WP4685: Melanoma; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Iodide,"Blood,Urine"
1688,HMDB0012238,PTPN2,,WP4197: Immune response to tuberculosis; WP5033: Genes associated with the development of rheumatoid arthritis; WP5380: 5q35 copy number variation,Iodide,"Blood,Urine"
1689,HMDB0012238,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Iodide,"Blood,Urine"
1690,HMDB0012238,IL6ST,,WP1528: Physiological and pathological hypertrophy of the heart; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2332: Interleukin-11 signaling pathway; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP2815: Mammary gland development pathway - Involution (Stage 4 of 4); WP364: IL6 signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5036: Angiotensin II receptor type 1 pathway; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5434: Pathways in cancer,Iodide,"Blood,Urine"
1691,HMDB0012238,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Iodide,"Blood,Urine"
1692,HMDB0012378,NPC1L1,,WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,PS(18:0/18:0),Blood
1693,HMDB0014118,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Trifluoroacetic acid,"Blood,Urine"
1694,HMDB0014118,NCOR1,,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Trifluoroacetic acid,"Blood,Urine"
1695,HMDB0014420,AGTR1,,"WP2328: Allograft rejection; WP24: Peptide GPCRs; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4883: SARS-CoV-2 and ACE2 receptor: molecular mechanisms; WP4969: RAS and bradykinin pathways in COVID-19; WP5036: Angiotensin II receptor type 1 pathway; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5076: Soluble ACE2-mediated cell entry of SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5158: Urotensin-II-mediated signaling pathway; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5360: KCNQ2-related epilepsies; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",Olmesartan,"Blood,Urine"
1696,HMDB0014437,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Etomidate,"Blood,Urine"
1697,HMDB0014437,GABRB3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Etomidate,"Blood,Urine"
1698,HMDB0014440,OPRM1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Morphine,"Blood,Urine"
1699,HMDB0014452,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Bexarotene,"Blood,Urine"
1700,HMDB0014462,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Gefitinib,"Blood,Urine"
1701,HMDB0014465,HTR1B,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP722: Serotonin HTR1 group and FOS pathway",Dihydroergotamine,"Blood,Urine"
1702,HMDB0014473,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Indomethacin,"Blood,Urine"
1703,HMDB0014487,SLC22A1,,WP4917: Proximal tubule transport; WP5238: Cholestasis; WP5362: TAR syndrome,Diltiazem,"Blood,Feces,Urine"
1704,HMDB0014494,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Minoxidil,"Blood,Urine"
1705,HMDB0014497,HTR5A,,"WP455: GPCRs, class A rhodopsin-like; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Methylergonovine,"Blood,Urine"
1706,HMDB0014497,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Methylergonovine,"Blood,Urine"
1707,HMDB0014511,PGR,,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Levonorgestrel,"Blood,Urine"
1708,HMDB0014542,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Sorafenib,"Blood,Urine"
1709,HMDB0014548,GABRB3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Alprazolam,"Blood,Urine"
1710,HMDB0014565,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Spironolactone,"Blood,Urine"
1711,HMDB0014605,CHRM2,,"WP117: GPCRs, other; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Methylscopolamine,"Blood,Urine"
1712,HMDB0014624,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Raloxifene,"Blood,Urine"
1713,HMDB0014645,SIGMAR1,,WP5356: Affected pathways in Duchenne muscular dystrophy,Haloperidol,"Blood,Urine"
1714,HMDB0014645,DRD2,,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Haloperidol,"Blood,Urine"
1715,HMDB0014671,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Erlotinib,"Blood,Urine"
1716,HMDB0014689,CYSLTR1,,"WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5424: Omega-6-fatty acids in senescence",Zafirlukast,"Blood,Urine"
1717,HMDB0014699,EDNRB,,"WP2197: Endothelin pathways; WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5434: Pathways in cancer; WP98: Prostaglandin synthesis and regulation",Bosentan,"Blood,Urine"
1718,HMDB0014703,SLC19A1,,WP176: Folate metabolism; WP3996: Ethanol effects on histone modifications; WP4259: Disorders of folate metabolism and transport; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Methotrexate,"Blood,Urine"
1719,HMDB0014703,FOLR2,,WP176: Folate metabolism; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Methotrexate,"Blood,Urine"
1720,HMDB0014724,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Diclofenac,"Blood,Urine"
1721,HMDB0014727,HTR5A,,"WP455: GPCRs, class A rhodopsin-like; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",Lisuride,"Blood,Urine"
1722,HMDB0014727,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Lisuride,"Blood,Urine"
1723,HMDB0014727,HTR2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Lisuride,"Blood,Urine"
1724,HMDB0014757,CSF1R,,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Imatinib,"Blood,Urine"
1725,HMDB0014757,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Imatinib,"Blood,Urine"
1726,HMDB0014757,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Imatinib,"Blood,Urine"
1727,HMDB0014757,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Imatinib,"Blood,Urine"
1728,HMDB0014757,PDGFRA,,WP1539: Angiogenesis; WP2261: Glioblastoma signaling pathways; WP2328: Allograft rejection; WP2406: Cardiac progenitor differentiation; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Imatinib,"Blood,Urine"
1729,HMDB0014757,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Imatinib,"Blood,Urine"
1730,HMDB0014775,HRH1,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Astemizole,"Blood,Urine"
1731,HMDB0014811,TACR1,,WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Aprepitant,"Blood,Urine"
1732,HMDB0014825,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Fludrocortisone,"Blood,Urine"
1733,HMDB0014834,HTR1B,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP722: Serotonin HTR1 group and FOS pathway",Ergotamine,"Blood,Urine"
1734,HMDB0014834,HTR2C,,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Ergotamine,"Blood,Urine"
1735,HMDB0014834,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Ergotamine,"Blood,Urine"
1736,HMDB0014838,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Eplerenone,"Blood,Urine"
1737,HMDB0014844,ADRA1A,,"WP1403: AMP-activated protein kinase signaling; WP2197: Endothelin pathways; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Tamsulosin,"Blood,Urine"
1738,HMDB0014844,OPRK1,,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Tamsulosin,"Blood,Urine"
1739,HMDB0014853,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Paroxetine,"Blood,Urine"
1740,HMDB0014853,GRK2,,WP3929: Chemokine signaling pathway; WP4249: Hedgehog signaling pathway; WP47: Hedgehog signaling pathway; WP5426: HDAC6 interactions in the central nervous system,Paroxetine,"Blood,Urine"
1741,HMDB0014855,PGR,,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Norethindrone,"Blood,Urine"
1742,HMDB0014878,TRPC5,,,Riluzole,"Blood,Urine"
1743,HMDB0014951,OPRM1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Fentanyl,"Blood,Urine"
1744,HMDB0014956,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Propofol,"Blood,Urine"
1745,HMDB0014967,GABRB3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Diazepam,"Blood,Urine"
1746,HMDB0014967,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Diazepam,"Blood,Urine"
1747,HMDB0014967,GABRA5,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Diazepam,"Blood,Urine"
1748,HMDB0014972,PGR,,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Mifepristone,"Blood,Urine"
1749,HMDB0014972,NR3C1,,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Mifepristone,"Blood,Urine"
1750,HMDB0014972,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Mifepristone,"Blood,Urine"
1751,HMDB0015042,SLC6A1,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport,Tiagabine,"Blood,Urine"
1752,HMDB0015070,ADRA1A,,"WP1403: AMP-activated protein kinase signaling; WP2197: Endothelin pathways; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Oxymetazoline,"Blood,Urine"
1753,HMDB0015101,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Telmisartan,"Blood,Urine"
1754,HMDB0015102,HRH1,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Desloratadine,"Blood,Urine"
1755,HMDB0015104,HTR3A,,WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Alosetron,"Blood,Urine"
1756,HMDB0015108,NPC1L1,,WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5304: Cholesterol metabolism; WP5333: Enterocyte cholesterol metabolism; WP716: Vitamin A and carotenoid metabolism,Ezetimibe,"Blood,Urine"
1757,HMDB0015109,CHRM4,,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Edetic Acid,"Blood,Urine"
1758,HMDB0015109,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Edetic Acid,"Blood,Urine"
1759,HMDB0015115,MTNR1A,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Ramelteon,"Blood,Urine"
1760,HMDB0015115,MTNR1B,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Ramelteon,"Blood,Urine"
1761,HMDB0015147,CASR,,"WP501: GPCRs, class C metabotropic glutamate, pheromone",Cinacalcet,"Blood,Urine"
1762,HMDB0015164,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Topotecan,"Blood,Urine"
1763,HMDB0015305,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Phenobarbital,"Blood,Urine"
1764,HMDB0015331,DRD2,,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Bromocriptine,"Blood,Urine"
1765,HMDB0015335,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Mitoxantrone,"Blood,Urine"
1766,HMDB0015336,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Flumazenil,"Blood,Urine"
1767,HMDB0015336,GABRA5,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Flumazenil,"Blood,Urine"
1768,HMDB0015336,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Flumazenil,"Blood,Urine"
1769,HMDB0015360,ABCB1,,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Paclitaxel,"Blood,Urine"
1770,HMDB0015364,NR3C1,,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Dexamethasone,"Blood,Urine"
1771,HMDB0015364,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Dexamethasone,"Blood,Urine"
1772,HMDB0015364,NR0B2,,WP138: Androgen receptor signaling pathway; WP2879: Farnesoid X receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway,Dexamethasone,"Blood,Urine"
1773,HMDB0015364,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Dexamethasone,"Blood,Urine"
1774,HMDB0015384,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Dasatinib,"Blood,Urine"
1775,HMDB0015384,EPHB4,,WP2877: Vitamin D receptor pathway; WP4331: Neovascularization processes; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Dasatinib,"Blood,Urine"
1776,HMDB0015384,EPHA4,,WP2431: Spinal cord injury; WP2854: Gene regulatory network modeling somitogenesis ; WP4549: Fragile X syndrome; WP4785: Somitogenesis in the context of spondylocostal dysostosis,Dasatinib,"Blood,Urine"
1777,HMDB0015384,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Dasatinib,"Blood,Urine"
1778,HMDB0015388,ERBB4,,WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3297: EV release from cardiac cells and their functional effects; WP3680: Physico-chemical features and toxicity-associated pathways; WP4685: Melanoma; WP5402: 10q22q23 copy number variation; WP673: ErbB signaling pathway,Lapatinib,"Blood,Urine"
1779,HMDB0015388,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Lapatinib,"Blood,Urine"
1780,HMDB0015397,PDGFRA,,WP1539: Angiogenesis; WP2261: Glioblastoma signaling pathways; WP2328: Allograft rejection; WP2406: Cardiac progenitor differentiation; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Sunitinib,"Blood,Urine"
1781,HMDB0015397,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Sunitinib,"Blood,Urine"
1782,HMDB0015397,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Sunitinib,"Blood,Urine"
1783,HMDB0015398,CHRNA4,,WP1602: Nicotine effect on dopaminergic neurons; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Varenicline,"Blood,Urine"
1784,HMDB0015399,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Arformoterol,"Blood,Urine"
1785,HMDB0015465,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Bezafibrate,"Blood,Urine"
1786,HMDB0015465,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Bezafibrate,"Blood,Urine"
1787,HMDB0015465,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Bezafibrate,"Blood,Urine"
1788,HMDB0015531,TFRC,Arachidonic acid metabolism; Galactose metabolism; Nucleotide sugars metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Steroid biosynthesis; Taurine and hypotaurine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Iron,"Blood,Urine"
1789,HMDB0015531,SLC11A2,Arachidonic acid metabolism; Galactose metabolism; Nucleotide sugars metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Steroid biosynthesis; Taurine and hypotaurine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis,WP2007: Iron metabolism in placenta; WP3286: Copper homeostasis; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4313: Ferroptosis; WP5172: Iron metabolism disorders; WP5189: Copper metabolism,Iron,"Blood,Urine"
1790,HMDB0015531,TFR2,Arachidonic acid metabolism; Galactose metabolism; Nucleotide sugars metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Steroid biosynthesis; Taurine and hypotaurine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis,WP2007: Iron metabolism in placenta; WP5172: Iron metabolism disorders,Iron,"Blood,Urine"
1791,HMDB0015531,SLC40A1,Arachidonic acid metabolism; Galactose metabolism; Nucleotide sugars metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Steroid biosynthesis; Taurine and hypotaurine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Iron,"Blood,Urine"
1792,HMDB0015531,TFR1,Arachidonic acid metabolism; Galactose metabolism; Nucleotide sugars metabolism; Phenylalanine and tyrosine metabolism; Porphyrin metabolism; Primary bile acid biosynthesis; Purine metabolism; Steroid biosynthesis; Taurine and hypotaurine metabolism; Tyrosine metabolism; Ubiquinone biosynthesis,,Iron,"Blood,Urine"
1793,HMDB0015532,NR3C2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1794,HMDB0015532,NR3C1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1795,HMDB0015532,NR4A2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1796,HMDB0015532,ADIPOR1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1797,HMDB0015532,NR2F1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP236: Adipogenesis,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1798,HMDB0015532,HNF4A,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1403: AMP-activated protein kinase signaling; WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP5236: Markers of kidney cell lineage; WP5417: Cell lineage map for neuronal differentiation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1799,HMDB0015532,PPARD,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1800,HMDB0015532,VDR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1801,HMDB0015532,RACK1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP4630: Measles virus infection; WP5036: Angiotensin II receptor type 1 pathway; WP5300: TROP2 regulatory signaling; WP585: Interferon type I signaling pathways,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1802,HMDB0015532,ESRRG,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1803,HMDB0015532,CLEC2D,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1804,HMDB0015532,TRAC,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP5078: T cell modulation in pancreatic cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1805,HMDB0015532,ITGB1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1806,HMDB0015532,ZP3,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP34: Ovarian infertility; WP5316: Primary ovarian insufficiency; WP5401: 7q11.23 distal copy number variation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1807,HMDB0015532,S100A6,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2363: Gastric cancer network 2; WP2877: Vitamin D receptor pathway; WP5055: Burn wound healing; WP98: Prostaglandin synthesis and regulation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1808,HMDB0015532,NR5A2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1809,HMDB0015532,MTNR1B,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1810,HMDB0015532,TSHR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1981: Thyroxine (thyroid hormone) production; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP24: Peptide GPCRs; WP4746: Thyroid hormones production and peripheral downstream signaling effects,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1811,HMDB0015532,DDR1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3670: Interactions between LOXL4 and oxidative stress pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1812,HMDB0015532,ESRRB,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP399: Wnt signaling pathway and pluripotency; WP5417: Cell lineage map for neuronal differentiation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1813,HMDB0015532,SLC3A2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1814,HMDB0015532,SNW1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP366: TGF-beta signaling pathway; WP3865: Novel intracellular components of RIG-I-like receptor pathway; WP4148: Splicing factor NOVA regulated synaptic proteins; WP61: Notch signaling pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1815,HMDB0015532,ESR1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1816,HMDB0015532,FGFR4,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3651: Pathways affected in adenoid cystic carcinoma; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4787: Osteoblast differentiation and related diseases; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5428: FGFR4 p.G388R signaling pathway; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1817,HMDB0015532,SLC6A19,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5145: COVID-19 structural coverage map,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1818,HMDB0015532,CRCP,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP289: Myometrial relaxation and contraction pathways,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1819,HMDB0015532,TRPV6,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2877: Vitamin D receptor pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1820,HMDB0015532,NTRK1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1821,HMDB0015532,GPR52,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP455: GPCRs, class A rhodopsin-like",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1822,HMDB0015532,TYRO3,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4217: Ebola virus infection in host; WP5090: Complement system in neuronal development and plasticity,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1823,HMDB0015532,PPARG,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1824,HMDB0015532,GLP1R,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP334: GPCRs, class B secretin-like",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1825,HMDB0015532,NR5A1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP34: Ovarian infertility; WP4814: Somatic sex determination; WP4842: Mammalian disorder of sexual development; WP5316: Primary ovarian insufficiency,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1826,HMDB0015532,RORC,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1827,HMDB0015532,AR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1828,HMDB0015532,NCOR2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP268: Notch signaling; WP4312: Rett syndrome; WP61: Notch signaling pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1829,HMDB0015532,GRIA2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP4549: Fragile X syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1830,HMDB0015532,NSD1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2369: Histone modifications; WP3651: Pathways affected in adenoid cystic carcinoma; WP5380: 5q35 copy number variation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1831,HMDB0015532,LRP8,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1832,HMDB0015532,RPSA,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP477: Cytoplasmic ribosomal proteins; WP4906: 3q29 copy number variation syndrome,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1833,HMDB0015532,NR6A1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1834,HMDB0015532,P2RY1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5360: KCNQ2-related epilepsies; WP80: Nucleotide GPCRs",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1835,HMDB0015532,CCR5,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP24: Peptide GPCRs; WP4298: Acute viral myocarditis; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5431: FLT3 p.Gln640SerfsTer8 signaling pathway",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1836,HMDB0015532,GRIA3,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1837,HMDB0015532,NR2C2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP170: Nuclear receptors; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1838,HMDB0015532,TRPC5,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1839,HMDB0015532,IL1RAPL1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1840,HMDB0015532,TREM1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP4478: LTF danger signal response pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1841,HMDB0015532,CCR2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP3624: Lung fibrosis; WP3929: Chemokine signaling pathway; WP4397: Model for regulation of MSMP expression in cancer cells and its proangiogenic role in ovarian tumors; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP455: GPCRs, class A rhodopsin-like; WP5088: Prostaglandin signaling; WP5284: Cell interactions of the pancreatic cancer microenvironment",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1842,HMDB0015532,PGR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1843,HMDB0015532,NR1D1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3594: Circadian rhythm genes; WP5130: Th17 cell differentiation pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1844,HMDB0015532,SLC11A2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2007: Iron metabolism in placenta; WP3286: Copper homeostasis; WP4206: Hereditary leiomyomatosis and renal cell carcinoma pathway; WP4313: Ferroptosis; WP5172: Iron metabolism disorders; WP5189: Copper metabolism,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1845,HMDB0015532,TRAV22,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1846,HMDB0015532,TRAF4,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4658: Small cell lung cancer; WP4963: p53 transcriptional gene network; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1847,HMDB0015532,NR4A1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP382: MAPK signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP5142: Calcium mediated T-cell apoptosis involved in inclusion body myositis,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1848,HMDB0015532,NCOA2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1849,HMDB0015532,RARB,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP170: Nuclear receptors; WP2857: Mesodermal commitment pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4255: Non-small cell lung cancer; WP4658: Small cell lung cancer; WP5053: Development of ureteric collection system; WP5236: Markers of kidney cell lineage; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1850,HMDB0015532,MYLIP,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1851,HMDB0015532,NRP1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1852,HMDB0015532,TBXA2R,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1853,HMDB0015532,APLNR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP455: GPCRs, class A rhodopsin-like",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1854,HMDB0015532,GABRA1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1855,HMDB0015532,FASLG,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1772: Apoptosis modulation and signaling; WP2328: Allograft rejection; WP2507: Nanomaterial induced apoptosis; WP254: Apoptosis; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3646: Hepatitis C and hepatocellular carcinoma; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4396: Nonalcoholic fatty liver disease; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4754: IL-18 signaling pathway; WP4864: Host-pathogen interaction of human coronaviruses - apoptosis; WP4963: p53 transcriptional gene network; WP5078: T cell modulation in pancreatic cancer; WP5090: Complement system in neuronal development and plasticity; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer; WP710: DNA damage response (only ATM dependent),Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1856,HMDB0015532,EGFR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1857,HMDB0015532,IGF1R,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1858,HMDB0015532,ALK,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1859,HMDB0015532,GLRA3,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP5417: Cell lineage map for neuronal differentiation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1860,HMDB0015532,TRPC3,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3676: BDNF-TrkB signaling; WP3888: VEGFA-VEGFR2 signaling; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5356: Affected pathways in Duchenne muscular dystrophy,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1861,HMDB0015532,RXRA,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1862,HMDB0015532,FLT1,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1863,HMDB0015532,TRPC6,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP3676: BDNF-TrkB signaling; WP4758: Nephrotic syndrome; WP5356: Affected pathways in Duchenne muscular dystrophy,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1864,HMDB0015532,EFNA5,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2877: Vitamin D receptor pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4172: PI3K-Akt signaling pathway; WP5087: Pleural mesothelioma,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1865,HMDB0015532,AGER,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1866,HMDB0015532,EPS15,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3888: VEGFA-VEGFR2 signaling; WP4217: Ebola virus infection in host; WP437: EGF/EGFR signaling pathway,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1867,HMDB0015532,HTR2A,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1868,HMDB0015532,PTH1R,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1869,HMDB0015532,ADIPOR2,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP1403: AMP-activated protein kinase signaling; WP3934: Leptin and adiponectin; WP4396: Nonalcoholic fatty liver disease,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1870,HMDB0015532,PTAFR,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism","WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like",Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1871,HMDB0015532,SLC30A8,"Alanine, aspartate and glutamate metabolism; Arachidonic acid metabolism; Aspartate metabolism; Beta-alanine metabolism; Cysteine metabolism; Fructose and mannose metabolism; Galactose metabolism; Glutamate metabolism; Glutathione metabolism; Glycine, serine and threonine metabolism; Glycine, serine and threonine metabolism; Histidine metabolism; Methionine metabolism; Nucleotide sugars metabolism; Porphyrin metabolism; Pterine biosynthesis; Purine metabolism; Pyrimidine metabolism; Pyruvate metabolism; Retinol metabolism; Riboflavin metabolism; Starch and sucrose metabolism; Tyrosine metabolism; Vitamin b6 metabolism",WP3529: Zinc homeostasis,Zinc,"Blood,Cerebrospinal Fluid (CSF),Saliva,Urine"
1872,HMDB0015567,VDR,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP34: Ovarian infertility; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4482: Vitamin D in inflammatory diseases; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4969: RAS and bradykinin pathways in COVID-19; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists",Calcipotriol,"Blood,Urine"
1873,HMDB0015619,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Sulfathiazole,"Blood,Urine"
1874,HMDB0015631,OPRM1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Alvimopan,"Blood,Urine"
1875,HMDB0015632,MCOLN1,,WP2007: Iron metabolism in placenta,Temsirolimus,"Blood,Urine"
1876,HMDB0015636,MTNR1A,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",Agomelatine,"Blood,Urine"
1877,HMDB0015637,SLC6A4,,WP1455: Serotonin transporter activity; WP2267: Synaptic vesicle pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3594: Circadian rhythm genes; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP727: Monoamine transport,Vilazodone,"Blood,Urine"
1878,HMDB0015639,HRH1,,"WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs",Mepyramine,"Blood,Urine"
1879,HMDB0029367,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Sanguinarine,
1880,HMDB0029758,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Herniarin,
1881,HMDB0029878,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",D-Tartaric acid,
1882,HMDB0029878,CCR7,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4542: Leukocyte-intrinsic Hippo pathway functions; WP455: GPCRs, class A rhodopsin-like; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2",D-Tartaric acid,
1883,HMDB0029878,EPOR,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,D-Tartaric acid,
1884,HMDB0030094,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Betulinic acid,
1885,HMDB0031518,IGF1R,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,D-Malic acid,Feces
1886,HMDB0031645,CHRM1,,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",Acetamide,"Blood,Feces"
1887,HMDB0031645,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",Acetamide,"Blood,Feces"
1888,HMDB0032133,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Bisphenol A,"Blood,Urine"
1889,HMDB0032133,ESRRB,,WP170: Nuclear receptors; WP399: Wnt signaling pathway and pluripotency; WP5417: Cell lineage map for neuronal differentiation,Bisphenol A,"Blood,Urine"
1890,HMDB0032133,ESRRG,,,Bisphenol A,"Blood,Urine"
1891,HMDB0032574,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Propylparaben,"Blood,Sweat,Urine"
1892,HMDB0032575,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Butylparaben,"Blood,Urine"
1893,HMDB0032876,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Rhein,
1894,HMDB0033007,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,"(2R,3R)-2,3-Butanediol",
1895,HMDB0034170,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",2-Hydroxybenzaldehyde,Feces
1896,HMDB0035731,TFRC,,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,Boric acid (H3BO3),
1897,HMDB0037790,KIR2DS2,,,Polyethylene glycol,Saliva
1898,HMDB0037790,IL7R,,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1899,HMDB0037790,FLT1,,WP1539: Angiogenesis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3640: Imatinib and chronic myeloid leukemia; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5385: Growth factors and hormones in beta cell proliferation,Polyethylene glycol,Saliva
1900,HMDB0037790,GHRHR,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like",Polyethylene glycol,Saliva
1901,HMDB0037790,ADGRB1,,WP4963: p53 transcriptional gene network,Polyethylene glycol,Saliva
1902,HMDB0037790,TGFBR1,,WP2795: Cardiac hypertrophic response; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP3646: Hepatitis C and hepatocellular carcinoma; WP366: TGF-beta signaling pathway; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP382: MAPK signaling pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3945: TYROBP causal network in microglia; WP400: p38 MAPK signaling pathway; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4263: Pancreatic adenocarcinoma pathway; WP4331: Neovascularization processes; WP4666: Hepatitis B infection; WP4816: TGF-beta receptor signaling in skeletal dysplasias; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4904: LDLRAD4 and what we know about it; WP5036: Angiotensin II receptor type 1 pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5382: TGFβ/Smad signaling pathway; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer; WP560: TGF-beta receptor signaling,Polyethylene glycol,Saliva
1903,HMDB0037790,NCOA5,,,Polyethylene glycol,Saliva
1904,HMDB0037790,NR0B1,,WP170: Nuclear receptors,Polyethylene glycol,Saliva
1905,HMDB0037790,PTK2B,,WP205: IL-7 signaling pathway; WP2263: Androgen receptor network in prostate cancer; WP2374: Oncostatin M signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP313: Hepatocyte growth factor receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3929: Chemokine signaling pathway; WP437: EGF/EGFR signaling pathway; WP4666: Hepatitis B infection; WP4747: Netrin-UNC5B signaling pathway; WP49: IL-2 signaling pathway; WP5097: CCL18 signaling pathway; WP5399: NPHP1 deletion syndrome; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP69: T-cell receptor signaling pathway,Polyethylene glycol,Saliva
1906,HMDB0037790,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Polyethylene glycol,Saliva
1907,HMDB0037790,TREM2,,WP3937: Microglia pathogen phagocytosis pathway,Polyethylene glycol,Saliva
1908,HMDB0037790,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Polyethylene glycol,Saliva
1909,HMDB0037790,TRAV24,,,Polyethylene glycol,Saliva
1910,HMDB0037790,RET,,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,Polyethylene glycol,Saliva
1911,HMDB0037790,AKAP13,,WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP35: G protein signaling pathways,Polyethylene glycol,Saliva
1912,HMDB0037790,EPHB4,,WP2877: Vitamin D receptor pathway; WP4331: Neovascularization processes; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Polyethylene glycol,Saliva
1913,HMDB0037790,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,Polyethylene glycol,Saliva
1914,HMDB0037790,MYLIP,,WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5329: Cholesterol biosynthesis pathway in hepatocytes,Polyethylene glycol,Saliva
1915,HMDB0037790,TNK2,,"WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3933: Kennedy pathway from sphingolipids; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP437: EGF/EGFR signaling pathway; WP524: G13 signaling pathway",Polyethylene glycol,Saliva
1916,HMDB0037790,GIPR,,"WP334: GPCRs, class B secretin-like",Polyethylene glycol,Saliva
1917,HMDB0037790,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Polyethylene glycol,Saliva
1918,HMDB0037790,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1919,HMDB0037790,FAS,,WP1403: AMP-activated protein kinase signaling; WP1530: miRNA regulation of DNA damage response; WP1772: Apoptosis modulation and signaling; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2059: Alzheimer's disease and miRNA effects; WP2328: Allograft rejection; WP236: Adipogenesis; WP2507: Nanomaterial induced apoptosis; WP254: Apoptosis; WP2874: Liver X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP357: Fatty acid biosynthesis; WP3594: Circadian rhythm genes; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3646: Hepatitis C and hepatocellular carcinoma; WP382: MAPK signaling pathway; WP384: Apoptosis modulation by HSP70; WP3888: VEGFA-VEGFR2 signaling; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3965: Lipid metabolism pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4290: Metabolic reprogramming in colon cancer; WP4396: Nonalcoholic fatty liver disease; WP4484: Control of immune tolerance by vasoactive intestinal peptide; WP4630: Measles virus infection; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP4724: Omega-9 fatty acid synthesis; WP4754: IL-18 signaling pathway; WP4864: Host-pathogen interaction of human coronaviruses - apoptosis; WP4932: 7q11.23 copy number variation syndrome; WP4963: p53 transcriptional gene network; WP5066: FOXA2 pathway; WP5078: T cell modulation in pancreatic cancer; WP5090: Complement system in neuronal development and plasticity; WP5111: Familial hyperlipidemia type 4; WP5124: Alzheimer's disease; WP5220: Metabolic reprogramming in pancreatic cancer; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5434: Pathways in cancer; WP707: DNA damage response; WP710: DNA damage response (only ATM dependent),Polyethylene glycol,Saliva
1920,HMDB0037790,NR3C1,,WP170: Nuclear receptors; WP236: Adipogenesis; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2853: Endoderm differentiation; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3599: Transcription factor regulation in adipogenesis; WP4149: White fat cell differentiation; WP4482: Vitamin D in inflammatory diseases; WP4949: 16p11.2 proximal deletion syndrome; WP5426: HDAC6 interactions in the central nervous system; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP734: Serotonin receptor 4/6/7 and NR3C signaling,Polyethylene glycol,Saliva
1921,HMDB0037790,GRID1,,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,Polyethylene glycol,Saliva
1922,HMDB0037790,CHRM1,,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",Polyethylene glycol,Saliva
1923,HMDB0037790,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Polyethylene glycol,Saliva
1924,HMDB0037790,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Polyethylene glycol,Saliva
1925,HMDB0037790,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Polyethylene glycol,Saliva
1926,HMDB0037790,TRAC,,WP5078: T cell modulation in pancreatic cancer,Polyethylene glycol,Saliva
1927,HMDB0037790,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1928,HMDB0037790,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Polyethylene glycol,Saliva
1929,HMDB0037790,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,Polyethylene glycol,Saliva
1930,HMDB0037790,IFNGR1,,"WP4197: Immune response to tuberculosis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4558: Overview of interferons-mediated signaling pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP619: Type II interferon signaling",Polyethylene glycol,Saliva
1931,HMDB0037790,NECTIN4,,WP4630: Measles virus infection,Polyethylene glycol,Saliva
1932,HMDB0037790,BMPR2,,WP1425: Bone morphogenic protein signaling and regulation; WP1591: Heart development; WP2857: Mesodermal commitment pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3931: Embryonic stem cell pluripotency pathways; WP4787: Osteoblast differentiation and related diseases; WP5053: Development of ureteric collection system; WP5205: Clock-controlled autophagy in bone metabolism; WP5316: Primary ovarian insufficiency,Polyethylene glycol,Saliva
1933,HMDB0037790,P2RX3,,WP4900: Purinergic signaling,Polyethylene glycol,Saliva
1934,HMDB0037790,SORL1,,,Polyethylene glycol,Saliva
1935,HMDB0037790,CHRNA9,,,Polyethylene glycol,Saliva
1936,HMDB0037790,CHRNB3,,,Polyethylene glycol,Saliva
1937,HMDB0037790,ACVR2A,,WP2857: Mesodermal commitment pathway,Polyethylene glycol,Saliva
1938,HMDB0037790,LRP6,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,Polyethylene glycol,Saliva
1939,HMDB0037790,NTRK1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3594: Circadian rhythm genes; WP382: MAPK signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1940,HMDB0037790,NCOR1,,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,Polyethylene glycol,Saliva
1941,HMDB0037790,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,Polyethylene glycol,Saliva
1942,HMDB0037790,GRID2,,,Polyethylene glycol,Saliva
1943,HMDB0037790,TNFRSF9,,WP5078: T cell modulation in pancreatic cancer,Polyethylene glycol,Saliva
1944,HMDB0037790,SLC3A2,,"WP3953: mRNA, protein, and metabolite inducation pathway by cyclosporin A; WP4313: Ferroptosis; WP4917: Proximal tubule transport; WP5029: Amino acid transport defects (IEMs); WP5087: Pleural mesothelioma",Polyethylene glycol,Saliva
1945,HMDB0037790,FCER2,,WP2806: Complement system,Polyethylene glycol,Saliva
1946,HMDB0037790,FCER1G,,WP3937: Microglia pathogen phagocytosis pathway,Polyethylene glycol,Saliva
1947,HMDB0037790,GRIN2B,,WP2059: Alzheimer's disease and miRNA effects; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4008: NO/cGMP/PKG mediated neuroprotection; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4222: Phosphodiesterases in neuronal function; WP4223: Ras signaling; WP4312: Rett syndrome; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4754: IL-18 signaling pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP5083: Neuroinflammation and glutamatergic signaling; WP5124: Alzheimer's disease; WP5380: 5q35 copy number variation; WP5398: NRXN1 deletion syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Polyethylene glycol,Saliva
1948,HMDB0037790,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Polyethylene glycol,Saliva
1949,HMDB0037790,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,Polyethylene glycol,Saliva
1950,HMDB0037790,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,Polyethylene glycol,Saliva
1951,HMDB0037790,HAVCR2,,WP4217: Ebola virus infection in host; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5078: T cell modulation in pancreatic cancer,Polyethylene glycol,Saliva
1952,HMDB0037790,OLR1,,WP176: Folate metabolism; WP3942: PPAR signaling pathway; WP4022: Pyrimidine metabolism; WP405: Eukaryotic transcription initiation; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP4655: Cytosolic DNA-sensing pathway; WP5222: 2q13 copy number variation syndrome; WP5367: Rubinstein-Taybi syndrome 1; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Polyethylene glycol,Saliva
1953,HMDB0037790,LAIR1,,,Polyethylene glycol,Saliva
1954,HMDB0037790,GFRAL,,,Polyethylene glycol,Saliva
1955,HMDB0037790,LEPR,,WP1403: AMP-activated protein kinase signaling; WP2034: Leptin signaling pathway; WP3934: Leptin and adiponectin; WP3935: Leptin-insulin signaling overlap; WP4396: Nonalcoholic fatty liver disease; WP5400: 6q16 copy number variation,Polyethylene glycol,Saliva
1956,HMDB0037790,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Polyethylene glycol,Saliva
1957,HMDB0037790,FGFR2,,WP1539: Angiogenesis; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2795: Cardiac hypertrophic response; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2858: Ectoderm differentiation; WP382: MAPK signaling pathway; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP4787: Osteoblast differentiation and related diseases; WP4790: FGF23 signaling in hypophosphatemic rickets and related disorders; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4842: Mammalian disorder of sexual development; WP4872: MAP3K1 role in promoting and blocking gonadal determination; WP5053: Development of ureteric collection system; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1958,HMDB0037790,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,Polyethylene glycol,Saliva
1959,HMDB0037790,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Polyethylene glycol,Saliva
1960,HMDB0037790,NCR1,,WP5092: Interactions of natural killer cells in pancreatic cancer,Polyethylene glycol,Saliva
1961,HMDB0037790,PGR,,WP170: Nuclear receptors; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4352: Ciliary landscape; WP4536: Genes related to primary cilium development (based on CRISPR); WP4656: Joubert syndrome; WP4803: Ciliopathies; WP5316: Primary ovarian insufficiency; WP5399: NPHP1 deletion syndrome,Polyethylene glycol,Saliva
1962,HMDB0037790,EPOR,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,Polyethylene glycol,Saliva
1963,HMDB0037790,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1964,HMDB0037790,ESRRG,,,Polyethylene glycol,Saliva
1965,HMDB0037790,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Polyethylene glycol,Saliva
1966,HMDB0037790,TEK,,WP1539: Angiogenesis; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Polyethylene glycol,Saliva
1967,HMDB0037790,TRAV26-1,,,Polyethylene glycol,Saliva
1968,HMDB0037790,FGFR4,,WP3651: Pathways affected in adenoid cystic carcinoma; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4787: Osteoblast differentiation and related diseases; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5428: FGFR4 p.G388R signaling pathway; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1969,HMDB0037790,PTH1R,,"WP322: Osteoblast signaling; WP334: GPCRs, class B secretin-like; WP474: Endochondral ossification; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias",Polyethylene glycol,Saliva
1970,HMDB0037790,CD320,,WP4271: Vitamin B12 disorders; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Polyethylene glycol,Saliva
1971,HMDB0037790,TYROBP,,WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway,Polyethylene glycol,Saliva
1972,HMDB0037790,TRGV4,,,Polyethylene glycol,Saliva
1973,HMDB0037790,IL6ST,,WP1528: Physiological and pathological hypertrophy of the heart; WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2332: Interleukin-11 signaling pathway; WP236: Adipogenesis; WP2374: Oncostatin M signaling pathway; WP2815: Mammary gland development pathway - Involution (Stage 4 of 4); WP364: IL6 signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP4337: ncRNAs involved in STAT3 signaling in hepatocellular carcinoma; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5033: Genes associated with the development of rheumatoid arthritis; WP5036: Angiotensin II receptor type 1 pathway; WP5063: FOXP3 in COVID-19; WP5083: Neuroinflammation and glutamatergic signaling; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1974,HMDB0037790,CNNM2,,,Polyethylene glycol,Saliva
1975,HMDB0037790,PIGR,,,Polyethylene glycol,Saliva
1976,HMDB0037790,RIPK2,,WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP69: T-cell receptor signaling pathway,Polyethylene glycol,Saliva
1977,HMDB0037790,TRBC1,,WP5078: T cell modulation in pancreatic cancer,Polyethylene glycol,Saliva
1978,HMDB0037790,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Polyethylene glycol,Saliva
1979,HMDB0037790,INSR,,WP1403: AMP-activated protein kinase signaling; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1584: Type II diabetes mellitus; WP176: Folate metabolism; WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2509: Nanoparticle triggered autophagic cell death; WP3599: Transcription factor regulation in adipogenesis; WP3634: Insulin signaling in adipocytes (normal condition); WP3635: Insulin signaling in adipocytes (diabetic condition); WP3651: Pathways affected in adenoid cystic carcinoma; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3935: Leptin-insulin signaling overlap; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4357: NRF2-ARE regulation; WP4396: Nonalcoholic fatty liver disease; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4673: Male infertility; WP481: Insulin signaling; WP4950: 16p11.2 distal deletion syndrome; WP5083: Neuroinflammation and glutamatergic signaling; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5181: Roles of ceramides in development of insulin resistance; WP5385: Growth factors and hormones in beta cell proliferation; WP5400: 6q16 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP710: DNA damage response (only ATM dependent),Polyethylene glycol,Saliva
1980,HMDB0037790,CD300LF,,,Polyethylene glycol,Saliva
1981,HMDB0037790,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Polyethylene glycol,Saliva
1982,HMDB0037790,AGER,,WP2059: Alzheimer's disease and miRNA effects; WP2324: AGE/RAGE pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP4478: LTF danger signal response pathway; WP4479: Supression of HMGB1 mediated inflammation by THBD; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5283: Chronic hyperglycemia impairment of neuron function; WP5331: Autophagy in pancreatic ductal adenocarcinoma,Polyethylene glycol,Saliva
1983,HMDB0037790,CALCRL,,"WP2197: Endothelin pathways; WP334: GPCRs, class B secretin-like; WP5224: 2q37 copy number variation syndrome",Polyethylene glycol,Saliva
1984,HMDB0041008,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway","1-Methyl-6-phenyl-1H-imidazo[4,5-b]pyridin-2-amine",
1985,HMDB0041827,HCRTR2,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Ammonium,"Blood,Sweat"
1986,HMDB0059570,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,trans-Nonachlor,Blood
1987,HMDB0060382,GABRG2,,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,3beta-Hydroxypregn-5-en-20-one sulfate,"Blood,Urine"
1988,HMDB0060382,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,3beta-Hydroxypregn-5-en-20-one sulfate,"Blood,Urine"
1989,HMDB0060382,GABRA2,,WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,3beta-Hydroxypregn-5-en-20-one sulfate,"Blood,Urine"
1990,HMDB0060510,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,SN-38,"Blood,Urine"
1991,HMDB0060530,ESR2,,WP170: Nuclear receptors; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP34: Ovarian infertility; WP4262: Breast cancer pathway; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP5316: Primary ovarian insufficiency; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,4-Hydroxytamoxifen,"Blood,Urine"
1992,HMDB0060530,ESRRG,,,4-Hydroxytamoxifen,"Blood,Urine"
1993,HMDB0060530,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",4-Hydroxytamoxifen,"Blood,Urine"
1994,HMDB0060614,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Sulindac sulfide,"Blood,Urine"
1995,HMDB0060666,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Endoxifen,"Blood,Urine"
1996,HMDB0060900,CHRM3,,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4874: CAMKK2 pathway; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",Clozapine N-oxide,"Blood,Urine"
1997,HMDB0060949,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",2-hydroxyflutamide,"Blood,Urine"
1998,HMDB0061029,NR1H4,,WP2289: Drug induction of bile acid pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4396: Nonalcoholic fatty liver disease; WP5238: Cholestasis,dehydrofelodipine,"Blood,Urine"
1999,HMDB0061047,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,simvastatin hydroxy acid,"Blood,Urine"
2000,HMDB0061919,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,2'-Hydroxyacetanilide,"Blood,Saliva,Urine"
2001,HMDB0243559,GABRR1,,WP3998: Prader-Willi and Angelman syndrome,"(1,2,5,6-Tetrahydropyridine-4-yl)methylphosphinic acid",Blood
2002,HMDB0243853,ESRRA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP3527: Pre-implantation embryo; WP391: Mitochondrial gene expression; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,1-Cyclohexyl-N-{[1-(4-Methylphenyl)-1h-Indol-3-Yl]methyl}methanamine,Blood
2003,HMDB0244201,RET,,WP236: Adipogenesis; WP2586: Aryl hydrocarbon receptor pathway; WP2855: Dopaminergic neurogenesis; WP4481: Resistin as a regulator of inflammation; WP4823: Genes controlling nephrogenesis; WP4830: GDNF/RET signaling axis; WP5053: Development of ureteric collection system; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism,"1,4-Butanediol",Blood
2004,HMDB0244201,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,"1,4-Butanediol",Blood
2005,HMDB0244201,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs","1,4-Butanediol",Blood
2006,HMDB0244201,GRID1,,WP3584: MECP2 and associated Rett syndrome; WP5402: 10q22q23 copy number variation,"1,4-Butanediol",Blood
2007,HMDB0244216,OLR1,,WP176: Folate metabolism; WP3942: PPAR signaling pathway; WP4022: Pyrimidine metabolism; WP405: Eukaryotic transcription initiation; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP4655: Cytosolic DNA-sensing pathway; WP5222: 2q13 copy number variation syndrome; WP5367: Rubinstein-Taybi syndrome 1; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Dioxane,Blood
2008,HMDB0244216,EPHB3,,WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer,Dioxane,Blood
2009,HMDB0244322,ACVRL1,,WP4331: Neovascularization processes; WP5300: TROP2 regulatory signaling,"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",Blood
2010,HMDB0244322,BMPR1B,,WP1425: Bone morphogenic protein signaling and regulation; WP34: Ovarian infertility; WP3931: Embryonic stem cell pluripotency pathways; WP4787: Osteoblast differentiation and related diseases; WP5316: Primary ovarian insufficiency; WP5352: 10q11.21q11.23 copy number variation syndrome,"4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline",Blood
2011,HMDB0244400,NCOR1,,WP138: Androgen receptor signaling pathway; WP236: Adipogenesis; WP34: Ovarian infertility; WP3584: MECP2 and associated Rett syndrome; WP3594: Circadian rhythm genes; WP3651: Pathways affected in adenoid cystic carcinoma; WP4312: Rett syndrome; WP4657: 22q11.2 copy number variation syndrome; WP61: Notch signaling pathway,3-Cyclohexyl-1-propylsulfonic acid,Blood
2012,HMDB0244493,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway","4-(2-Amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",Blood
2013,HMDB0244537,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway","2,2',4,4'-Tetrahydroxybenzophenone",Blood
2014,HMDB0244568,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs","4-(2-((7-Amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino)ethyl)phenol",Blood
2015,HMDB0244694,RXRB,,"WP1531: Vitamin D metabolism; WP170: Nuclear receptors; WP3942: PPAR signaling pathway; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4658: Small cell lung cancer; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism","6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid",Blood
2016,HMDB0244694,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism","6-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid",Blood
2017,HMDB0244714,DRD4,,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs","3-((4-(4-Chlorophenyl)piperazin-1-yl)methyl)-1H-pyrrolo[2,3-b]pyridine",Blood
2018,HMDB0244804,EPHA3,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,"1,4,7,10,13,16-Hexaoxacyclooctadecane",Blood
2019,HMDB0245181,MTNR1A,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",2-Iodomelatonin,Blood
2020,HMDB0245190,S100A6,,WP2363: Gastric cancer network 2; WP2877: Vitamin D receptor pathway; WP5055: Burn wound healing; WP98: Prostaglandin synthesis and regulation,beta-Mercaptoethanol,Blood
2021,HMDB0245190,GRIK1,,WP5083: Neuroinflammation and glutamatergic signaling,beta-Mercaptoethanol,Blood
2022,HMDB0245190,EPHA8,,,beta-Mercaptoethanol,Blood
2023,HMDB0245190,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",beta-Mercaptoethanol,Blood
2024,HMDB0245190,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,beta-Mercaptoethanol,Blood
2025,HMDB0245190,FCGRT,,,beta-Mercaptoethanol,Blood
2026,HMDB0245190,ABCB6,,,beta-Mercaptoethanol,Blood
2027,HMDB0245190,EPHA3,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,beta-Mercaptoethanol,Blood
2028,HMDB0245234,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",2-Methylindole,Blood
2029,HMDB0245327,ESRRG,,,Bisphenol B,Blood
2030,HMDB0245386,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,"2,3-Diaminotoluene",Blood
2031,HMDB0245622,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,"1-(Tert-Butyl)-3-(2-((4-(diethylamino)butyl)amino)-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimidin-7-yl)urea",Blood
2032,HMDB0245742,HCRTR1,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway","N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]urea",Blood
2033,HMDB0246120,TGFBR1,,WP2795: Cardiac hypertrophic response; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP3646: Hepatitis C and hepatocellular carcinoma; WP366: TGF-beta signaling pathway; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP382: MAPK signaling pathway; WP3874: Canonical and non-canonical TGF-B signaling; WP3945: TYROBP causal network in microglia; WP400: p38 MAPK signaling pathway; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4263: Pancreatic adenocarcinoma pathway; WP4331: Neovascularization processes; WP4666: Hepatitis B infection; WP4816: TGF-beta receptor signaling in skeletal dysplasias; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4904: LDLRAD4 and what we know about it; WP5036: Angiotensin II receptor type 1 pathway; WP5083: Neuroinflammation and glutamatergic signaling; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5382: TGFβ/Smad signaling pathway; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer; WP560: TGF-beta receptor signaling,"4-(4-(Benzo[d][1,3]dioxol-5-yl)-5-(pyridin-2-yl)-1H-imidazol-2-yl)benzamide",Blood
2034,HMDB0246142,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",2-Chloro-5-nitro-N-4-pyridinylbenzamide,Blood
2035,HMDB0246147,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Endurobol,Blood
2036,HMDB0246386,ESRRG,,,4-Chloro-3-methylphenol,Blood
2037,HMDB0246678,GRM5,,"WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",2-(N-Morpholino)-ethanesulfonic acid,Blood
2038,HMDB0246678,MRC1,,,2-(N-Morpholino)-ethanesulfonic acid,Blood
2039,HMDB0246678,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,2-(N-Morpholino)-ethanesulfonic acid,Blood
2040,HMDB0246678,MCOLN2,,,2-(N-Morpholino)-ethanesulfonic acid,Blood
2041,HMDB0246678,IGF1R,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2032: Thyroid stimulating hormone (TSH) signaling pathway; WP2261: Glioblastoma signaling pathways; WP254: Apoptosis; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3584: MECP2 and associated Rett syndrome; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4186: Somatroph axis (GH) and its relationship to dietary restriction and aging; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4808: Endochondral ossification with skeletal dysplasias; WP481: Insulin signaling; WP5087: Pleural mesothelioma; WP5192: Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids; WP5300: TROP2 regulatory signaling; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5380: 5q35 copy number variation; WP5385: Growth factors and hormones in beta cell proliferation; WP5434: Pathways in cancer,2-(N-Morpholino)-ethanesulfonic acid,Blood
2042,HMDB0246678,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,2-(N-Morpholino)-ethanesulfonic acid,Blood
2043,HMDB0246678,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",2-(N-Morpholino)-ethanesulfonic acid,Blood
2044,HMDB0246678,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",2-(N-Morpholino)-ethanesulfonic acid,Blood
2045,HMDB0246678,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",2-(N-Morpholino)-ethanesulfonic acid,Blood
2046,HMDB0246678,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",2-(N-Morpholino)-ethanesulfonic acid,Blood
2047,HMDB0246678,GRK2,,WP3929: Chemokine signaling pathway; WP4249: Hedgehog signaling pathway; WP47: Hedgehog signaling pathway; WP5426: HDAC6 interactions in the central nervous system,2-(N-Morpholino)-ethanesulfonic acid,Blood
2048,HMDB0246678,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",2-(N-Morpholino)-ethanesulfonic acid,Blood
2049,HMDB0246678,TFRC,,WP2007: Iron metabolism in placenta; WP4313: Ferroptosis; WP4906: 3q29 copy number variation syndrome; WP5172: Iron metabolism disorders,2-(N-Morpholino)-ethanesulfonic acid,Blood
2050,HMDB0246678,OLR1,,WP176: Folate metabolism; WP3942: PPAR signaling pathway; WP4022: Pyrimidine metabolism; WP405: Eukaryotic transcription initiation; WP4217: Ebola virus infection in host; WP4259: Disorders of folate metabolism and transport; WP4655: Cytosolic DNA-sensing pathway; WP5222: 2q13 copy number variation syndrome; WP5367: Rubinstein-Taybi syndrome 1; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,2-(N-Morpholino)-ethanesulfonic acid,Blood
2051,HMDB0246678,ERBB2,,WP2034: Leptin signaling pathway; WP2037: Prolactin signaling pathway; WP2261: Glioblastoma signaling pathways; WP2571: Polycystic kidney disease pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3651: Pathways affected in adenoid cystic carcinoma; WP3680: Physico-chemical features and toxicity-associated pathways; WP4155: Endometrial cancer; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP437: EGF/EGFR signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5221: 2q11.2 copy number variation syndrome; WP5287: 17q12 copy number variation syndrome; WP5434: Pathways in cancer; WP673: ErbB signaling pathway; WP710: DNA damage response (only ATM dependent),2-(N-Morpholino)-ethanesulfonic acid,Blood
2052,HMDB0246678,LRP6,,WP1544: MicroRNAs in cardiomyocyte hypertrophy; WP2059: Alzheimer's disease and miRNA effects; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP363: Wnt signaling pathway; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP399: Wnt signaling pathway and pluripotency; WP4150: Wnt signaling in kidney disease; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4258: lncRNA in canonical Wnt signaling and colorectal cancer; WP4262: Breast cancer pathway; WP428: Wnt signaling; WP4336: ncRNAs involved in Wnt signaling in hepatocellular carcinoma; WP4786: Type I collagen synthesis in the context of osteogenesis imperfecta; WP4787: Osteoblast differentiation and related diseases; WP5087: Pleural mesothelioma; WP5124: Alzheimer's disease; WP5434: Pathways in cancer; WP5442: Wnt/Beta-catenin signaling inhibitors in current and past clinical trials,2-(N-Morpholino)-ethanesulfonic acid,Blood
2053,HMDB0246761,HTR5A,,"WP455: GPCRs, class A rhodopsin-like; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",5-Carboxamidotryptamine,Blood
2054,HMDB0247005,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Tris(2-carboxyethyl)phosphine,Blood
2055,HMDB0247151,NR1H4,,WP2289: Drug induction of bile acid pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4396: Nonalcoholic fatty liver disease; WP5238: Cholestasis,Turofexorate isopropyl,Blood
2056,HMDB0247396,HCRTR1,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway","1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea",Blood
2057,HMDB0247399,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,2-(4-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy)phenoxy)acetic acid,Blood
2058,HMDB0247513,ESRRG,,,"1,1-Bis(4-hydroxyphenyl)cyclohexane",Blood
2059,HMDB0247543,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Infigratinib,Blood
2060,HMDB0248129,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Alectinib,Blood
2061,HMDB0248139,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Alisertib,Blood
2062,HMDB0248270,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,"4-{[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid",Blood
2063,HMDB0248270,RARA,,WP170: Nuclear receptors; WP236: Adipogenesis; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP4149: White fat cell differentiation; WP4342: Vitamins A and D - action mechanisms; WP5053: Development of ureteric collection system; WP5130: Th17 cell differentiation pathway; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism,"4-{[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino}benzoic acid",Blood
2064,HMDB0248441,GRIA3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,aniracetam,Blood
2065,HMDB0248754,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",N-(5-((4-(1H-Indol-3-yl)pyrimidin-2-yl)amino)-2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxyphenyl)acrylamide,Blood
2066,HMDB0248778,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Osimertinib,Blood
2067,HMDB0248898,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Bazedoxifene,Blood
2068,HMDB0248970,LILRB2,,,Benzamidine,Blood
2069,HMDB0248970,GABRB3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Benzamidine,Blood
2070,HMDB0248986,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,Benzenesulfonic acid,Blood
2071,HMDB0249068,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Benzyl butyl phthalate,Blood
2072,HMDB0249241,CRHR1,,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events","2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol",Blood
2073,HMDB0249241,LTK,,,"2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol",Blood
2074,HMDB0249241,TNFRSF17,,,"2-[Bis-(2-hydroxy-ethyl)-amino]-2-hydroxymethyl-propane-1,3-diol",Blood
2075,HMDB0249276,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Bisphenol AF,Blood
2076,HMDB0249277,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Bisphenol C,Blood
2077,HMDB0249380,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Brigatinib,Blood
2078,HMDB0249380,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,Brigatinib,Blood
2079,HMDB0249821,ALK,,WP2848: Pluripotent stem cell differentiation pathway; WP4205: MET in type 1 papillary renal cell carcinoma; WP4255: Non-small cell lung cancer; WP4928: MAPK pathway in congenital thyroid cancer; WP4931: Direct reversal repair; WP5173: Disorders of galactose metabolism ; WP5348: 11p11.2 copy number variation syndrome ; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5434: Pathways in cancer,ceritinib,Blood
2080,HMDB0249851,GABBR2,,"WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5417: Cell lineage map for neuronal differentiation",3-Aminopropyl(diethoxymethyl)phosphinic acid,Blood
2081,HMDB0250341,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Clofibric acid,Blood
2082,HMDB0250534,PDGFRA,,WP1539: Angiogenesis; WP2261: Glioblastoma signaling pathways; WP2328: Allograft rejection; WP2406: Cardiac progenitor differentiation; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Crenolanib,Blood
2083,HMDB0250727,NR4A1,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2431: Spinal cord injury; WP382: MAPK signaling pathway; WP3888: VEGFA-VEGFR2 signaling; WP5142: Calcium mediated T-cell apoptosis involved in inclusion body myositis,Cytosporone B,Blood
2084,HMDB0250818,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Dabrafenib,Blood
2085,HMDB0250836,TBXA2R,,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP98: Prostaglandin synthesis and regulation",Daltroban,Blood
2086,HMDB0251222,GABRB2,,WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Didesethylflurazepam,Blood
2087,HMDB0251245,P2RY12,,"WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling",DI(Hydroxyethyl)ether,Blood
2088,HMDB0251245,CHRNA7,,WP2059: Alzheimer's disease and miRNA effects; WP4222: Phosphodiesterases in neuronal function; WP4942: 15q13.3 copy number variation syndrome; WP5055: Burn wound healing; WP5124: Alzheimer's disease; WP5407: 15q11q13 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,DI(Hydroxyethyl)ether,Blood
2089,HMDB0251245,TRAC,,WP5078: T cell modulation in pancreatic cancer,DI(Hydroxyethyl)ether,Blood
2090,HMDB0251245,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,DI(Hydroxyethyl)ether,Blood
2091,HMDB0251245,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",DI(Hydroxyethyl)ether,Blood
2092,HMDB0251245,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2093,HMDB0251245,OXTR,,"WP24: Peptide GPCRs; WP2889: Oxytocin signaling; WP289: Myometrial relaxation and contraction pathways; WP3591: Sleep regulation; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",DI(Hydroxyethyl)ether,Blood
2094,HMDB0251245,HTR2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",DI(Hydroxyethyl)ether,Blood
2095,HMDB0251245,ADRA2A,,"WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",DI(Hydroxyethyl)ether,Blood
2096,HMDB0251245,ITGB1,,WP185: Integrin-mediated cell adhesion; WP2037: Prolactin signaling pathway; WP2064: Neural crest differentiation; WP2118: Arrhythmogenic right ventricular cardiomyopathy; WP2272: Pathogenic Escherichia coli infection; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2643: Nanoparticle-mediated activation of receptor signaling; WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP313: Hepatocyte growth factor receptor signaling; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP366: TGF-beta signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4493: Cells and molecules involved in local acute inflammatory response ; WP4534: Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms; WP4541: Hippo-Merlin signaling dysregulation; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4823: Genes controlling nephrogenesis; WP5053: Development of ureteric collection system; WP5087: Pleural mesothelioma; WP5300: TROP2 regulatory signaling; WP5348: 11p11.2 copy number variation syndrome ; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5362: TAR syndrome; WP5417: Cell lineage map for neuronal differentiation; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2097,HMDB0251245,CYTH3,,WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,DI(Hydroxyethyl)ether,Blood
2098,HMDB0251245,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",DI(Hydroxyethyl)ether,Blood
2099,HMDB0251245,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,DI(Hydroxyethyl)ether,Blood
2100,HMDB0251245,TACR1,,WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,DI(Hydroxyethyl)ether,Blood
2101,HMDB0251245,HCAR2,,,DI(Hydroxyethyl)ether,Blood
2102,HMDB0251245,LEPR,,WP1403: AMP-activated protein kinase signaling; WP2034: Leptin signaling pathway; WP3934: Leptin and adiponectin; WP3935: Leptin-insulin signaling overlap; WP4396: Nonalcoholic fatty liver disease; WP5400: 6q16 copy number variation,DI(Hydroxyethyl)ether,Blood
2103,HMDB0251245,DRD4,,"WP117: GPCRs, other; WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",DI(Hydroxyethyl)ether,Blood
2104,HMDB0251245,GPR52,,"WP455: GPCRs, class A rhodopsin-like",DI(Hydroxyethyl)ether,Blood
2105,HMDB0251245,PDGFRA,,WP1539: Angiogenesis; WP2261: Glioblastoma signaling pathways; WP2328: Allograft rejection; WP2406: Cardiac progenitor differentiation; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP306: Focal adhesion; WP322: Osteoblast signaling; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2106,HMDB0251245,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",DI(Hydroxyethyl)ether,Blood
2107,HMDB0251245,FCGR3A,,WP2806: Complement system; WP5092: Interactions of natural killer cells in pancreatic cancer,DI(Hydroxyethyl)ether,Blood
2108,HMDB0251245,CD3G,,WP4585: Cancer immunotherapy by PD-1 blockade; WP4630: Measles virus infection; WP4884: Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex; WP5072: Modulators of TCR signaling and T cell activation; WP5098: T-cell activation SARS-CoV-2; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5130: Th17 cell differentiation pathway; WP69: T-cell receptor signaling pathway,DI(Hydroxyethyl)ether,Blood
2109,HMDB0251245,IL7R,,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2110,HMDB0251245,ERBB4,,WP2813: Mammary gland development pathway - Embryonic development (Stage 1 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP3297: EV release from cardiac cells and their functional effects; WP3680: Physico-chemical features and toxicity-associated pathways; WP4685: Melanoma; WP5402: 10q22q23 copy number variation; WP673: ErbB signaling pathway,DI(Hydroxyethyl)ether,Blood
2111,HMDB0251245,DRD2,,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",DI(Hydroxyethyl)ether,Blood
2112,HMDB0251245,HTR2B,,"WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",DI(Hydroxyethyl)ether,Blood
2113,HMDB0251245,NRP1,,WP4846: SARS-CoV-2 and COVID-19 pathway; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5284: Cell interactions of the pancreatic cancer microenvironment,DI(Hydroxyethyl)ether,Blood
2114,HMDB0251245,NR4A2,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,DI(Hydroxyethyl)ether,Blood
2115,HMDB0251245,CD300LF,,,DI(Hydroxyethyl)ether,Blood
2116,HMDB0251245,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2117,HMDB0251245,DDR1,,WP3670: Interactions between LOXL4 and oxidative stress pathway,DI(Hydroxyethyl)ether,Blood
2118,HMDB0251245,VIPR1,,"WP334: GPCRs, class B secretin-like; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",DI(Hydroxyethyl)ether,Blood
2119,HMDB0251245,TRBC1,,WP5078: T cell modulation in pancreatic cancer,DI(Hydroxyethyl)ether,Blood
2120,HMDB0251245,GNRHR,,"WP117: GPCRs, other; WP24: Peptide GPCRs; WP5362: TAR syndrome",DI(Hydroxyethyl)ether,Blood
2121,HMDB0251245,SELL,,WP2806: Complement system; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2,DI(Hydroxyethyl)ether,Blood
2122,HMDB0251245,TRGV4,,,DI(Hydroxyethyl)ether,Blood
2123,HMDB0251245,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,DI(Hydroxyethyl)ether,Blood
2124,HMDB0251245,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,DI(Hydroxyethyl)ether,Blood
2125,HMDB0251245,MRC1,,,DI(Hydroxyethyl)ether,Blood
2126,HMDB0251245,TYROBP,,WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway,DI(Hydroxyethyl)ether,Blood
2127,HMDB0251245,ITGAM,,WP185: Integrin-mediated cell adhesion; WP2877: Vitamin D receptor pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3945: TYROBP causal network in microglia; WP4136: Fibrin complement receptor 3 signaling pathway; WP4541: Hippo-Merlin signaling dysregulation; WP5090: Complement system in neuronal development and plasticity; WP5293: Acute myeloid leukemia,DI(Hydroxyethyl)ether,Blood
2128,HMDB0251245,HTR2C,,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",DI(Hydroxyethyl)ether,Blood
2129,HMDB0251245,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",DI(Hydroxyethyl)ether,Blood
2130,HMDB0251245,EPOR,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,DI(Hydroxyethyl)ether,Blood
2131,HMDB0251245,CNR1,,"WP117: GPCRs, other; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP247: Small ligand GPCRs; WP3679: Cell-type dependent selectivity of CCK2R signaling; WP3869: Cannabinoid receptor signaling; WP4321: Thermogenesis; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",DI(Hydroxyethyl)ether,Blood
2132,HMDB0251245,KLRK1,,WP5092: Interactions of natural killer cells in pancreatic cancer,DI(Hydroxyethyl)ether,Blood
2133,HMDB0251245,CNR2,,"WP247: Small ligand GPCRs; WP3869: Cannabinoid receptor signaling; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",DI(Hydroxyethyl)ether,Blood
2134,HMDB0251245,ADGRL3,,"WP117: GPCRs, other; WP334: GPCRs, class B secretin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",DI(Hydroxyethyl)ether,Blood
2135,HMDB0251245,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",DI(Hydroxyethyl)ether,Blood
2136,HMDB0251245,MTNR1A,,"WP247: Small ligand GPCRs; WP3298: Melatonin metabolism and effects; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like",DI(Hydroxyethyl)ether,Blood
2137,HMDB0251245,OPRK1,,"WP24: Peptide GPCRs; WP3584: MECP2 and associated Rett syndrome; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",DI(Hydroxyethyl)ether,Blood
2138,HMDB0251245,FCER1G,,WP3937: Microglia pathogen phagocytosis pathway,DI(Hydroxyethyl)ether,Blood
2139,HMDB0251245,GCGR,,"WP334: GPCRs, class B secretin-like",DI(Hydroxyethyl)ether,Blood
2140,HMDB0251363,SLC29A1,,WP1601: Fluoropyrimidine activity; WP3591: Sleep regulation,Dilazep,Blood
2141,HMDB0251535,GABRA5,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",Blood
2142,HMDB0251535,GABRA1,,WP3947: Serotonin and anxiety; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",Blood
2143,HMDB0251587,PTK2B,,WP205: IL-7 signaling pathway; WP2263: Androgen receptor network in prostate cancer; WP2374: Oncostatin M signaling pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP313: Hepatocyte growth factor receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3929: Chemokine signaling pathway; WP437: EGF/EGFR signaling pathway; WP4666: Hepatitis B infection; WP4747: Netrin-UNC5B signaling pathway; WP49: IL-2 signaling pathway; WP5097: CCL18 signaling pathway; WP5399: NPHP1 deletion syndrome; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP69: T-cell receptor signaling pathway,Doramapimod,Blood
2144,HMDB0251587,EPHA3,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP5347: IL-26 signaling pathways,Doramapimod,Blood
2145,HMDB0251590,ACVR2A,,WP2857: Mesodermal commitment pathway,Dorsomorphin,Blood
2146,HMDB0251597,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Dovitinib,Blood
2147,HMDB0251597,FGFR4,,WP3651: Pathways affected in adenoid cystic carcinoma; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4787: Osteoblast differentiation and related diseases; WP5055: Burn wound healing; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5428: FGFR4 p.G388R signaling pathway; WP5434: Pathways in cancer,Dovitinib,Blood
2148,HMDB0251728,ABCB1,,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Elacridar,Blood
2149,HMDB0251903,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Erdafitinib,Blood
2150,HMDB0251942,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,Esaxerenone,Blood
2151,HMDB0252124,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,"5,8,11,14-Eicosatetraynoic acid",Blood
2152,HMDB0252204,GRM5,,"WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Fenobam,Blood
2153,HMDB0252207,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Fenofibric acid,Blood
2154,HMDB0252207,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Fenofibric acid,Blood
2155,HMDB0252238,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",Fevipiprant,Blood
2156,HMDB0252245,THRB,,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Roxadustat,Blood
2157,HMDB0252331,AR,,"WP106: Alanine and aspartate metabolism; WP117: GPCRs, other; WP12: Osteoclast signaling; WP138: Androgen receptor signaling pathway; WP1403: AMP-activated protein kinase signaling; WP1433: Nucleotide-binding oligomerization domain (NOD) pathway; WP15: Selenium micronutrient network; WP1533: Vitamin B12 metabolism; WP1539: Angiogenesis; WP1541: Energy metabolism; WP170: Nuclear receptors; WP176: Folate metabolism; WP1772: Apoptosis modulation and signaling; WP185: Integrin-mediated cell adhesion; WP1971: Integrated cancer pathway; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP2038: Microtubule cytoskeleton regulation; WP2059: Alzheimer's disease and miRNA effects; WP2261: Glioblastoma signaling pathways; WP2263: Androgen receptor network in prostate cancer; WP2267: Synaptic vesicle pathway; WP2272: Pathogenic Escherichia coli infection; WP23: B cell receptor signaling pathway; WP231: TNF-alpha signaling pathway; WP2328: Allograft rejection; WP2338: miRNA biogenesis; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2369: Histone modifications; WP2371: Parkinson's disease pathway; WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP24: Peptide GPCRs; WP241: One-carbon metabolism; WP2431: Spinal cord injury; WP2446: Retinoblastoma gene in cancer; WP2456: HIF1A and PPARG regulation of glycolysis; WP247: Small ligand GPCRs; WP2507: Nanomaterial induced apoptosis; WP2513: Nanoparticle triggered regulated necrosis; WP2525: Trans-sulfuration, one-carbon metabolism and related pathways; WP2526: PDGF pathway; WP254: Apoptosis; WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2586: Aryl hydrocarbon receptor pathway; WP2636: Common pathways underlying drug addiction; WP2643: Nanoparticle-mediated activation of receptor signaling; WP28: Selenium metabolism and selenoproteins; WP2806: Complement system; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2828: Bladder cancer; WP2839: Hair follicle development: organogenesis - part 2 of 3; WP2853: Endoderm differentiation; WP2857: Mesodermal commitment pathway; WP2858: Ectoderm differentiation; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP289: Myometrial relaxation and contraction pathways; WP2895: Differentiation of white and brown adipocyte; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP299: Nuclear receptors in lipid metabolism and toxicity; WP306: Focal adhesion; WP314: Fas ligand pathway and stress induction of heat shock proteins; WP3298: Melatonin metabolism and effects; WP3407: FTO obesity variant mechanism; WP3413: NOTCH1 regulation of endothelial cell calcification; WP35: G protein signaling pathways; WP3527: Pre-implantation embryo; WP3584: MECP2 and associated Rett syndrome; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3596: miR-517 relationship with ARCN1 and USP1; WP3599: Transcription factor regulation in adipogenesis; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3613: Photodynamic therapy-induced unfolded protein response; WP3614: Photodynamic therapy-induced HIF-1 survival signaling; WP3617: Photodynamic therapy-induced NF-kB survival signaling; WP3624: Lung fibrosis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3644: NAD+ metabolism; WP3645: NAD+ biosynthetic pathways; WP3651: Pathways affected in adenoid cystic carcinoma; WP3655: Hypothetical craniofacial development pathway; WP3657: Hematopoietic stem cell gene regulation by GABP alpha/beta complex; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP366: TGF-beta signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP3863: T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection; WP3869: Cannabinoid receptor signaling; WP3888: VEGFA-VEGFR2 signaling; WP3890: Nanomaterial-induced inflammasome activation; WP3893: Development and heterogeneity of the ILC family; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP391: Mitochondrial gene expression; WP3925: Amino acid metabolism; WP3929: Chemokine signaling pathway; WP3930: EDA signaling in hair follicle development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3937: Microglia pathogen phagocytosis pathway; WP3940: One-carbon metabolism and related pathways; WP3941: Oxidative damage response; WP3942: PPAR signaling pathway; WP3944: Serotonin and anxiety-related events; WP3945: TYROBP causal network in microglia; WP3947: Serotonin and anxiety; WP3958: GPR40 pathway; WP3959: DNA IR-double strand breaks and cellular response via ATM; WP3965: Lipid metabolism pathway; WP3967: miR-509-3p alteration of YAP1/ECM axis; WP3981: miRNA regulation of prostate cancer signaling pathways; WP399: Wnt signaling pathway and pluripotency; WP4016: DNA IR-damage and cellular response via ATR; WP4018: Clear cell renal cell carcinoma pathways; WP4030: SCFA and skeletal muscle substrate metabolism; WP410: Exercise-induced circadian regulation; WP4149: White fat cell differentiation; WP4153: Degradation pathway of sphingolipids, including diseases; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4191: Caloric restriction and aging; WP4197: Immune response to tuberculosis; WP4204: Tumor suppressor activity of SMARCB1; WP4205: MET in type 1 papillary renal cell carcinoma; WP4211: Transcriptional cascade regulating adipogenesis; WP4216: Chromosomal and microsatellite instability in colorectal cancer ; WP422: MAPK cascade; WP4223: Ras signaling; WP4224: Purine metabolism and related disorders; WP4239: Epithelial to mesenchymal transition in colorectal cancer; WP4241: Type 2 papillary renal cell carcinoma; WP4249: Hedgehog signaling pathway; WP4255: Non-small cell lung cancer; WP4259: Disorders of folate metabolism and transport; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4288: MTHFR deficiency; WP4290: Metabolic reprogramming in colon cancer; WP4298: Acute viral myocarditis; WP430: Statin inhibition of cholesterol production; WP4301: Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells; WP4312: Rett syndrome; WP4321: Thermogenesis; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4352: Ciliary landscape; WP437: EGF/EGFR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4507: Molybdenum cofactor (Moco) biosynthesis; WP4522: Metabolic pathway of LDL, HDL and TG, including diseases; WP4523: Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism; WP4524: Alternative pathway of fetal androgen synthesis; WP4536: Genes related to primary cilium development (based on CRISPR); WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP455: GPCRs, class A rhodopsin-like; WP4558: Overview of interferons-mediated signaling pathway; WP4564: Neural crest cell migration during development; WP4565: Neural crest cell migration in cancer; WP4571: Urea cycle and related diseases; WP4583: Biomarkers for urea cycle disorders; WP4595: Urea cycle and associated pathways; WP4630: Measles virus infection; WP4655: Cytosolic DNA-sensing pathway; WP4656: Joubert syndrome; WP4657: 22q11.2 copy number variation syndrome; WP4658: Small cell lung cancer; WP4659: Gastrin signaling pathway; WP4666: Hepatitis B infection; WP4673: Male infertility; WP4685: Melanoma; WP47: Hedgehog signaling pathway; WP4705: Pathways of nucleic acid metabolism and innate immune sensing; WP4707: Aspirin and miRNAs; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4747: Netrin-UNC5B signaling pathway; WP4752: Base excision repair; WP4754: IL-18 signaling pathway; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4758: Nephrotic syndrome; WP4787: Osteoblast differentiation and related diseases; WP4803: Ciliopathies; WP4806: EGFR tyrosine kinase inhibitor resistance; WP481: Insulin signaling; WP4815: Glycosaminoglycan degradation; WP4838: Regucalcin in proximal tubule epithelial kidney cells; WP4844: Influence of laminopathies on Wnt signaling; WP4846: SARS-CoV-2 and COVID-19 pathway; WP4868: Type I interferon induction and signaling during SARS-CoV-2 infection; WP4871: Kisspeptin/kisspeptin receptor system in the ovary; WP4873: Peroxiredoxin 2 induced ovarian failure; WP4874: CAMKK2 pathway; WP4875: Disruption of postsynaptic signaling by CNV; WP4876: Activation of NLRP3 inflammasome by SARS-CoV-2; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4880: Host-pathogen interaction of human coronaviruses - interferon induction; WP4900: Purinergic signaling; WP4912: SARS coronavirus and innate immunity; WP4928: MAPK pathway in congenital thyroid cancer; WP4932: 7q11.23 copy number variation syndrome; WP4936: Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins; WP4941: GPR143 in melanocytes and retinal pigment epithelium cells; WP4942: 15q13.3 copy number variation syndrome; WP4946: DNA repair pathways, full network; WP4947: Nitric oxide metabolism in cystic fibrosis; WP4949: 16p11.2 proximal deletion syndrome; WP4963: p53 transcriptional gene network; WP497: Urea cycle and metabolism of amino groups; WP4970: Galanin receptor pathway; WP5039: SARS-CoV-2 innate immunity evasion and cell-specific immune response; WP5046: NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence; WP5053: Development of ureteric collection system; WP5066: FOXA2 pathway; WP5072: Modulators of TCR signaling and T cell activation; WP5078: T cell modulation in pancreatic cancer; WP5083: Neuroinflammation and glutamatergic signaling; WP5085: Vasopressin-regulated water reabsorption; WP5087: Pleural mesothelioma; WP5088: Prostaglandin signaling; WP5090: Complement system in neuronal development and plasticity; WP5093: Opioid receptor pathways; WP5094: Orexin receptor pathway; WP5095: Overview of proinflammatory and profibrotic mediators; WP5098: T-cell activation SARS-CoV-2; WP51: Regulation of actin cytoskeleton; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5110: Familial hyperlipidemia type 3; WP5114: Nucleotide excision repair in xeroderma pigmentosum ; WP5115: Network map of SARS-CoV-2 signaling pathway; WP5124: Alzheimer's disease; WP5130: Th17 cell differentiation pathway; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5145: COVID-19 structural coverage map; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP5152: Iron-sulfur cluster biogenesis; WP5180: DYRK1A involvement regarding cell proliferation in brain development; WP5205: Clock-controlled autophagy in bone metabolism; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2; WP5220: Metabolic reprogramming in pancreatic cancer; WP5221: 2q11.2 copy number variation syndrome; WP5222: 2q13 copy number variation syndrome; WP5223: 2q21.1 copy number variation syndrome; WP5224: 2q37 copy number variation syndrome; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5234: Bardet-Biedl syndrome; WP5236: Markers of kidney cell lineage; WP5238: Cholestasis; WP524: G13 signaling pathway; WP5258: Role of ROS in COVID-19 endothelial dysfunction; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5275: Ether lipid biosynthesis; WP5287: 17q12 copy number variation syndrome; WP5292: Glycosphingolipid metabolism; WP5293: Acute myeloid leukemia; WP5294: Sildenafil treatment; WP5304: Cholesterol metabolism; WP5312: Metabolic pathways of fibroblasts; WP5313: Carnosine metabolism of glial cells; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes; WP5333: Enterocyte cholesterol metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP5345: 1p36 copy number variation syndrome; WP5348: 11p11.2 copy number variation syndrome ; WP5351: Kleefstra syndrome; WP5352: 10q11.21q11.23 copy number variation syndrome; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5355: Metabolic Epileptic Disorders; WP5356: Affected pathways in Duchenne muscular dystrophy; WP536: Calcium regulation in cardiac cells; WP5362: TAR syndrome; WP5365: 4p16.3 copy number variation; WP5366: NF1 copy number variation syndrome ; WP5367: Rubinstein-Taybi syndrome 1; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5380: 5q35 copy number variation; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation; WP5382: TGFβ/Smad signaling pathway; WP5390: Pancreatic cancer subtypes; WP5397: Vitamin A1 and A5/X pathways; WP5399: NPHP1 deletion syndrome; WP5400: 6q16 copy number variation; WP5402: 10q22q23 copy number variation; WP5412: 8q11.23 (RB1CC1) copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP5440: EPAC1 and PKA reduction of retinal inflammation; WP558: Complement and coagulation cascades; WP585: Interferon type I signaling pathways; WP673: ErbB signaling pathway; WP69: T-cell receptor signaling pathway; WP697: Estrogen metabolism; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP716: Vitamin A and carotenoid metabolism; WP75: Toll-like receptor signaling pathway; WP80: Nucleotide GPCRs; WP98: Prostaglandin synthesis and regulation",Flufenamic acid,Blood
2158,HMDB0252437,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Foretinib,Blood
2159,HMDB0252456,PTAFR,,"WP247: Small ligand GPCRs; WP455: GPCRs, class A rhodopsin-like",Foropafant,Blood
2160,HMDB0252570,GABRD,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4312: Rett syndrome; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5345: 1p36 copy number variation syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Gaboxadol,Blood
2161,HMDB0252652,THRB,,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,"[4-(3-Benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy]acetic acid",Blood
2162,HMDB0252717,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,Gilteritinib,Blood
2163,HMDB0252909,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,Golvatinib,Blood
2164,HMDB0252987,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,"{4-[({2-[3-Fluoro-4-(Trifluoromethyl)phenyl]-4-Methyl-1,3-Thiazol-5-Yl}methyl)sulfanyl]-2-Methylphenoxy}acetic Acid",Blood
2165,HMDB0252989,NTRK2,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP3676: BDNF-TrkB signaling; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4539: Synaptic signaling pathways associated with autism spectrum disorder; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4549: Fragile X syndrome; WP4565: Neural crest cell migration in cancer; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5087: Pleural mesothelioma; WP5372: Involvement of δ-secretase in neurodegenerative diseases; WP5400: 6q16 copy number variation; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,"5-(3-Methoxy-4-((4-methoxybenzyl)oxy)benzyl)pyrimidine-2,4-diamine",Blood
2166,HMDB0252991,NR1H3,,WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2878: PPAR-alpha pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4396: Nonalcoholic fatty liver disease; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,"3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid",Blood
2167,HMDB0252991,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,"3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid",Blood
2168,HMDB0252991,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,"3-(3-(N-(2-Chloro-3-trifluoromethylbenzyl)(2,2-diphenylethyl)amino)propoxy)phenylacetic acid",Blood
2169,HMDB0252992,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,2-[(4-{2-[(4-Cyclohexylbutyl)(cyclohexylcarbamoyl)amino]ethyl}phenyl)sulfanyl]-2-methylpropanoic acid,Blood
2170,HMDB0252995,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,2-Chloro-5-nitro-N-phenylbenzamide,Blood
2171,HMDB0252995,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",2-Chloro-5-nitro-N-phenylbenzamide,Blood
2172,HMDB0252995,NCOA2,,WP138: Androgen receptor signaling pathway; WP2355: Corticotropin-releasing hormone signaling pathway; WP236: Adipogenesis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP3594: Circadian rhythm genes,2-Chloro-5-nitro-N-phenylbenzamide,Blood
2173,HMDB0253260,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Hydroxychlor,Blood
2174,HMDB0253260,ESRRG,,,Hydroxychlor,Blood
2175,HMDB0253771,THRB,,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,"{3,5-Dichloro-4-[4-Hydroxy-3-(Propan-2-Yl)phenoxy]phenyl}acetic Acid",Blood
2176,HMDB0253771,THRA,,WP170: Nuclear receptors; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias,"{3,5-Dichloro-4-[4-Hydroxy-3-(Propan-2-Yl)phenoxy]phenyl}acetic Acid",Blood
2177,HMDB0254011,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Lenvatinib,Blood
2178,HMDB0254011,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Lenvatinib,Blood
2179,HMDB0254108,CCKAR,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",Lintitript,Blood
2180,HMDB0254194,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,Lucitanib,Blood
2181,HMDB0254240,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Lilly 117018,Blood
2182,HMDB0254278,GRM5,,"WP2636: Common pathways underlying drug addiction; WP4224: Purine metabolism and related disorders; WP4549: Fragile X syndrome; WP4698: Vitamin D-sensitive calcium signaling in depression; WP501: GPCRs, class C metabotropic glutamate, pheromone; WP5083: Neuroinflammation and glutamatergic signaling; WP5408: 15q25 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",2-[2-(3-Methoxyphenyl)ethynyl]-6-methylpyridine,Blood
2183,HMDB0254305,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Magnolol,Blood
2184,HMDB0254305,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",Magnolol,Blood
2185,HMDB0254805,EPHA2,,WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma,"4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid",Blood
2186,HMDB0254880,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",3[N-Morpholino]propane sulfonic acid,Blood
2187,HMDB0254901,KDR,,WP1539: Angiogenesis; WP2406: Cardiac progenitor differentiation; WP2571: Polycystic kidney disease pathway; WP306: Focal adhesion; WP3888: VEGFA-VEGFR2 signaling; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3943: Robo4 and VEGF signaling pathways crosstalk; WP4018: Clear cell renal cell carcinoma pathways; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4685: Melanoma; WP4747: Netrin-UNC5B signaling pathway; WP4806: EGFR tyrosine kinase inhibitor resistance; WP4823: Genes controlling nephrogenesis; WP4950: 16p11.2 distal deletion syndrome; WP5065: SARS-CoV-2 altering angiogenesis via NRP1; WP5087: Pleural mesothelioma; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5216: Warburg effect modulated by deubiquitinating enzymes and their substrates; WP5236: Markers of kidney cell lineage; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5316: Primary ovarian insufficiency; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy,Motesanib,Blood
2188,HMDB0255106,NCOA1,,WP138: Androgen receptor signaling pathway; WP1541: Energy metabolism; WP2034: Leptin signaling pathway; WP236: Adipogenesis; WP2873: Aryl hydrocarbon receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP364: IL6 signaling pathway; WP4262: Breast cancer pathway; WP5434: Pathways in cancer,N-Cyclohexyltaurine,Blood
2189,HMDB0255106,NR3C2,,WP3527: Pre-implantation embryo; WP554: ACE inhibitor pathway,N-Cyclohexyltaurine,Blood
2190,HMDB0255106,FCGRT,,,N-Cyclohexyltaurine,Blood
2191,HMDB0255221,TRPA1,,WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5283: Chronic hyperglycemia impairment of neuron function; WP5444: Acetaminophen in analgesia and antipyresis,N-Oxalylglycine,Blood
2192,HMDB0255494,SIGMAR1,,WP5356: Affected pathways in Duchenne muscular dystrophy,N-(4-Methoxy-3-phenethoxyphenethyl)-N-propylpropan-1-amine,Blood
2193,HMDB0255552,TACR1,,WP24: Peptide GPCRs; WP2431: Spinal cord injury; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Netupitant,Blood
2194,HMDB0255574,MERTK,,WP4217: Ebola virus infection in host; WP4533: Transcription co-factors SKI and SKIL protein partners; WP5090: Complement system in neuronal development and plasticity; WP5222: 2q13 copy number variation syndrome,2-(2-Hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine,Blood
2195,HMDB0256256,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Pentaethylene glycol,Blood
2196,HMDB0256256,HCRTR2,,"WP24: Peptide GPCRs; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP455: GPCRs, class A rhodopsin-like; WP5094: Orexin receptor pathway",Pentaethylene glycol,Blood
2197,HMDB0256256,VIPR1,,"WP334: GPCRs, class B secretin-like; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",Pentaethylene glycol,Blood
2198,HMDB0256256,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Pentaethylene glycol,Blood
2199,HMDB0256256,LTB4R,,"WP117: GPCRs, other; WP2431: Spinal cord injury; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5191: Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution; WP80: Nucleotide GPCRs",Pentaethylene glycol,Blood
2200,HMDB0256256,CRHR1,,"WP2355: Corticotropin-releasing hormone signaling pathway; WP289: Myometrial relaxation and contraction pathways; WP334: GPCRs, class B secretin-like; WP3944: Serotonin and anxiety-related events",Pentaethylene glycol,Blood
2201,HMDB0256256,CYSLTR2,,"WP3624: Lung fibrosis; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX)",Pentaethylene glycol,Blood
2202,HMDB0256256,OPRM1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like; WP5093: Opioid receptor pathways; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP",Pentaethylene glycol,Blood
2203,HMDB0256256,FFAR1,,"WP3958: GPR40 pathway; WP455: GPCRs, class A rhodopsin-like",Pentaethylene glycol,Blood
2204,HMDB0256256,PTPRE,,,Pentaethylene glycol,Blood
2205,HMDB0256256,P2RY1,,"WP117: GPCRs, other; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5360: KCNQ2-related epilepsies; WP80: Nucleotide GPCRs",Pentaethylene glycol,Blood
2206,HMDB0256256,CYSLTR1,,"WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5122: Prostaglandin and leukotriene metabolism in senescence ; WP5321: Prostaglandin and leukotriene metabolism in senescence ; WP5424: Omega-6-fatty acids in senescence",Pentaethylene glycol,Blood
2207,HMDB0256256,NR5A2,,WP170: Nuclear receptors,Pentaethylene glycol,Blood
2208,HMDB0256256,CHRNA3,,WP1602: Nicotine effect on dopaminergic neurons; WP1603: Nicotine effect on chromaffin cells,Pentaethylene glycol,Blood
2209,HMDB0256256,HTR2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",Pentaethylene glycol,Blood
2210,HMDB0256360,KIT,,WP2406: Cardiac progenitor differentiation; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2848: Pluripotent stem cell differentiation pathway; WP2849: Hematopoietic stem cell differentiation; WP304: Kit receptor signaling pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4331: Neovascularization processes; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP4685: Melanoma; WP5087: Pleural mesothelioma; WP5236: Markers of kidney cell lineage; WP5293: Acute myeloid leukemia; WP5316: Primary ovarian insufficiency; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer,Pexidartinib,Blood
2211,HMDB0256360,CSF1R,,WP2848: Pluripotent stem cell differentiation pathway; WP3640: Imatinib and chronic myeloid leukemia; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP5087: Pleural mesothelioma; WP5284: Cell interactions of the pancreatic cancer microenvironment; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,Pexidartinib,Blood
2212,HMDB0256585,GRIA3,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP2636: Common pathways underlying drug addiction; WP3584: MECP2 and associated Rett syndrome; WP4760: PKC-gamma calcium signaling pathway in ataxia; WP5083: Neuroinflammation and glutamatergic signaling; WP5398: NRXN1 deletion syndrome; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,Piracetam,Blood
2213,HMDB0256601,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Pirinixic acid,Blood
2214,HMDB0256601,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Pirinixic acid,Blood
2215,HMDB0256769,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,Pretilachlor,Blood
2216,HMDB0257243,HTR2C,,"WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP3998: Prader-Willi and Angelman syndrome; WP455: GPCRs, class A rhodopsin-like; WP58: Monoamine GPCRs; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",ritanserin,Blood
2217,HMDB0257250,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Rivoglitazone,Blood
2218,HMDB0257255,GABRA5,,WP3998: Prader-Willi and Angelman syndrome; WP4159: GABA receptor signaling; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,"Ethyl 8-azido-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",Blood
2219,HMDB0257255,GABRG2,,WP3998: Prader-Willi and Angelman syndrome; WP4148: Splicing factor NOVA regulated synaptic proteins; WP4159: GABA receptor signaling; WP4549: Fragile X syndrome; WP4829: mBDNF and proBDNF regulation of GABA neurotransmission; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP,"Ethyl 8-azido-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate",Blood
2220,HMDB0257287,EGFR,,"WP138: Androgen receptor signaling pathway; WP2261: Glioblastoma signaling pathways; WP2324: AGE/RAGE pathway; WP2363: Gastric cancer network 2; WP2431: Spinal cord injury; WP2586: Aryl hydrocarbon receptor pathway; WP2643: Nanoparticle-mediated activation of receptor signaling; WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2828: Bladder cancer; WP2840: Hair follicle development: cytodifferentiation - part 3 of 3; WP2868: TCA cycle nutrient use and invasiveness of ovarian cancer; WP2870: Extracellular vesicle-mediated signaling in recipient cells; WP2873: Aryl hydrocarbon receptor pathway; WP2882: Nuclear receptors meta-pathway; WP306: Focal adhesion; WP3303: RAC1/PAK1/p38/MMP2 pathway; WP3611: Photodynamic therapy-induced AP-1 survival signaling; WP3680: Physico-chemical features and toxicity-associated pathways; WP382: MAPK signaling pathway; WP3853: ERK pathway in Huntington's disease; WP3873: RIOK1 and RIOK2 in EGFR- and PI3K-mediated tumorigenesis; WP3927: BMP signaling in eyelid development; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4018: Clear cell renal cell carcinoma pathways; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4217: Ebola virus infection in host; WP4223: Ras signaling; WP4255: Non-small cell lung cancer; WP4262: Breast cancer pathway; WP4263: Pancreatic adenocarcinoma pathway; WP4300: Extracellular vesicles in the crosstalk of cardiac cells; WP437: EGF/EGFR signaling pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4659: Gastrin signaling pathway; WP4674: Head and neck squamous cell carcinoma; WP4806: EGFR tyrosine kinase inhibitor resistance; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5144: NRP1-triggered signaling pathways in pancreatic cancer ; WP5158: Urotensin-II-mediated signaling pathway; WP5224: 2q37 copy number variation syndrome; WP5300: TROP2 regulatory signaling; WP5362: TAR syndrome; WP5366: NF1 copy number variation syndrome ; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5426: HDAC6 interactions in the central nervous system; WP5434: Pathways in cancer; WP673: ErbB signaling pathway",Rociletinib,Blood
2221,HMDB0258355,THRA,,WP170: Nuclear receptors; WP2916: Interactome of polycomb repressive complex 2 (PRC2) ; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4767: FGFR3 signaling in chondrocyte proliferation and terminal differentiation; WP4808: Endochondral ossification with skeletal dysplasias,Sobetirome,Blood
2222,HMDB0258355,THRB,,WP170: Nuclear receptors; WP2849: Hematopoietic stem cell differentiation; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways,Sobetirome,Blood
2223,HMDB0258423,DRD2,,"WP1602: Nicotine effect on dopaminergic neurons; WP2636: Common pathways underlying drug addiction; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4657: 22q11.2 copy number variation syndrome; WP5380: 5q35 copy number variation; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",spiperone,Blood
2224,HMDB0258663,NR1H3,,WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2878: PPAR-alpha pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4396: Nonalcoholic fatty liver disease; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",Blood
2225,HMDB0258663,NR1I2,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2876: Pregnane X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP4545: Oxysterols derived from cholesterol; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists,"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",Blood
2226,HMDB0258663,NR1H2,,WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP4545: Oxysterols derived from cholesterol; WP4718: Cholesterol metabolism with Bloch and Kandutsch-Russell pathways; WP5329: Cholesterol biosynthesis pathway in hepatocytes; WP5381: Smith-Magenis and Potocki-Lupski syndrome copy number variation,"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",Blood
2227,HMDB0258663,RORC,,WP170: Nuclear receptors; WP3594: Circadian rhythm genes; WP4545: Oxysterols derived from cholesterol; WP4657: 22q11.2 copy number variation syndrome; WP5130: Th17 cell differentiation pathway; WP5198: Inflammatory bowel disease signaling; WP5347: IL-26 signaling pathways,"N-(2,2,2-Trifluoroethyl)-N-{4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl}benzenesulfonamide",Blood
2228,HMDB0258730,ABCB1,,WP1604: Codeine and morphine metabolism; WP2289: Drug induction of bile acid pathway; WP2328: Allograft rejection; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3640: Imatinib and chronic myeloid leukemia; WP3672: lncRNA-mediated mechanisms of therapeutic resistance; WP4389: Bile acids synthesis and enterohepatic circulation ; WP4673: Male infertility; WP4917: Proximal tubule transport; WP5176: Disorders of bile acid synthesis and biliary transport; WP5238: Cholestasis; WP5304: Cholesterol metabolism; WP5396: Enterohepatic circulation of bile acids,Tariquidar,Blood
2229,HMDB0258730,ABCG2,,WP1601: Fluoropyrimidine activity; WP229: Irinotecan pathway; WP3612: Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling; WP3640: Imatinib and chronic myeloid leukemia; WP4917: Proximal tubule transport,Tariquidar,Blood
2230,HMDB0258757,NR1I3,,WP170: Nuclear receptors; WP2289: Drug induction of bile acid pathway; WP2875: Constitutive androstane receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP5238: Cholestasis; WP5351: Kleefstra syndrome,Tcpobop,Blood
2231,HMDB0258867,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Tetrac,Blood
2232,HMDB0258870,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",Tetrachlorobisphenol A,Blood
2233,HMDB0258870,PPARG,,"WP1403: AMP-activated protein kinase signaling; WP1541: Energy metabolism; WP170: Nuclear receptors; WP1982: Sterol regulatory element-binding proteins (SREBP) signaling; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2456: HIF1A and PPARG regulation of glycolysis; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2879: Farnesoid X receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2895: Differentiation of white and brown adipocyte; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3407: FTO obesity variant mechanism; WP3594: Circadian rhythm genes; WP3599: Transcription factor regulation in adipogenesis; WP363: Wnt signaling pathway; WP3630: NAD metabolism, sirtuins and aging; WP3850: Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling; WP391: Mitochondrial gene expression; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3942: PPAR signaling pathway; WP4149: White fat cell differentiation; WP4191: Caloric restriction and aging; WP4211: Transcriptional cascade regulating adipogenesis; WP4321: Thermogenesis; WP4659: Gastrin signaling pathway; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4844: Influence of laminopathies on Wnt signaling; WP4879: Overlap between signal transduction pathways contributing to LMNA laminopathies; WP4949: 16p11.2 proximal deletion syndrome; WP4970: Galanin receptor pathway; WP5066: FOXA2 pathway; WP5087: Pleural mesothelioma; WP5102: Familial partial lipodystrophy; WP5103: Progeria-associated lipodystrophy; WP5231: Hippocampal synaptogenesis and neurogenesis; WP5294: Sildenafil treatment; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5402: 10q22q23 copy number variation; WP5434: Pathways in cancer; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP98: Prostaglandin synthesis and regulation",Tetrachlorobisphenol A,Blood
2234,HMDB0258889,PPARA,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP2011: SREBF and miR33 in cholesterol and lipid homeostasis; WP236: Adipogenesis; WP2878: PPAR-alpha pathway; WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3594: Circadian rhythm genes; WP3942: PPAR signaling pathway; WP4396: Nonalcoholic fatty liver disease; WP4707: Aspirin and miRNAs; WP4720: Eicosanoid metabolism via cytochrome P450 monooxygenases pathway; WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5102: Familial partial lipodystrophy; WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5318: Female steroid hormones in cardiomyocyte energy metabolism,Tetradecylthioacetic acid,Blood
2235,HMDB0259193,PLAUR,,WP2572: Primary focal segmental glomerulosclerosis (FSGS); WP2806: Complement system; WP3888: VEGFA-VEGFR2 signaling; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP558: Complement and coagulation cascades,TRIETHYLENE GLYCOL,Blood
2236,HMDB0259193,KLRK1,,WP5092: Interactions of natural killer cells in pancreatic cancer,TRIETHYLENE GLYCOL,Blood
2237,HMDB0259193,VIPR1,,"WP334: GPCRs, class B secretin-like; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways",TRIETHYLENE GLYCOL,Blood
2238,HMDB0259193,GPR52,,"WP455: GPCRs, class A rhodopsin-like",TRIETHYLENE GLYCOL,Blood
2239,HMDB0259193,PTGDR2,,"WP455: GPCRs, class A rhodopsin-like; WP4719: Eicosanoid metabolism via cyclooxygenases (COX)",TRIETHYLENE GLYCOL,Blood
2240,HMDB0259193,CD44,,WP3646: Hepatitis C and hepatocellular carcinoma; WP399: Wnt signaling pathway and pluripotency; WP4541: Hippo-Merlin signaling dysregulation; WP4659: Gastrin signaling pathway; WP5087: Pleural mesothelioma,TRIETHYLENE GLYCOL,Blood
2241,HMDB0259193,NR4A2,,WP170: Nuclear receptors; WP2355: Corticotropin-releasing hormone signaling pathway; WP2855: Dopaminergic neurogenesis; WP3888: VEGFA-VEGFR2 signaling; WP5417: Cell lineage map for neuronal differentiation,TRIETHYLENE GLYCOL,Blood
2242,HMDB0259193,CD300LF,,,TRIETHYLENE GLYCOL,Blood
2243,HMDB0259193,OPRD1,,"WP24: Peptide GPCRs; WP455: GPCRs, class A rhodopsin-like",TRIETHYLENE GLYCOL,Blood
2244,HMDB0259193,CYTH3,,WP481: Insulin signaling; WP5224: 2q37 copy number variation syndrome,TRIETHYLENE GLYCOL,Blood
2245,HMDB0259193,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",TRIETHYLENE GLYCOL,Blood
2246,HMDB0259193,IL7R,,WP205: IL-7 signaling pathway; WP2203: Thymic stromal lymphopoietin (TSLP) signaling pathway; WP2864: Apoptosis-related network due to altered Notch3 in ovarian cancer; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP5063: FOXP3 in COVID-19; WP5434: Pathways in cancer,TRIETHYLENE GLYCOL,Blood
2247,HMDB0259193,C5AR1,,WP24: Peptide GPCRs; WP2806: Complement system; WP3896: Dengue-2 interactions with complement and coagulation cascades; WP3941: Oxidative damage response; WP5090: Complement system in neuronal development and plasticity; WP5148: Complement-mediated inflammation of pulmonary alveolus in COVID-19 (hypothetical pathway); WP558: Complement and coagulation cascades,TRIETHYLENE GLYCOL,Blood
2248,HMDB0259193,ZP3,,WP34: Ovarian infertility; WP5316: Primary ovarian insufficiency; WP5401: 7q11.23 distal copy number variation,TRIETHYLENE GLYCOL,Blood
2249,HMDB0259193,PPARD,,WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2858: Ectoderm differentiation; WP2877: Vitamin D receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP299: Nuclear receptors in lipid metabolism and toxicity; WP3658: Wnt/beta-catenin signaling pathway in leukemia; WP3942: PPAR signaling pathway; WP399: Wnt signaling pathway and pluripotency; WP4030: SCFA and skeletal muscle substrate metabolism; WP4719: Eicosanoid metabolism via cyclooxygenases (COX); WP4721: Eicosanoid metabolism via lipooxygenases (LOX); WP5273: Effect of intestinal microbiome on anticoagulant response of vitamin K antagonists; WP5293: Acute myeloid leukemia; WP5434: Pathways in cancer,TRIETHYLENE GLYCOL,Blood
2250,HMDB0259193,SORT1,,WP2380: Brain-derived neurotrophic factor (BDNF) signaling pathway; WP4565: Neural crest cell migration in cancer; WP5304: Cholesterol metabolism; WP5323: Fatty acids and lipoproteins transport in hepatocytes,TRIETHYLENE GLYCOL,Blood
2251,HMDB0259193,CHRM1,,"WP2597: Secretion of hydrochloric acid in parietal cells; WP3594: Circadian rhythm genes; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4698: Vitamin D-sensitive calcium signaling in depression; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP5360: KCNQ2-related epilepsies; WP58: Monoamine GPCRs",TRIETHYLENE GLYCOL,Blood
2252,HMDB0259193,CYSLTR2,,"WP3624: Lung fibrosis; WP455: GPCRs, class A rhodopsin-like; WP4721: Eicosanoid metabolism via lipooxygenases (LOX)",TRIETHYLENE GLYCOL,Blood
2253,HMDB0259193,PLXNB1,,,TRIETHYLENE GLYCOL,Blood
2254,HMDB0259193,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",TRIETHYLENE GLYCOL,Blood
2255,HMDB0259193,EPOR,,WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP4172: PI3K-Akt signaling pathway; WP5358: JAK-STAT signaling in the regulation of beta cells; WP5434: Pathways in cancer; WP581: EPO receptor signaling,TRIETHYLENE GLYCOL,Blood
2256,HMDB0259193,FGFR1,,WP2064: Neural crest differentiation; WP2261: Glioblastoma signaling pathways; WP2857: Mesodermal commitment pathway; WP382: MAPK signaling pathway; WP3931: Embryonic stem cell pluripotency pathways; WP3932: Focal adhesion: PI3K-Akt-mTOR-signaling pathway; WP3995: Prion disease pathway; WP4155: Endometrial cancer; WP4172: PI3K-Akt signaling pathway; WP4223: Ras signaling; WP4262: Breast cancer pathway; WP4321: Thermogenesis; WP4540: Hippo signaling regulation pathways; WP4541: Hippo-Merlin signaling dysregulation; WP4657: 22q11.2 copy number variation syndrome; WP4674: Head and neck squamous cell carcinoma; WP474: Endochondral ossification; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP4787: Osteoblast differentiation and related diseases; WP4808: Endochondral ossification with skeletal dysplasias; WP5055: Burn wound healing; WP5074: Kallmann syndrome; WP5087: Pleural mesothelioma; WP51: Regulation of actin cytoskeleton; WP5312: Metabolic pathways of fibroblasts; WP5353: Macrophage-stimulating protein (MSP) signaling network map; WP5373: Osteoarthritic chondrocyte hypertrophy; WP5434: Pathways in cancer,TRIETHYLENE GLYCOL,Blood
2257,HMDB0259193,HTR5A,,"WP455: GPCRs, class A rhodopsin-like; WP5417: Cell lineage map for neuronal differentiation; WP58: Monoamine GPCRs",TRIETHYLENE GLYCOL,Blood
2258,HMDB0259193,CCR7,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP4494: Selective expression of chemokine receptors during T-cell polarization; WP4542: Leukocyte-intrinsic Hippo pathway functions; WP455: GPCRs, class A rhodopsin-like; WP5218: Extrafollicular and follicular B cell activation by SARS-CoV-2",TRIETHYLENE GLYCOL,Blood
2259,HMDB0259193,ADRB2,,"WP117: GPCRs, other; WP2877: Vitamin D receptor pathway; WP3888: VEGFA-VEGFR2 signaling; WP455: GPCRs, class A rhodopsin-like; WP4589: Major receptors targeted by epinephrine and norepinephrine; WP4962: Airway smooth muscle cell contraction; WP5342: Pathophysiological roles of DUX4 in FSHD1; WP5344: Cardiomyocyte signaling pathways converging on titin; WP536: Calcium regulation in cardiac cells; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs",TRIETHYLENE GLYCOL,Blood
2260,HMDB0259788,CCR9,,"WP24: Peptide GPCRs; WP3929: Chemokine signaling pathway; WP455: GPCRs, class A rhodopsin-like",Vercirnon,Blood
2261,HMDB0259832,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Vipadenant,Blood
2262,HMDB0259903,ESR1,,"WP170: Nuclear receptors; WP2034: Leptin signaling pathway; WP2586: Aryl hydrocarbon receptor pathway; WP2814: Mammary gland development pathway - Puberty (Stage 2 of 4); WP2817: Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4); WP2881: Estrogen receptor pathway; WP2882: Nuclear receptors meta-pathway; WP4262: Breast cancer pathway; WP4483: Relationship between inflammation, COX-2 and EGFR; WP4545: Oxysterols derived from cholesterol; WP4673: Male infertility; WP4949: 16p11.2 proximal deletion syndrome; WP5235: Estradiol regulation in porto-sinusoidal vascular disease; WP5269: Genetic causes of porto-sinusoidal vascular disease; WP5316: Primary ovarian insufficiency; WP5318: Female steroid hormones in cardiomyocyte energy metabolism; WP5345: 1p36 copy number variation syndrome; WP5368: Sulfatase and aromatase pathway; WP5434: Pathways in cancer; WP712: Estrogen signaling pathway",2-((3-Aminopropyl)amino)ethanethiol,Blood
2263,HMDB0259915,CHRM4,,"WP455: GPCRs, class A rhodopsin-like; WP51: Regulation of actin cytoskeleton; WP536: Calcium regulation in cardiac cells; WP58: Monoamine GPCRs",XANOMELINE,Blood
2264,HMDB0259918,ADORA2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3594: Circadian rhythm genes; WP3869: Cannabinoid receptor signaling; WP4222: Phosphodiesterases in neuronal function; WP455: GPCRs, class A rhodopsin-like; WP4900: Purinergic signaling; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP727: Monoamine transport; WP80: Nucleotide GPCRs",Xanthine amine congener,Blood
2265,HMDB0259992,AGTR1,,"WP2328: Allograft rejection; WP24: Peptide GPCRs; WP3668: Hypothesized pathways in pathogenesis of cardiovascular disease; WP4538: Regulatory circuits of the STAT3 signaling pathway; WP455: GPCRs, class A rhodopsin-like; WP4756: Renin-angiotensin-aldosterone system (RAAS); WP4799: Downregulation of ACE2 by SARS-CoV-2 spike protein; WP4883: SARS-CoV-2 and ACE2 receptor: molecular mechanisms; WP4969: RAS and bradykinin pathways in COVID-19; WP5036: Angiotensin II receptor type 1 pathway; WP5038: Mitochondrial immune response to SARS-CoV-2; WP5076: Soluble ACE2-mediated cell entry of SARS-CoV-2; WP5133: Non-classical role of vitamin D; WP5158: Urotensin-II-mediated signaling pathway; WP5356: Affected pathways in Duchenne muscular dystrophy; WP5360: KCNQ2-related epilepsies; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP5434: Pathways in cancer; WP554: ACE inhibitor pathway",ZD-7155,Blood
2266,HMDB0260049,HTR2A,,"WP117: GPCRs, other; WP3591: Sleep regulation; WP3944: Serotonin and anxiety-related events; WP3947: Serotonin and anxiety; WP455: GPCRs, class A rhodopsin-like; WP5420: ADHD and autism (ASD) linked metabolic pathways and SNP; WP58: Monoamine GPCRs; WP706: Sudden infant death syndrome (SIDS) susceptibility pathways; WP722: Serotonin HTR1 group and FOS pathway; WP732: Serotonin receptor 2 and ELK-SRF/GATA4 signaling",zotepine,Blood
2267,HMDB0260356,RXRA,,"WP1531: Vitamin D metabolism; WP1541: Energy metabolism; WP170: Nuclear receptors; WP236: Adipogenesis; WP2874: Liver X receptor pathway; WP2875: Constitutive androstane receptor pathway; WP2876: Pregnane X receptor pathway; WP2877: Vitamin D receptor pathway; WP2878: PPAR-alpha pathway; WP2879: Farnesoid X receptor pathway; WP2880: Glucocorticoid receptor pathway; WP2882: Nuclear receptors meta-pathway; WP2884: NRF2 pathway; WP3599: Transcription factor regulation in adipogenesis; WP3915: Angiopoietin-like protein 8 regulatory pathway; WP3942: PPAR signaling pathway; WP3995: Prion disease pathway; WP4141: PI3K/AKT/mTOR - vitamin D3 signaling; WP4255: Non-small cell lung cancer; WP4341: Non-genomic actions of 1,25 dihydroxyvitamin D3; WP4342: Vitamins A and D - action mechanisms; WP4396: Nonalcoholic fatty liver disease; WP4482: Vitamin D in inflammatory diseases; WP4658: Small cell lung cancer; WP4698: Vitamin D-sensitive calcium signaling in depression; WP4746: Thyroid hormones production and peripheral downstream signaling effects; WP5113: Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway; WP5130: Th17 cell differentiation pathway; WP5238: Cholestasis; WP5351: Kleefstra syndrome; WP5397: Vitamin A1 and A5/X pathways; WP5434: Pathways in cancer; WP716: Vitamin A and carotenoid metabolism",6-[Ethyl-(3-isobutoxy-4-isopropylphenyl)amino]nicotinic acid,Blood
